<!DOCTYPE html><html lang="en" class="bg-surface-base antialiased"><head><meta charSet="utf-8"/><meta name="viewport" content="width=device-width, initial-scale=1, interactive-widget=resizes-content"/><link rel="stylesheet" href="/_next/static/css/62c4caba71dfda84.css" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/eb3d87f98fe1565f.css" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/1b5e561215938d4d.css" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/0227d069a630d414.css" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm" data-precedence="next"/><link rel="stylesheet" href="/_next/static/css/f87fff2ab93d05a7.css" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm" data-precedence="next"/><link rel="preload" as="script" fetchPriority="low" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm" href="/_next/static/chunks/webpack-e121ed42680f327e.js"/><script src="/_next/static/chunks/78a669d9-e7993486b22c4915.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/40c4a5a7-abdabb07419d1cfc.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/2230-f7c87dc9fa57c408.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/main-app-536d4b8fca62396a.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/63f0ec43-8ee6a76d70472249.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/7670-7326298c9856172b.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/282-691fffb366e24ca5.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/7515-336759ef5dad2b52.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/927-34e2a6da3e15e26b.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/5855-243eeca8f0e4cabd.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/4393-1c8dff25ec904469.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/2225-454cf9f44775e7ce.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/7618-43536a8fb0dd3bfe.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/7720-3a1e7e411adba2d3.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/7086-1f1c4891d766e04f.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/app/global-error-4d07d20223cd4b4c.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/8208b75a-a48e5a4507a0de91.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/5497-ab85ef3ea59dd353.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/6281-c6e84786dade3614.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/2660-d983a7f287e89f18.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/5002-9735c25beda556ba.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/3655-6717081f7512305a.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/8945-e4e3cf487f5e27c7.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/9214-a10614844a67ba31.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/4789-2080f6497f78b5b6.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/app/layout-226f2bd71acf9f9e.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/24cf1b50-159cca90b09285e0.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/9ffa21ba-c069766d809bd4c7.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/600-9a9fcafaaa6c1c4c.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/5448-2a3cfd853d899c9a.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/8-8ca70ca619d8e099.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/app/error-4a29e9399afba038.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><script src="/_next/static/chunks/app/not-found-dd95690acf732f18.js" async="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script><meta name="next-size-adjust" content=""/><title>Grokipedia</title><meta name="description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><link rel="icon" type="image/x-icon" href="/favicon.ico" sizes="48x48"/><link rel="icon" href="/images/icon-dark.png" media="(prefers-color-scheme: light)" type="image/png"/><link rel="icon" href="/images/icon-light.png" media="(prefers-color-scheme: dark)" type="image/png"/><link rel="apple-touch-icon" href="/icon-192x192.png"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><meta property="og:title" content="Grokipedia"/><meta property="og:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta property="og:url" content="https://grokipedia.com"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en_US"/><meta property="og:type" content="website"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Grokipedia"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Grokipedia"/><meta name="twitter:description" content="Grokipedia is an open source, comprehensive collection of all knowledge."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><title>Cytokine</title><meta name="description" content="Cytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis. Produced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which..."/><meta name="author" content="system"/><link rel="manifest" href="/manifest.webmanifest"/><meta name="robots" content="index, follow"/><meta name="googlebot" content="index, follow, max-snippet:-1"/><link rel="canonical" href="https://grokipedia.com/page/Cytokine"/><meta property="og:title" content="Cytokine"/><meta property="og:description" content="Cytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis. Produced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which..."/><meta property="og:url" content="https://grokipedia.com/page/Cytokine"/><meta property="og:site_name" content="Grokipedia"/><meta property="og:locale" content="en"/><meta property="og:image" content="https://grokipedia.com/icon-512x512.png"/><meta property="og:image:width" content="512"/><meta property="og:image:height" content="512"/><meta property="og:image:alt" content="Cytokine"/><meta property="og:type" content="article"/><meta property="article:modified_time" content="1970-01-21T09:19:44.844Z"/><meta name="twitter:card" content="summary"/><meta name="twitter:creator" content="@Grokipedia"/><meta name="twitter:title" content="Cytokine"/><meta name="twitter:description" content="Cytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis. Produced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which..."/><meta name="twitter:image" content="https://grokipedia.com/icon-512x512.png"/><link rel="icon" href="/favicon.ico" type="image/x-icon" sizes="16x16"/><meta name="sentry-trace" content="8009b8b3a89d47093572ec3bf08468da-ea1631fc3f1db3d2-1"/><meta name="baggage" content="sentry-environment=production,sentry-public_key=5f2258f71198ee26a355127af230c3a6,sentry-trace_id=8009b8b3a89d47093572ec3bf08468da,sentry-org_id=4508179396558848,sentry-transaction=GET%20%2Fpage%2F%5Bslug%5D,sentry-sampled=true,sentry-sample_rand=0.9217133736302576,sentry-sample_rate=1"/><script src="/_next/static/chunks/polyfills-42372ed130431b0a.js" noModule="" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm"></script></head><body class="flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b"><div hidden=""><!--$--><!--/$--></div><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">((a,b,c,d,e,f,g,h)=>{let i=document.documentElement,j=["light","dark"];function k(b){var c;(Array.isArray(a)?a:[a]).forEach(a=>{let c="class"===a,d=c&&f?e.map(a=>f[a]||a):e;c?(i.classList.remove(...d),i.classList.add(f&&f[b]?f[b]:b)):i.setAttribute(a,b)}),c=b,h&&j.includes(c)&&(i.style.colorScheme=c)}if(d)k(d);else try{let a=localStorage.getItem(b)||c,d=g&&"system"===a?window.matchMedia("(prefers-color-scheme: dark)").matches?"dark":"light":a;k(d)}catch(a){}})("class","theme","dark",null,["light","dark"],null,true,true)</script><header class="h-16 bg-surface-base fixed top-0 z-50 w-full"><div class="hidden h-full grid-cols-[1fr_3fr_1fr] items-center gap-4 !py-0 md:grid max-w-full py-6 px-4 w-full mx-auto"><div class="-ml-2 justify-self-start"><a class="cursor-pointer" href="/"><svg width="200" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="mx-auto flex w-full"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full px-3 shadow-none sm:w-80 focus-visible:z-1 mx-auto h-full w-full rounded-full bg-surface-l1" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div><div class="flex items-center gap-2 justify-self-end"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0" type="button" id="radix-_R_7apfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button></div></div><div class="flex h-full items-center md:hidden justify-between max-w-full py-6 px-4 w-full mx-auto pt-8"><div class="flex items-center"><div class="-ml-2"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button" aria-label="Toggle table of contents"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-list h-6 w-6"><path d="M3 12h.01"></path><path d="M3 18h.01"></path><path d="M3 6h.01"></path><path d="M8 12h13"></path><path d="M8 18h13"></path><path d="M8 6h13"></path></svg></button></div><a class="cursor-pointer" href="/"><svg width="160" height="auto" viewBox="0 0 955 225" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M99.6937 159.214C90.008 159.214 81.5652 157.414 74.3652 153.814C67.1652 150.214 61.5509 144.986 57.5223 138.129C53.5794 131.271 51.608 123.043 51.608 113.443C51.608 103.843 53.5794 95.4857 57.5223 88.3714C61.5509 81.2572 67.1652 75.7286 74.3652 71.7857C81.6509 67.8429 90.1794 65.8714 99.9509 65.8714C103.208 65.8714 106.679 66.1286 110.365 66.6429C114.051 67.0714 117.222 67.6714 119.879 68.4429C121.508 68.8714 123.008 69.2572 124.379 69.6C125.751 69.9429 127.122 70.1143 128.494 70.1143C129.522 70.1143 130.551 69.9857 131.579 69.7286C131.751 73.5 131.922 77.4 132.094 81.4286C132.265 85.4572 132.522 89.6572 132.865 94.0286C131.065 94.2857 129.565 94.3714 128.365 94.2857C126.651 86.4 123.522 80.5714 118.979 76.8C114.437 72.9429 108.394 71.0143 100.851 71.0143C94.8509 71.0143 89.708 72.1286 85.4223 74.3572C81.2223 76.5 77.7937 79.4572 75.1366 83.2286C72.5652 87 70.6794 91.3714 69.4794 96.3429C68.2794 101.229 67.6794 106.457 67.6794 112.029C67.6794 120.171 68.9223 127.371 71.408 133.629C73.8937 139.886 77.6652 144.814 82.7223 148.414C87.8652 151.929 94.2937 153.686 102.008 153.686C104.408 153.686 107.065 153.471 109.979 153.043C112.894 152.529 115.679 151.757 118.337 150.729V134.529C118.337 131.871 118.208 129.814 117.951 128.357C117.779 126.814 117.222 125.7 116.279 125.014C115.422 124.329 114.008 123.857 112.037 123.6C110.151 123.257 107.537 122.957 104.194 122.7C103.937 121.329 103.937 119.957 104.194 118.586C105.994 118.586 108.179 118.629 110.751 118.714C113.322 118.714 115.894 118.757 118.465 118.843C121.122 118.843 123.308 118.843 125.022 118.843C127.679 118.843 130.722 118.8 134.151 118.714C137.665 118.629 140.665 118.586 143.151 118.586C143.322 119.871 143.322 121.2 143.151 122.571C139.637 123 137.108 123.429 135.565 123.857C134.022 124.286 133.079 125.143 132.737 126.429C132.394 127.714 132.222 129.9 132.222 132.986V137.1C132.222 141.129 132.308 144.514 132.479 147.257C132.737 150 132.951 151.971 133.122 153.171C121.208 157.2 110.065 159.214 99.6937 159.214ZM148.19 157.414C147.933 156.043 147.933 154.714 148.19 153.429C151.105 153.257 153.248 153 154.619 152.657C155.99 152.229 156.89 151.371 157.319 150.086C157.748 148.8 157.962 146.743 157.962 143.914V115.114C157.962 111.771 157.79 109.286 157.448 107.657C157.19 106.029 156.376 104.914 155.005 104.314C153.719 103.629 151.49 103.071 148.319 102.643C148.062 101.443 148.062 100.329 148.319 99.3C151.748 98.6143 155.09 97.8429 158.348 96.9857C161.605 96.0429 165.033 94.8429 168.633 93.3857L170.819 94.1572V105.471C176.819 97.8429 182.948 94.0286 189.205 94.0286C192.205 94.0286 194.433 94.8429 195.89 96.4714C197.348 98.0143 198.076 99.7714 198.076 101.743C198.076 104.057 197.305 105.857 195.762 107.143C194.219 108.343 192.462 108.943 190.49 108.943C188.862 108.943 187.233 108.514 185.605 107.657C184.062 106.8 182.905 105.471 182.133 103.671C179.219 103.671 176.605 104.829 174.29 107.143C172.062 109.371 170.948 111.986 170.948 114.986V142.629C170.948 145.971 171.119 148.371 171.462 149.829C171.89 151.286 172.919 152.229 174.548 152.657C176.262 153 179.005 153.257 182.776 153.429C182.948 154.629 182.948 155.957 182.776 157.414C179.862 157.414 176.862 157.371 173.776 157.286C170.69 157.2 167.519 157.157 164.262 157.157C161.09 157.157 158.262 157.2 155.776 157.286C153.376 157.371 150.848 157.414 148.19 157.414ZM229.285 158.829C223.028 158.829 217.542 157.5 212.828 154.843C208.199 152.1 204.599 148.371 202.028 143.657C199.457 138.857 198.171 133.371 198.171 127.2C198.171 120.514 199.499 114.686 202.157 109.714C204.899 104.743 208.714 100.886 213.599 98.1429C218.485 95.4 224.099 94.0286 230.442 94.0286C236.699 94.0286 242.142 95.4 246.771 98.1429C251.399 100.886 254.999 104.657 257.571 109.457C260.142 114.257 261.428 119.7 261.428 125.786C261.428 132.043 260.057 137.7 257.314 142.757C254.657 147.729 250.928 151.671 246.128 154.586C241.328 157.414 235.714 158.829 229.285 158.829ZM212.699 125.657C212.699 134.4 214.114 141.343 216.942 146.486C219.857 151.543 224.185 154.071 229.928 154.071C235.414 154.071 239.614 151.671 242.528 146.871C245.442 141.986 246.899 135.471 246.899 127.329C246.899 118.671 245.442 111.771 242.528 106.629C239.614 101.486 235.371 98.9143 229.799 98.9143C224.314 98.9143 220.071 101.271 217.071 105.986C214.157 110.7 212.699 117.257 212.699 125.657ZM267.394 157.414C267.308 157.071 267.265 156.729 267.265 156.386C267.265 156.043 267.265 155.7 267.265 155.357C267.265 155.014 267.265 154.714 267.265 154.457C267.265 154.114 267.308 153.771 267.394 153.429C270.308 153.257 272.451 153 273.822 152.657C275.194 152.229 276.094 151.371 276.522 150.086C276.951 148.8 277.165 146.743 277.165 143.914V79.5C277.165 76.8429 276.908 74.8714 276.394 73.5857C275.965 72.2143 274.979 71.2714 273.437 70.7572C271.979 70.1572 269.751 69.7286 266.751 69.4714C266.665 69.1286 266.622 68.8286 266.622 68.5714C266.622 68.3143 266.622 68.0572 266.622 67.8C266.622 67.4572 266.622 67.1572 266.622 66.9C266.622 66.6429 266.665 66.3429 266.751 66C270.179 65.5714 273.694 64.9286 277.294 64.0714C280.894 63.1286 284.579 61.8429 288.351 60.2143L290.537 60.9857C290.451 62.8714 290.365 65.0143 290.279 67.4143C290.279 69.8143 290.279 72.4286 290.279 75.2572V122.957C291.308 122.957 292.165 122.786 292.851 122.443C293.537 122.1 294.094 121.757 294.522 121.414C294.694 121.243 295.037 120.943 295.551 120.514C296.065 120 296.965 119.1 298.251 117.814C299.537 116.529 301.379 114.6 303.779 112.029C306.008 109.543 307.765 107.614 309.051 106.243C310.422 104.786 311.108 103.586 311.108 102.643C311.108 101.957 310.508 101.4 309.308 100.971C308.194 100.457 306.651 100.157 304.679 100.071C304.594 99.7286 304.551 99.3857 304.551 99.0429C304.551 98.7 304.551 98.3572 304.551 98.0143C304.551 97.6714 304.551 97.3286 304.551 96.9857C304.551 96.6429 304.594 96.3 304.679 95.9572C306.394 95.9572 308.537 96 311.108 96.0857C313.765 96.1714 316.122 96.2143 318.179 96.2143C319.208 96.2143 320.665 96.2143 322.551 96.2143C324.522 96.1286 326.494 96.0857 328.465 96.0857C330.437 96.0857 331.894 96.0857 332.837 96.0857C332.922 96.4286 332.965 96.7714 332.965 97.1143C333.051 97.4572 333.094 97.8 333.094 98.1429C333.094 98.4857 333.051 98.8286 332.965 99.1714C332.965 99.4286 332.922 99.7286 332.837 100.071C328.379 100.157 324.608 101.271 321.522 103.414C318.437 105.471 315.479 107.914 312.651 110.743L303.394 120L321.137 143.4C323.022 145.886 324.565 147.857 325.765 149.314C327.051 150.686 328.422 151.671 329.879 152.271C331.337 152.871 333.351 153.257 335.922 153.429C336.094 154.629 336.094 155.957 335.922 157.414C334.808 157.414 333.137 157.371 330.908 157.286C328.765 157.2 325.379 157.157 320.751 157.157C320.065 157.157 319.037 157.157 317.665 157.157C316.294 157.157 315.008 157.243 313.808 157.414C313.808 156.471 313.294 155.186 312.265 153.557C311.237 151.843 310.422 150.6 309.822 149.829C309.565 149.4 308.922 148.5 307.894 147.129C306.865 145.671 305.622 144 304.165 142.114C302.794 140.143 301.379 138.171 299.922 136.2C298.465 134.143 297.137 132.343 295.937 130.8C294.994 129.514 294.094 128.529 293.237 127.843C292.465 127.071 291.479 126.686 290.279 126.686V142.629C290.279 145.971 290.408 148.371 290.665 149.829C291.008 151.286 291.737 152.229 292.851 152.657C294.051 153 295.851 153.257 298.251 153.429C298.422 154.714 298.422 156.043 298.251 157.414C296.022 157.414 293.665 157.371 291.179 157.286C288.779 157.2 286.165 157.157 283.337 157.157C280.594 157.157 277.894 157.2 275.237 157.286C272.579 157.371 269.965 157.414 267.394 157.414ZM369.34 157.414C366.94 157.414 364.454 157.371 361.883 157.286C359.311 157.2 356.526 157.157 353.526 157.157C350.783 157.157 347.997 157.2 345.169 157.286C342.426 157.371 339.769 157.414 337.197 157.414C336.94 156.043 336.94 154.714 337.197 153.429C340.111 153.257 342.254 153 343.626 152.657C344.997 152.229 345.897 151.371 346.326 150.086C346.754 148.8 346.969 146.743 346.969 143.914V115.114C346.969 111.771 346.84 109.286 346.583 107.657C346.326 106.029 345.511 104.914 344.14 104.314C342.854 103.629 340.583 103.071 337.326 102.643C337.069 101.443 337.069 100.329 337.326 99.3C341.097 98.6143 344.697 97.7572 348.126 96.7286C351.554 95.7 354.854 94.5857 358.026 93.3857L360.211 94.1572C360.126 96.8143 360.04 99.3 359.954 101.614C359.954 103.929 359.954 106.114 359.954 108.171V142.629C359.954 145.971 360.126 148.371 360.469 149.829C360.897 151.286 361.754 152.229 363.04 152.657C364.411 153 366.511 153.257 369.34 153.429C369.597 154.714 369.597 156.043 369.34 157.414ZM343.626 71.5286C343.626 69.0429 344.483 66.9429 346.197 65.2286C347.997 63.5143 350.14 62.6572 352.626 62.6572C355.026 62.6572 357.083 63.5143 358.797 65.2286C360.597 66.9429 361.497 69 361.497 71.4C361.497 73.6286 360.64 75.6857 358.926 77.5715C357.211 79.3714 355.026 80.2714 352.369 80.2714C349.969 80.2714 347.911 79.4143 346.197 77.7C344.483 75.9857 343.626 73.9286 343.626 71.5286ZM372.678 188.914C372.592 187.543 372.592 186.214 372.678 184.929C375.678 184.757 377.864 184.457 379.235 184.029C380.607 183.6 381.464 182.743 381.807 181.457C382.235 180.257 382.45 178.286 382.45 175.543V115.114C382.45 111.771 382.278 109.286 381.935 107.657C381.678 106.029 380.864 104.914 379.492 104.314C378.207 103.629 375.978 103.071 372.807 102.643C372.635 101.443 372.635 100.329 372.807 99.3C376.321 98.6143 379.75 97.8 383.092 96.8572C386.435 95.9143 389.907 94.7572 393.507 93.3857L395.307 94.2857C395.221 96.4286 395.178 98.2714 395.178 99.8143C395.178 101.271 395.178 102.686 395.178 104.057C398.521 100.543 401.821 98.0143 405.078 96.4714C408.335 94.8429 411.807 94.0286 415.492 94.0286C420.892 94.0286 425.435 95.4429 429.121 98.2714C432.892 101.1 435.764 104.786 437.735 109.329C439.707 113.871 440.692 118.8 440.692 124.114C440.692 130.371 439.321 136.157 436.578 141.471C433.921 146.7 430.192 150.9 425.392 154.071C420.592 157.243 415.021 158.829 408.678 158.829C406.192 158.829 403.835 158.614 401.607 158.186C399.378 157.843 397.278 157.329 395.307 156.643V174C395.307 177.343 395.564 179.743 396.078 181.2C396.592 182.657 397.707 183.557 399.421 183.9C401.135 184.329 403.835 184.629 407.521 184.8C407.607 186.171 407.607 187.543 407.521 188.914C404.607 188.914 401.65 188.871 398.65 188.786C395.735 188.7 392.521 188.657 389.007 188.657C385.664 188.657 382.792 188.7 380.392 188.786C377.992 188.871 375.421 188.914 372.678 188.914ZM395.178 146.1C398.864 151.414 403.75 154.071 409.835 154.071C414.121 154.071 417.507 152.871 419.992 150.471C422.564 148.071 424.407 144.943 425.521 141.086C426.721 137.229 427.321 133.157 427.321 128.871C427.321 124.586 426.764 120.386 425.65 116.271C424.535 112.157 422.692 108.771 420.121 106.114C417.635 103.371 414.207 102 409.835 102C404.607 102 399.721 104.529 395.178 109.586V146.1ZM477.335 158.829C471.25 158.829 466.107 157.414 461.907 154.586C457.707 151.757 454.493 147.986 452.264 143.271C450.121 138.471 449.05 133.2 449.05 127.457C449.05 121.543 450.164 116.057 452.393 111C454.707 105.943 458.05 101.871 462.421 98.7857C466.793 95.6143 472.107 94.0286 478.364 94.0286C485.907 94.0286 491.778 96.3 495.978 100.843C500.264 105.3 502.407 111.086 502.407 118.2C502.407 119.057 502.364 119.829 502.278 120.514C502.278 121.114 502.235 121.629 502.15 122.057L461.65 121.671C461.65 122.014 461.65 122.314 461.65 122.571C461.65 130.971 463.578 137.571 467.435 142.371C471.293 147.171 476.693 149.571 483.635 149.571C489.464 149.571 495.207 147.686 500.864 143.914C501.721 144.943 502.364 145.929 502.793 146.871C495.507 154.843 487.021 158.829 477.335 158.829ZM462.035 116.914L488.65 116.4C488.735 116.229 488.778 116.014 488.778 115.757C488.778 115.414 488.778 115.2 488.778 115.114C488.778 110.486 487.75 106.629 485.693 103.543C483.721 100.457 480.764 98.9143 476.821 98.9143C473.135 98.9143 469.921 100.414 467.178 103.414C464.435 106.414 462.721 110.914 462.035 116.914ZM559.644 158.957L557.587 158.057L557.073 149.186C554.073 152.443 550.987 154.886 547.816 156.514C544.73 158.057 541.302 158.829 537.53 158.829C532.216 158.829 527.544 157.414 523.516 154.586C519.573 151.671 516.53 147.9 514.387 143.271C512.244 138.643 511.173 133.629 511.173 128.229C511.173 121.971 512.502 116.271 515.159 111.129C517.902 105.986 521.716 101.871 526.602 98.7857C531.573 95.6143 537.359 94.0286 543.959 94.0286C545.93 94.0286 547.987 94.2 550.13 94.5429C552.273 94.8 554.502 95.2714 556.816 95.9572V79.5C556.816 76.8429 556.559 74.8714 556.044 73.5857C555.53 72.2143 554.502 71.2714 552.959 70.7572C551.502 70.1572 549.273 69.7286 546.273 69.4714C546.016 68.3572 546.016 67.2 546.273 66C549.702 65.5714 553.216 64.9286 556.816 64.0714C560.416 63.1286 564.102 61.8429 567.873 60.2143L570.059 60.9857C569.973 62.8714 569.887 65.0143 569.802 67.4143C569.802 69.8143 569.802 72.4286 569.802 75.2572V139.029C569.802 142.286 569.93 144.729 570.187 146.357C570.445 147.986 571.216 149.143 572.502 149.829C573.787 150.429 575.973 150.986 579.059 151.5C579.316 152.614 579.316 153.771 579.059 154.971C575.63 155.486 572.287 156.043 569.03 156.643C565.773 157.243 562.644 158.014 559.644 158.957ZM556.944 106.886C553.259 101.829 548.416 99.3 542.416 99.3C536.502 99.3 532.044 101.486 529.044 105.857C526.044 110.143 524.544 116.1 524.544 123.729C524.544 128.186 525.144 132.471 526.344 136.586C527.544 140.7 529.516 144.086 532.259 146.743C535.002 149.4 538.644 150.729 543.187 150.729C548.93 150.729 553.516 148.243 556.944 143.271V106.886ZM615.699 157.414C613.299 157.414 610.813 157.371 608.242 157.286C605.67 157.2 602.885 157.157 599.885 157.157C597.142 157.157 594.356 157.2 591.527 157.286C588.785 157.371 586.127 157.414 583.556 157.414C583.299 156.043 583.299 154.714 583.556 153.429C586.47 153.257 588.613 153 589.985 152.657C591.356 152.229 592.256 151.371 592.685 150.086C593.113 148.8 593.327 146.743 593.327 143.914V115.114C593.327 111.771 593.199 109.286 592.942 107.657C592.685 106.029 591.87 104.914 590.499 104.314C589.213 103.629 586.942 103.071 583.685 102.643C583.427 101.443 583.427 100.329 583.685 99.3C587.456 98.6143 591.056 97.7572 594.485 96.7286C597.913 95.7 601.213 94.5857 604.385 93.3857L606.57 94.1572C606.485 96.8143 606.399 99.3 606.313 101.614C606.313 103.929 606.313 106.114 606.313 108.171V142.629C606.313 145.971 606.485 148.371 606.827 149.829C607.256 151.286 608.113 152.229 609.399 152.657C610.77 153 612.87 153.257 615.699 153.429C615.956 154.714 615.956 156.043 615.699 157.414ZM589.985 71.5286C589.985 69.0429 590.842 66.9429 592.556 65.2286C594.356 63.5143 596.499 62.6572 598.985 62.6572C601.385 62.6572 603.442 63.5143 605.156 65.2286C606.956 66.9429 607.856 69 607.856 71.4C607.856 73.6286 606.999 75.6857 605.285 77.5715C603.57 79.3714 601.385 80.2714 598.727 80.2714C596.327 80.2714 594.27 79.4143 592.556 77.7C590.842 75.9857 589.985 73.9286 589.985 71.5286ZM665.837 158.571C660.18 158.571 656.623 155.743 655.165 150.086C649.08 155.914 642.865 158.829 636.523 158.829C632.151 158.829 628.423 157.543 625.337 154.971C622.337 152.314 620.837 148.671 620.837 144.043C620.837 132.729 632.365 125.614 655.423 122.7C655.423 120.643 655.423 118.543 655.423 116.4C655.508 114.257 655.551 111.986 655.551 109.586C655.551 106.586 654.437 104.271 652.208 102.643C650.065 100.929 647.451 100.071 644.365 100.071C642.137 100.071 640.251 100.414 638.708 101.1C638.708 103.071 638.28 105.086 637.423 107.143C636.565 109.2 635.365 110.957 633.823 112.414C632.365 113.786 630.565 114.471 628.423 114.471C626.537 114.471 625.037 113.957 623.923 112.929C622.894 111.814 622.38 110.486 622.38 108.943C622.38 106.886 623.323 104.957 625.208 103.157C627.18 101.271 629.665 99.6857 632.665 98.4C635.665 97.0286 638.794 95.9572 642.051 95.1857C645.308 94.4143 648.223 94.0286 650.794 94.0286C653.965 94.0286 656.88 94.6286 659.537 95.8286C662.28 96.9429 664.465 98.6572 666.094 100.971C667.808 103.2 668.665 105.986 668.665 109.329C668.665 111.386 668.623 114.086 668.537 117.429C668.451 120.686 668.365 124.2 668.28 127.971C668.28 131.657 668.237 135.171 668.151 138.514C668.065 141.857 668.023 144.557 668.023 146.614C668.023 149.357 669.223 150.729 671.623 150.729C673.165 150.729 675.523 150.214 678.694 149.186C679.037 149.614 679.251 150.086 679.337 150.6C679.508 151.114 679.637 151.586 679.723 152.014C677.58 154.329 675.308 156 672.908 157.029C670.594 158.057 668.237 158.571 665.837 158.571ZM655.165 146.614L655.423 127.329C647.537 128.357 642.094 130.029 639.094 132.343C636.18 134.657 634.723 137.614 634.723 141.214C634.723 144.214 635.494 146.529 637.037 148.157C638.665 149.7 640.68 150.471 643.08 150.471C644.623 150.471 646.337 150.129 648.223 149.443C650.194 148.757 652.508 147.814 655.165 146.614Z" fill="currentColor"></path><rect x="715" y="65" width="195" height="105" rx="52.5" fill="currentColor" fill-opacity="0.05"></rect><path d="M767.529 142.875L754.049 107.938H762.552L769.309 127.582C769.705 128.812 770.078 130.032 770.43 131.24C770.781 132.449 771.078 133.559 771.32 134.569H771.616C771.858 133.559 772.144 132.449 772.473 131.24C772.825 130.032 773.198 128.812 773.594 127.582L780.186 107.938H788.689L775.472 142.875H767.529ZM810.856 143.633C806.901 143.633 803.528 142.71 800.737 140.865C797.969 138.997 795.871 136.305 794.442 132.79C793.014 129.252 792.3 124.989 792.3 120.001V118.255C792.3 113.245 793.014 108.982 794.442 105.467C795.871 101.929 797.969 99.2373 800.737 97.3916C803.528 95.5239 806.901 94.5901 810.856 94.5901C814.789 94.5901 818.129 95.5129 820.875 97.3586C823.644 99.2043 825.731 101.907 827.138 105.467C828.566 109.004 829.28 113.267 829.28 118.255V120.001C829.28 124.989 828.577 129.252 827.171 132.79C825.764 136.327 823.677 139.019 820.908 140.865C818.162 142.71 814.811 143.633 810.856 143.633ZM810.889 136.382C813.064 136.382 814.877 135.789 816.327 134.602C817.799 133.416 818.898 131.658 819.623 129.329C820.348 126.978 820.711 124.066 820.711 120.595V117.694C820.711 114.223 820.337 111.311 819.59 108.96C818.865 106.609 817.777 104.84 816.327 103.654C814.877 102.445 813.064 101.841 810.889 101.841C808.714 101.841 806.879 102.434 805.385 103.621C803.912 104.785 802.792 106.554 802.023 108.927C801.276 111.278 800.902 114.201 800.902 117.694V120.595C800.902 124.044 801.287 126.945 802.056 129.296C802.825 131.647 803.945 133.416 805.418 134.602C806.89 135.789 808.714 136.382 810.889 136.382ZM838.988 143.205C838 143.205 837.099 142.985 836.286 142.545C835.495 142.106 834.879 141.491 834.44 140.7C834.001 139.909 833.781 139.019 833.781 138.03C833.781 137.019 834.001 136.118 834.44 135.327C834.879 134.536 835.495 133.921 836.286 133.482C837.099 133.042 838 132.823 838.988 132.823C839.977 132.823 840.867 133.042 841.658 133.482C842.449 133.921 843.064 134.536 843.504 135.327C843.943 136.118 844.163 137.019 844.163 138.03C844.163 139.019 843.943 139.909 843.504 140.7C843.064 141.491 842.449 142.106 841.658 142.545C840.867 142.985 839.977 143.205 838.988 143.205ZM857.365 142.875V104.511L846.39 111.663V103.357L858.453 95.3481H865.802V142.875H857.365Z" fill="currentColor"></path></svg></a></div><div class="flex items-center gap-1"><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover px-4 py-2 w-9 h-9 flex-shrink-0 [&amp;_svg]:!w-5" type="button" id="radix-_R_aipfiumdb_" aria-haspopup="menu" aria-expanded="false" data-state="closed"><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 rotate-0 scale-100 transition-all dark:-rotate-90 dark:scale-0" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M12 18a6 6 0 1 1 0-12 6 6 0 0 1 0 12m0-2a4 4 0 1 0 0-8 4 4 0 0 0 0 8M11 1h2v3h-2zm0 19h2v3h-2zM3.515 4.929l1.414-1.414L7.05 5.636 5.636 7.05zM16.95 18.364l1.414-1.414 2.121 2.121-1.414 1.414zm2.121-14.85 1.414 1.415-2.121 2.121-1.414-1.414zM5.636 16.95l1.414 1.414-2.121 2.121-1.414-1.414zM23 11v2h-3v-2zM4 11v2H1v-2z"></path></svg></span><span class="inline-flex items-center justify-center p-0 m-0 w-6 h-6 absolute rotate-90 scale-0 transition-all dark:rotate-0 dark:scale-100" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-6 h-6" focusable="false" style="fill:currentColor"><path d="M10 7a7 7 0 0 0 12 4.9v.1c0 5.523-4.477 10-10 10S2 17.523 2 12 6.477 2 12 2h.1A6.98 6.98 0 0 0 10 7m-6 5a8 8 0 0 0 15.062 3.762A9 9 0 0 1 8.238 4.938 8 8 0 0 0 4 12"></path></svg></span><span class="sr-only">Toggle theme</span></button><button class="focus-visible:ring-ring inline-flex items-center justify-center gap-x-2 whitespace-nowrap rounded-full text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary hover:bg-overlay-hover h-9 w-9" type="button"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-search h-5 w-5"><circle cx="11" cy="11" r="8"></circle><path d="m21 21-4.3-4.3"></path></svg></button></div></div></header><div class="bg-surface-base fixed right-0 top-16 z-50 h-[calc(100vh-4rem)] w-full transform border-l transition-transform duration-300 ease-in-out sm:w-1/2 md:hidden translate-x-full"><div class="flex flex-col gap-4 p-4"><div class="flex flex-row gap-2"><button class="focus-visible:ring-ring inline-flex items-center gap-x-2 whitespace-nowrap text-sm font-medium transition-colors focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 border-input text-primary hover:border-primary/15 border hover:bg-overlay-hover py-2 max-w-full shadow-none sm:w-80 h-10 w-full justify-start rounded-full bg-surface-l1 px-4" type="button"><div class="flex items-center justify-between sm:w-full gap-4"><div class="flex items-center justify-start gap-2"><span class="inline-flex items-center justify-center p-0 m-0 w-4 h-4 text-muted" data-namespace="@xai/icons" data-slot="icon"><svg xmlns="http://www.w3.org/2000/svg" fill="currentColor" viewBox="0 0 24 24" aria-hidden="true" class="w-4 h-4" focusable="false" style="fill:currentColor"><path d="m18.031 16.617 4.283 4.282-1.415 1.415-4.282-4.283A8.96 8.96 0 0 1 11 20c-4.968 0-9-4.032-9-9s4.032-9 9-9 9 4.032 9 9a8.96 8.96 0 0 1-1.969 5.617m-2.006-.742A6.98 6.98 0 0 0 18 11c0-3.867-3.133-7-7-7s-7 3.133-7 7 3.133 7 7 7a6.98 6.98 0 0 0 4.875-1.975z"></path></svg></span><p class="text-sm text-muted hidden sm:block">Search</p></div><span class="hidden sm:block"><div class="bg-foreground/10 text-muted inline-flex items-center rounded-md px-1 py-0.5 text-center font-sans text-xs font-normal tracking-widest rtl:space-x-reverse"><span>âŒ˜</span><span class="text-xs">K</span></div></span></div></button></div></div></div><div><div class="min-[1350px]:grid min-[1350px]:grid-cols-[1fr_3fr_1fr]"><nav class="bg-surface-base hidden h-[calc(100vh-4rem)] overflow-y-auto px-6 pb-32 min-[1350px]:sticky min-[1350px]:top-16 min-[1350px]:block scrollbar-none [-ms-overflow-style:none] [scrollbar-width:none] [&amp;::-webkit-scrollbar]:hidden [overscroll-behavior:contain] pt-8"><ul class="space-y-2 text-sm"><li style="padding-left:0rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cytokine" class="transition-opacity hover:opacity-100 opacity-50">Cytokine</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#definition-and-characteristics" class="transition-opacity hover:opacity-100 opacity-50">Definition and Characteristics</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#core-definition-and-properties" class="transition-opacity hover:opacity-100 opacity-50">Core Definition and Properties</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pleiotropy-redundancy-and-antagonism" class="transition-opacity hover:opacity-100 opacity-50">Pleiotropy, Redundancy, and Antagonism</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#nomenclature-and-classification" class="transition-opacity hover:opacity-100 opacity-50">Nomenclature and Classification</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#terminology-evolution" class="transition-opacity hover:opacity-100 opacity-50">Terminology Evolution</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#structural-classification" class="transition-opacity hover:opacity-100 opacity-50">Structural Classification</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#functional-classification" class="transition-opacity hover:opacity-100 opacity-50">Functional Classification</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#distinctions-from-other-signaling-molecules" class="transition-opacity hover:opacity-100 opacity-50">Distinctions from Other Signaling Molecules</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#comparison-to-hormones" class="transition-opacity hover:opacity-100 opacity-50">Comparison to Hormones</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#comparison-to-chemokines-and-growth-factors" class="transition-opacity hover:opacity-100 opacity-50">Comparison to Chemokines and Growth Factors</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#molecular-mechanisms" class="transition-opacity hover:opacity-100 opacity-50">Molecular Mechanisms</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#receptors-and-binding-affinity" class="transition-opacity hover:opacity-100 opacity-50">Receptors and Binding Affinity</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#intracellular-signaling-pathways" class="transition-opacity hover:opacity-100 opacity-50">Intracellular Signaling Pathways</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#physiological-roles" class="transition-opacity hover:opacity-100 opacity-50">Physiological Roles</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#immune-regulation-and-defense" class="transition-opacity hover:opacity-100 opacity-50">Immune Regulation and Defense</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#developmental-and-homeostatic-functions" class="transition-opacity hover:opacity-100 opacity-50">Developmental and Homeostatic Functions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#tissue-repair-and-regeneration" class="transition-opacity hover:opacity-100 opacity-50">Tissue Repair and Regeneration</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pathological-roles" class="transition-opacity hover:opacity-100 opacity-50">Pathological Roles</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#acute-inflammation-and-infections" class="transition-opacity hover:opacity-100 opacity-50">Acute Inflammation and Infections</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#chronic-inflammation-and-autoimmunity" class="transition-opacity hover:opacity-100 opacity-50">Chronic Inflammation and Autoimmunity</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cancer-promotion-and-suppression" class="transition-opacity hover:opacity-100 opacity-50">Cancer Promotion and Suppression</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#neuroinflammation-and-behavioral-modulation" class="transition-opacity hover:opacity-100 opacity-50">Neuroinflammation and Behavioral Modulation</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#dysregulation-and-adverse-effects" class="transition-opacity hover:opacity-100 opacity-50">Dysregulation and Adverse Effects</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#cytokine-release-syndromes" class="transition-opacity hover:opacity-100 opacity-50">Cytokine Release Syndromes</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#inflammaging-and-age-related-decline" class="transition-opacity hover:opacity-100 opacity-50">Inflammaging and Age-Related Decline</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#fatigue-and-chronic-syndromes-empirical-evidence" class="transition-opacity hover:opacity-100 opacity-50">Fatigue and Chronic Syndromes: Empirical Evidence</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#therapeutic-applications" class="transition-opacity hover:opacity-100 opacity-50">Therapeutic Applications</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#pro-inflammatory-cytokine-therapies" class="transition-opacity hover:opacity-100 opacity-50">Pro-Inflammatory Cytokine Therapies</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#anti-cytokine-interventions" class="transition-opacity hover:opacity-100 opacity-50">Anti-Cytokine Interventions</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#engineering-and-next-generation-developments" class="transition-opacity hover:opacity-100 opacity-50">Engineering and Next-Generation Developments</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#historical-and-evolutionary-context" class="transition-opacity hover:opacity-100 opacity-50">Historical and Evolutionary Context</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#discovery-timeline" class="transition-opacity hover:opacity-100 opacity-50">Discovery Timeline</a></li><li style="padding-left:1.5rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#evolutionary-origins-and-first-principles-rationale" class="transition-opacity hover:opacity-100 opacity-50">Evolutionary Origins and First-Principles Rationale</a></li><li style="padding-left:0.75rem" class="flex items-start gap-2"><div class="bg-foreground mt-[0.5rem] h-1 w-1 flex-shrink-0 transition-opacity opacity-0"></div><a href="#references" class="transition-opacity hover:opacity-100 opacity-50">References</a></li></ul></nav><div class="relative top-16 pb-32 pt-8 px-4 md:px-8"><div class="mx-auto max-w-[850px]"><button data-state="closed" type="button" class="flex items-center"><div class="text-fg-tertiary mb-2 flex cursor-help items-center gap-2 text-sm"><span class="inline-flex items-center justify-center p-0 m-0" data-namespace="@xai/icons" data-slot="icon" style="height:16px;width:16px"><svg xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 33 33" aria-hidden="true" class="" focusable="false" style="fill:currentColor;height:16px;width:16px"><path fill="currentColor" d="m13.237 21.04 11.082-8.19c.543-.4 1.32-.244 1.578.38 1.363 3.288.754 7.241-1.957 9.955-2.71 2.714-6.482 3.31-9.93 1.954l-3.765 1.745c5.401 3.697 11.96 2.782 16.059-1.324 3.251-3.255 4.258-7.692 3.317-11.693l.008.009c-1.365-5.878.336-8.227 3.82-13.031q.123-.17.247-.345l-4.585 4.59v-.014L13.234 21.044M10.95 23.031c-3.877-3.707-3.208-9.446.1-12.755 2.446-2.449 6.454-3.448 9.952-1.979L24.76 6.56c-.677-.49-1.545-1.017-2.54-1.387A12.465 12.465 0 0 0 8.675 7.901c-3.519 3.523-4.625 8.94-2.725 13.561 1.42 3.454-.907 5.898-3.251 8.364-.83.874-1.664 1.749-2.335 2.674l10.583-9.466"></path></svg></span><span>Fact-checked by Grok<!-- --> <!-- -->4 days ago</span></div></button><article class="text-[16px]"><h1 id="cytokine" class="group relative mb-2 scroll-mt-24 font-serif text-[2.125em] font-semibold tracking-[-1px] [&amp;:not(:first-child)]:mt-14" node="[object Object]">Cytokine<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h1>
<span class="mb-4 block break-words text-[1em] leading-7">
Cytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_60qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_80qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[2]</sup>
Produced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which trigger intracellular cascades such as the JAK-STAT pathway to modulate gene expression and cellular behaviors like proliferation, differentiation, apoptosis, and migration.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup>
Major cytokine families include interleukins (e.g., IL-1, IL-6), interferons (e.g., IFN-Î±, IFN-Î³), tumor necrosis factors (e.g., TNF-Î±), and chemokines, characterized by pleiotropyâ€”where one cytokine influences multiple cell types and functionsâ€”and redundancy, allowing overlapping biological activities across different molecules.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup>
Essential for orchestrating innate and adaptive immunity against pathogens, cytokines also contribute to wound healing and developmental processes, yet their dysregulation underlies numerous pathologies, including autoimmune disorders, chronic inflammatory conditions, and life-threatening cytokine storms in severe infections or during cytokine-based immunotherapies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_o0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_q0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[8]</sup></span>
<h2 id="definition-and-characteristics" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Definition and Characteristics<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="core-definition-and-properties" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Core Definition and Properties<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines constitute a diverse group of small secreted proteins produced primarily by immune cells, such as lymphocytes, macrophages, and dendritic cells, that serve as key mediators of intercellular signaling in the regulation of immunity, inflammation, hematopoiesis, and tissue repair.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> These proteins are synthesized de novo in response to environmental stimuli like pathogens or tissue damage, rather than being pre-stored, enabling precise, transient control over cellular activities.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_82abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[9]</sup> The term &quot;cytokine,&quot; introduced by Stanley Cohen in 1974, originates from Greek roots denoting &quot;cell movement,&quot; underscoring their role in coordinating dynamic cellular interactions within the immune system.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e2abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[10]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Structurally, cytokines are typically polypeptides or glycoproteins with molecular weights between 8 and 30 kilodaltons, often featuring alpha-helical bundles or four-helix motifs that facilitate receptor binding.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_42qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[11]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_62qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> This compact size allows for rapid diffusion and local action, predominantly in paracrine or autocrine fashions, though certain cytokines like interleukins can exhibit endocrine effects at systemic levels under specific conditions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> Their production is tightly regulated, with expression levels fluctuating dramaticallyâ€”often increasing by orders of magnitude within hours of stimulationâ€”to amplify or suppress immune responses as needed.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A fundamental property of cytokines is their high specificity for cognate receptors on target cells, which are transmembrane proteins that, upon ligand binding, initiate signal transduction pathways such as JAK-STAT, MAPK, or PI3K-Akt, ultimately altering gene transcription and protein synthesis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_43abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[13]</sup> This receptor-mediated mechanism ensures directional signaling, distinguishing cytokines from nonspecific soluble factors, while their short half-livesâ€”typically minutes to hoursâ€”prevent prolonged effects without continuous production.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_83abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup> Cytokines lack intrinsic enzymatic activity, relying entirely on receptor engagement for biological function, which underscores their dependence on cellular context for efficacy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[14]</sup></span>
<h3 id="pleiotropy-redundancy-and-antagonism" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pleiotropy, Redundancy, and Antagonism<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines frequently display <strong>pleiotropy</strong>, the capacity of a single cytokine to exert diverse biological effects on multiple cell types or within different physiological contexts, often mediated by widespread receptor expression and variable downstream signaling. For example, interleukin-6 (IL-6) promotes acute-phase responses in hepatocytes, supports B-cell differentiation into plasma cells, and drives T-cell differentiation toward Th17 phenotypes, while also exhibiting context-dependent pro- or anti-inflammatory roles depending on signaling via classic or trans-signaling pathways.75588-9/fulltext)<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_84abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[15]</sup> This pleiotropic nature enhances adaptive immune flexibility but poses challenges for selective therapeutic intervention, as inhibiting one function may disrupt others.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c4abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Redundancy</strong> characterizes the overlap in functions among distinct cytokines, where multiple molecules induce similar cellular responses through shared receptor subunits or convergent signaling cascades, providing evolutionary robustness to immune signaling networks. Type I interferons (e.g., IFN-Î± and IFN-Î²) exemplify this, as over a dozen subtypes bind a common heterodimeric receptor (IFNAR), eliciting comparable antiviral states, natural killer cell activation, and upregulation of MHC class I molecules across target cells. Similarly, within the common Î³-chain receptor family, cytokines like IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 share signaling components, yielding redundant T-cell proliferation and survival signals. This redundancy buffers against single-cytokine deficiencies but amplifies risks of hyperactivation in pathological states.75588-9/fulltext)<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_64qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[16]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Antagonism</strong> describes instances where one cytokine directly inhibits or offsets the effects of another, facilitating balanced regulation of inflammation and immune polarization. Pro-inflammatory cytokines such as IFN-Î³, which enhances macrophage phagocytosis and Th1 responses, are antagonized by IL-4, which promotes Th2 differentiation and suppresses IFN-Î³-driven pathways via STAT6 activation. IL-10 further exemplifies antagonism by binding its receptor on immune cells to transcriptionally repress pro-inflammatory genes, thereby inhibiting TNF-Î± and IL-1 production and mitigating excessive tissue damage during infection or autoimmunity. These interactions, rooted in competitive receptor engagement or opposing transcription factor activation, underscore cytokines&#x27; role in dynamic homeostasis, though their disruption contributes to chronic diseases like rheumatoid arthritis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_65abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[17]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_85abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[18]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[19]</sup></span>
<h2 id="nomenclature-and-classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Nomenclature and Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="terminology-evolution" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Terminology Evolution<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The term &quot;lymphokine&quot; emerged in the late 1960s to describe soluble proteins secreted by activated lymphocytes that modulated immune responses, distinguishing them from hormones due to their localized paracrine action.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_46qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> This nomenclature reflected an early emphasis on cellular origin, as researchers identified factors like migration inhibition factor from lymphocyte supernatants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_86qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> Similarly, &quot;monokine&quot; was coined for analogous mediators from monocytes and macrophages, such as those promoting fever or acute-phase responses, highlighting source-specific classification amid limited understanding of functional overlap.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e6qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[22]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In 1974, Stanley Cohen and colleagues proposed the term &quot;cytokine,&quot; derived from Greek roots <em>cyto-</em> (cell) and <em>-kine</em> (movement), to unify these factors under a broader descriptor for any cell-derived, non-immunoglobulin signaling proteins that induce cellular movement or activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[23]</sup> This shift addressed the recognition that non-leukocytic cells, including fibroblasts and endothelial cells, also produced such mediators, rendering cell-type-specific terms like lymphokine and monokine overly restrictive.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> Cytokines were characterized as low-molecular-weight (typically under 30 kDa) regulatory peptides acting primarily via paracrine or autocrine mechanisms, contrasting with endocrine hormones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_m7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[24]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Subsequent refinements introduced systematic subclassifications. The &quot;interleukin&quot; nomenclature began in 1979 with IL-1 (initially termed lymphocyte-activating factor) and IL-2 (T-cell growth factor), assigning sequential numbers to cytokines presumed to act on leukocytes, moving away from activity-based naming (e.g., macrophage migration inhibitory factor) toward a neutral, discovery-order system.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_47qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_67qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[26]</sup> This evolved to encompass broader immunomodulatory roles, with interleukins now numbering over 30 distinct members, though the term&#x27;s leukocyte-centric origin proved imprecise as targets expanded to diverse cell types.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_a7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[25]</sup> Parallel terms like &quot;interferons&quot; (coined in 1957 for antiviral proteins) and &quot;chemokines&quot; (1990s, for chemoattractants) further diversified the lexicon, reflecting functional specialization while retaining &quot;cytokine&quot; as the inclusive category for pleiotropic, redundant signaling molecules.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_e7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup> By the 1990s, cytokine terminology stabilized around structural families (e.g., four-helix bundles) and functional clusters (pro- vs. anti-inflammatory), informed by cloning and receptor studies that revealed evolutionary conservation from invertebrates.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_i7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_k7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[27]</sup></span>
<h3 id="structural-classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Structural Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines are classified into structural families primarily based on their tertiary protein structures, which often correlate with shared evolutionary origins and receptor-binding mechanisms. The largest and most prominent family consists of those exhibiting a four Î±-helical bundle motif with an up-up-down-down topological arrangement, encompassing both short-chain and long-chain variants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_48qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup> Short-chain cytokines, such as interleukin-2 (IL-2) and IL-3, feature compact bundles with helices A-B separated by a longer loop, while long-chain members like erythropoietin (EPO) and growth hormone (GH) have extended loops between helices.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_88qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> This family includes class I cytokines (hematopoietins), which bind receptors with cytokine-binding homology domains, and class II cytokines (interferons and IL-10 family), distinguished by a flatter bundle interface and distinct receptor architecture.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[4]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The interleukin-1 (IL-1) family cytokines, including IL-1Î±, IL-1Î², and IL-18, adopt a unique six-stranded Î²-trefoil fold resembling a beta-barrel, lacking helical elements and instead relying on a globular arrangement of Î²-sheets for stability and receptor engagement.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[29]</sup> In contrast, the tumor necrosis factor (TNF) superfamily members, such as TNF-Î± and lymphotoxin-Î±, form elongated, trimeric structures with a jelly-roll Î²-sandwich fold per monomer, where each subunit contributes two Î²-sheets stabilized by disulfide bonds, enabling membrane-bound or soluble forms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Chemokines represent a distinct family of small (8-10 kDa), structurally conserved proteins featuring a flexible N-terminal region, a core of three Î²-strands in a Greek key motif, and a C-terminal Î±-helix, with classification into subfamilies (e.g., CXC, CC) dictated by the spacing and pairing of conserved cysteine residues that form disulfide bridges essential for their chemotactic function.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_49qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> The IL-17 family cytokines exhibit a conserved cystine-knot-like fold with five Î²-strands and an additional disulfide bond, forming homodimers that diverge from the helical bundles of other families and bind heterodimeric receptors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_89qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup> These structural motifs underpin cytokine-receptor specificity and signaling efficiency, though pleiotropy arises from convergent evolutionary adaptations rather than strict structural determinism.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_c9qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<h3 id="functional-classification" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Functional Classification<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines are functionally classified according to their predominant biological effects, such as promoting inflammation, suppressing immune responses, stimulating hematopoiesis, or driving specific adaptive immunity pathways like Th1, Th2, or Th17 responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> This classification reflects their pleiotropic nature, where individual cytokines may exhibit context-dependent activities, but groupings emphasize primary roles in immune regulation, host defense, and tissue homeostasis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup> Unlike structural or nomenclature-based schemes, functional categorization prioritizes observed outcomes in physiological and pathological contexts, informed by in vitro, animal, and clinical data.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_caqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Pro-inflammatory cytokines</strong> initiate and amplify acute inflammatory responses by activating endothelial cells, recruiting leukocytes, and inducing fever and acute-phase proteins. Key examples include interleukin-1 (IL-1Î± and IL-1Î²), which stimulate prostaglandin synthesis and neutrophil activation; tumor necrosis factor-alpha (TNF-Î±), which promotes vascular permeability and apoptosis; and IL-6, which drives B-cell differentiation and hepatic acute-phase responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ababav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> Additional members such as IL-12, IL-18, and interferon-gamma (IFN-Î³) enhance macrophage activation and cytotoxic T-cell function, contributing to antimicrobial defense but also implicated in chronic diseases like rheumatoid arthritis when dysregulated.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ebabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Anti-inflammatory cytokines</strong> counteract excessive inflammation to prevent tissue damage and maintain immune tolerance, often by inhibiting pro-inflammatory signaling or promoting regulatory T-cell activity. Prominent examples are IL-10, which suppresses cytokine production in macrophages and dendritic cells; IL-4 and IL-13, which downregulate Th1 responses and support IgE-mediated immunity; and transforming growth factor-beta (TGF-Î²), which inhibits T-cell proliferation and promotes fibrosis resolution.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_abqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup> IL-1 receptor antagonist (IL-1Ra) specifically neutralizes IL-1 activity, as demonstrated in therapeutic applications for conditions like sepsis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ebqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Type 1 (Th1-associated) cytokines</strong> support cell-mediated immunity against intracellular pathogens, characterized by delayed-type hypersensitivity and IFN-Î³ dominance. This group includes IL-2 for T-cell expansion, IFN-Î³ for antiviral and antitumor effects, and IL-12 for natural killer cell activation, contrasting with humoral responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> Conversely, <strong>Type 2 (Th2-associated) cytokines</strong> favor antibody production and extracellular parasite clearance, encompassing IL-4 for B-cell class switching to IgE, IL-5 for eosinophil recruitment, IL-6 for plasma cell differentiation, IL-10 for suppression, and IL-13 for mucus hypersecretion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ecabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_icabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Th17-associated cytokines</strong> drive neutrophil-mediated responses against fungi and bacteria at mucosal sites, featuring IL-17 family members (e.g., IL-17A, IL-17F) that induce antimicrobial peptides and IL-23 for Th17 cell maintenance, with roles in autoimmunity like psoriasis when overactive.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6cqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7"><strong>Hematopoietic growth factors</strong>, a subset functioning as colony-stimulating factors, regulate blood cell production in bone marrow. Examples include granulocyte-macrophage colony-stimulating factor (GM-CSF) for myeloid lineage expansion and macrophage activation, and granulocyte colony-stimulating factor (G-CSF) for neutrophil mobilization, clinically used since the 1990s for chemotherapy-induced neutropenia.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></span>



































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Functional Category</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Key Examples</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Primary Effects</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Pro-inflammatory</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">IL-1, TNF-Î±, IL-6, IL-12</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Inflammation amplification, leukocyte recruitment</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mcdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Anti-inflammatory</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">IL-10, TGF-Î², IL-4</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Immune suppression, tolerance induction</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_mkdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Th1-associated</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">IL-2, IFN-Î³</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Cell-mediated immunity</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_msdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Th2-associated</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">IL-4, IL-5, IL-13</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Humoral immunity, allergy</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_n4dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[5]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Hematopoietic</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">GM-CSF, G-CSF</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Blood cell proliferation</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ncdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[30]</sup></td></tr></tbody></table></div>
<span class="mb-4 block break-words text-[1em] leading-7">This classification is not rigid, as cytokines like IL-6 exhibit dual pro- and anti-inflammatory properties depending on signaling pathways (e.g., classical vs. trans-signaling), underscoring the need for context-specific interpretation in research and therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[7]</sup></span>
<h2 id="distinctions-from-other-signaling-molecules" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Distinctions from Other Signaling Molecules<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="comparison-to-hormones" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Comparison to Hormones<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines and hormones both function as soluble signaling molecules that bind to cell-surface receptors to initiate intracellular cascades, regulating physiological processes such as growth, differentiation, and response to stimuli.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> Many cytokines, like hormones, are polypeptides or glycoproteins produced in response to environmental cues, though hormones may also include steroids derived from cholesterol.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[31]</sup> This shared capacity for receptor-mediated signal transduction underscores functional parallels, with cytokines sometimes described as the &quot;hormones of the immune system&quot; due to their role in coordinating immune cell activities akin to hormonal orchestration of endocrine targets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Key distinctions arise in production, range of action, and potency. Hormones are secreted constitutively or in regulated pulses by specialized endocrine glands (e.g., thyroid for thyroxine or pancreas for insulin) and travel via the bloodstream to exert systemic endocrine effects on distant organs, often at low circulating concentrations (picomolar to nanomolar) with longer half-lives enabling sustained influence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[32]</sup> Cytokines, by contrast, are produced transiently by diverse cell typesâ€”predominantly leukocytes but also endothelial, epithelial, and fibroblastsâ€”upon activation by pathogens or injury, primarily acting locally through paracrine (on neighboring cells) or autocrine (on the producing cell) mechanisms, with rapid degradation yielding short half-lives (minutes) and high local concentrations but minimal basal systemic levels.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[33]</sup> While cytokines can disseminate systemically during acute inflammation (e.g., contributing to fever via IL-1 or IL-6), their effects remain more context-dependent and less predictably endocrine than those of hormones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ggabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines exhibit greater potency on a molar basis, eliciting responses at lower concentrations; for example, IL-1 induces cyclooxygenase-2 gene expression at approximately 10 pM, surpassing the efficacy thresholds of many hormones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> Hormones typically target specific tissues with narrower functional repertoires, whereas cytokines display pleiotropy (multiple effects per molecule) and redundancy (overlapping functions among molecules), reflecting their evolutionary adaptation for dynamic immune modulation rather than homeostatic regulation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup> These differences, though increasingly blurred by discoveries of cytokine endocrine actions (e.g., IL-6 influencing hypothalamic-pituitary-adrenal axis), maintain cytokines&#x27; primary association with localized, inducible responses over the broader, organ-specific signaling of hormones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[34]</sup></span>
<h3 id="comparison-to-chemokines-and-growth-factors" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Comparison to Chemokines and Growth Factors<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Chemokines constitute a subclass of cytokines, distinguished primarily by their specialized role in inducing directed cell migration, or chemotaxis, particularly among leukocytes. Structurally, chemokines feature conserved cysteine motifs that form disulfide bonds, enabling classification into subfamilies such as CXC (e.g., CXCL8/IL-8) and CC (e.g., CCL2/MCP-1), which dictate ligand-receptor interactions and functional specificity. In contrast, cytokines broadly encompass pleiotropic mediators of immune regulation, including pro-inflammatory signals like tumor necrosis factor-alpha (TNF-Î±) and anti-inflammatory ones like interleukin-10 (IL-10), without the obligatory chemotactic emphasis. This functional divergence reflects chemokines&#x27; adaptation for immune cell trafficking to infection sites, whereas general cytokines orchestrate activation, differentiation, and apoptosis across diverse cellular contexts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4hqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Growth factors share mechanistic similarities with cytokines, such as autocrine/paracrine signaling via membrane receptors and induction of intracellular cascades like JAK-STAT or MAPK pathways, but are functionally oriented toward promoting cellular proliferation, survival, and tissue morphogenesis. Exemplars include epidermal growth factor (EGF) and fibroblast growth factor (FGF), which primarily drive epithelial and mesenchymal cell expansion in development and repair, often produced by non-immune cells. Certain cytokines, however, blur these lines by exhibiting growth-promoting effects, as seen with IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in hematopoiesis, leading to conceptual overlap where growth factors can be viewed as a cytokine subset focused on mitogenesis rather than immunomodulation. This terminological distinction persists due to historical and contextual usage, though empirical evidence from receptor binding affinities and downstream effects reveals substantial redundancy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[35]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[6]</sup></span>
<h2 id="molecular-mechanisms" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Molecular Mechanisms<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="receptors-and-binding-affinity" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Receptors and Binding Affinity<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokine receptors comprise a heterogeneous group of transmembrane glycoproteins that selectively bind cytokines to initiate cellular signaling, featuring extracellular ligand-binding domains, a transmembrane helix, and intracellular motifs for signal propagation. These receptors are structurally classified into several superfamilies based on conserved extracellular motifs: the type I cytokine receptor family (hematopoietin receptors, including shared chains like gp130, Î²c, and Î³c), the type II family (interferon and IL-10 receptors), the immunoglobulin-like IL-1 receptor family, the tumor necrosis factor receptor (TNFR) superfamily, G-protein-coupled receptors (primarily for chemokines), and others such as the IL-17 receptor family.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[36]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6jqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[37]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Binding typically requires assembly of multi-subunit complexes, where cytokines engage a specific low-affinity chain before recruiting accessory signaling chains to achieve high-affinity interaction and receptor dimerization or oligomerization. In type I receptors, such as those for IL-3, IL-5, and GM-CSF sharing the Î²c chain, or the Î³c family (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21), the cytokine binds first to a cytokine-specific Î±-chain (low affinity, often nM range), inducing recruitment of the shared chain for ternary complex formation. Type II receptors, like IFNAR for type I interferons, involve sequential binding where high-affinity interaction with one chain (e.g., IFNAR2) precedes low-affinity recruitment of the second (IFNAR1). IL-1 family receptors form heterodimers with accessory proteins, while TNFRs often trimerize upon ligand binding.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[38]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[39]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">High-affinity binding constants (Kd) generally fall in the picomolar to low nanomolar range, enabling response to trace cytokine levels, though individual chains exhibit lower affinities. For IL-2, the trimeric high-affinity receptor (Î±Î²Î³) has a Kd of ~10 pM, the intermediate Î²Î³ dimer ~1 nM, and the low-affinity Î± chain ~10-100 nM. Type I interferons bind IFNAR2 with Kd values of 0.4-5 nM and IFNAR1 at 0.5-5 Î¼M, with the ternary complex optimizing overall potency through cooperative effects. Variations in affinity influence signaling duration and selectivity, as seen in engineered IL-6 variants where altered gp130 binding (Kd differences) modulates functional outcomes like proliferation versus inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[40]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[41]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[42]</sup></span>
<h3 id="intracellular-signaling-pathways" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Intracellular Signaling Pathways<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
Cytokines transduce signals primarily through cell surface receptors lacking intrinsic kinase domains, which associate with intracellular Janus kinases (JAKs) upon ligand binding, leading to receptor dimerization or oligomerization and subsequent activation of downstream cascades.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> This process initiates rapid gene expression changes critical for immune responses, hematopoiesis, and inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_alqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway represents the canonical mechanism for many cytokines, including interleukins (e.g., IL-2, IL-4, IL-6), interferons (e.g., IFN-Î±, IFN-Î³), and colony-stimulating factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> Ligand-induced receptor clustering activates specific JAK family members (JAK1, JAK2, JAK3, TYK2), which cross-phosphorylate each other and receptor tyrosine residues, recruiting and phosphorylating STAT proteins (STAT1-6).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup> Phosphorylated STATs dimerize, translocate to the nucleus, and bind gamma-activated sites to drive transcription of target genes involved in proliferation, differentiation, and apoptosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup> Over 50 cytokines utilize this pathway, with specificity arising from distinct JAK-STAT combinations; for example, IL-6 signaling predominantly activates STAT3 via JAK1 and JAK2.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[28]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Beyond JAK-STAT, cytokine receptors engage mitogen-activated protein kinase (MAPK) pathways, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK, which modulate cellular responses to stress, growth, and inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup> Receptor tyrosine phosphorylation recruits adapter proteins like Shc or IRS, activating Ras-Raf cascades that culminate in MAPK nuclear translocation and regulation of AP-1 transcription factors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8mqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[45]</sup> Cytokines such as IL-1 and TNF-Î± also activate NF-ÎºB via the canonical pathway involving the IÎºB kinase (IKK) complex, which phosphorylates inhibitory IÎºB proteins for degradation, freeing NF-ÎºB to enter the nucleus and induce proinflammatory gene expression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[46]</sup> The phosphoinositide 3-kinase (PI3K)/Akt pathway, triggered by cytokines like IL-3 and GM-CSF, promotes survival and metabolism through receptor-associated adapters.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_gmqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">These pathways exhibit extensive cross-talk; for instance, JAK activation can enhance MAPK or PI3K signaling, integrating inputs for context-dependent outcomes, while negative regulators like suppressors of cytokine signaling (SOCS) proteins provide feedback to prevent excessive activation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[44]</sup> Dysregulation of these cascades underlies pathologies such as chronic inflammation and autoimmunity, highlighting their causal role in cytokine-mediated diseases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[43]</sup></span>
<h2 id="physiological-roles" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Physiological Roles<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="immune-regulation-and-defense" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Immune Regulation and Defense<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
Cytokines function as critical signaling molecules in immune regulation and defense, coordinating both innate and adaptive responses to pathogens while preventing excessive tissue damage. Produced primarily by immune cells such as macrophages, dendritic cells, and lymphocytes, they mediate paracrine and autocrine signaling to activate effector cells, promote leukocyte recruitment, and modulate inflammation intensity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6oqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[1]</sup> In innate immunity, cytokines like interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-Î±), and IL-6 trigger acute-phase responses, inducing fever, endothelial activation for leukocyte adhesion, and antimicrobial protein synthesis in the liver.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_aoqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[3]</sup> These pro-inflammatory cytokines amplify pathogen clearance by enhancing phagocytosis and natural killer cell cytotoxicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_eoqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[47]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Anti-inflammatory cytokines, including IL-10 and transforming growth factor-beta (TGF-Î²), counteract pro-inflammatory signals to resolve inflammation and maintain immune homeostasis, inhibiting excessive cytokine production and promoting regulatory T cell activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[48]</sup> This balance is essential, as dysregulated pro-inflammatory dominance can lead to immunopathology, while insufficient responses impair defense.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[49]</sup> Type I interferons (IFN-Î± and IFN-Î²), secreted by virus-infected cells, exemplify antiviral defense by inducing an intracellular antiviral state, upregulating MHC class I for enhanced T cell recognition, and activating NK cells for early cytotoxicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cpabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[50]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In bridging innate and adaptive immunity, cytokines from antigen-presenting cells direct T helper cell differentiation: IL-12 promotes Th1 cells for intracellular pathogen control via IFN-Î³ production, while IL-4 drives Th2 responses against helminths through IL-5 and IL-13 for eosinophil and IgE-mediated defense.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[51]</sup> B cell activation and antibody class switching rely on cytokines like IL-4 for IgE and IFN-Î³ for IgG2a, tailoring humoral responses to threat type.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[52]</sup> Overall, cytokine networks ensure rapid innate containment followed by antigen-specific adaptive amplification, with empirical studies showing their necessity in vaccine efficacy and infection outcomes.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_cpqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[53]</sup></span>
<h3 id="developmental-and-homeostatic-functions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Developmental and Homeostatic Functions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines play essential roles in embryonic development by regulating cell proliferation, differentiation, and migration during critical phases such as implantation and organogenesis. For instance, growth factors and cytokines like leukemia inhibitory factor (LIF) and interleukin-11 (IL-11) facilitate blastocyst implantation by modulating endometrial receptivity and trophoblast invasion in the uterus.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[54]</sup> In fetal development, interferons and proinflammatory cytokines such as interferon-gamma (IFN-Î³) influence placental formation and vascular remodeling, ensuring adequate nutrient exchange, though dysregulation can lead to developmental defects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[55]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Hematopoiesis, the formation of blood cells, exemplifies cytokine-driven developmental processes from embryonic stages onward. Cytokines including stem cell factor (SCF), FMS-like tyrosine kinase 3 ligand (FLT3L), and interleukin-3 (IL-3) support hematopoietic stem cell (HSC) survival, self-renewal, and lineage commitment toward myeloid or lymphoid progenitors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[56]</sup> These signals act via receptor complexes to promote differentiation into mature blood cells, with SCF and FLT3L specifically enhancing Stat5-mediated expression of anti-apoptotic proteins like Mcl1 in lymphoid-primed multipotent progenitors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[57]</sup> Embryonic hematopoiesis further relies on inflammatory cytokines to establish definitive HSC compartments in the fetal liver and bone marrow.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_crabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[58]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In homeostatic functions, cytokines maintain physiological balance by fine-tuning cell populations and tissue integrity without eliciting overt inflammation. Common gamma-chain (Î³c) cytokines such as IL-7 and IL-15 are pivotal for lymphocyte homeostasis, promoting naive and memory T-cell survival through signaling pathways that prevent apoptosis and support basal proliferation in peripheral lymphoid organs.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[59]</sup> IL-10, produced by regulatory T cells and other subsets, preserves immune tolerance and mucosal barrier integrity by suppressing excessive effector responses, thereby preventing chronic activation that could disrupt tissue equilibrium.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[60]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The IL-17 cytokine family contributes to epithelial and barrier tissue homeostasis by coordinating repair and antimicrobial defenses in the skin, gut, and lungs, where IL-17A and IL-17F stimulate keratinocyte proliferation and neutrophil recruitment to sustain microbial control under steady-state conditions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[61]</sup> Overall, these homeostatic roles ensure adaptive responses to minor perturbations, with cytokines integrating signals from multiple cell types to sustain organismal stability, as evidenced by perturbations in cytokine-deficient models leading to lymphopenia or barrier dysfunction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[62]</sup></span>
<h3 id="tissue-repair-and-regeneration" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Tissue Repair and Regeneration<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines orchestrate the transition from inflammatory to reparative phases in tissue repair, recruiting immune cells, stimulating fibroblast proliferation, and regulating extracellular matrix (ECM) deposition to restore structural integrity. In wound healing, proinflammatory cytokines such as TNF-Î± and IL-1Î² initiate leukocyte infiltration and proteolytic activity during the early inflammatory stage, while IL-6 supports epithelialization and acute-phase responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6tabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> TGF-Î²1 then drives granulation tissue formation by recruiting fibroblasts, inducing collagen synthesis (types I, III, and V), and promoting angiogenesis, though sustained elevation risks excessive ECM accumulation and fibrosis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_atabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ctabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Regenerative outcomes vary by cytokine profile and context; fetal wounds achieve scarless repair through elevated TGF-Î²3 and IL-10, which dampen inflammation, favor type III collagen, and enhance hyaluronan-mediated remodeling, unlike adult wounds where TGF-Î²1/2 dominance yields scarring.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup> Experimental overexpression of IL-10 in adult models reduces scar formation by curbing proinflammatory cascades.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8tqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup> In contrast, PDGF, often acting alongside cytokines, amplifies fibroblast mitogenesis and granulation but can exacerbate fibrosis if unbalanced.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ctqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[63]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Organ-specific regeneration highlights cytokine specificity: IL-6 is indispensable for liver repair post-hepatectomy, activating hepatocyte STAT3 to drive DNA synthesis and mass restoration; IL-6 knockout mice exhibit regeneration failure and elevated mortality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_6uabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[66]</sup> TNF-Î± complements this by NF-ÎºB-mediated anti-apoptosis and IL-6 induction, with TNFR1-deficient models showing impaired proliferation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_auabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> In skeletal muscle, muscle-derived IL-6 and TGF-Î² regulate satellite cell activation and myoblast fusion, while TNF-Î± and IL-1Î² from macrophages sustain early inflammation to clear debris, enabling myogenic differentiation; disruptions prolong recovery.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_euabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[67]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_guabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[68]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">IL-22 further exemplifies reparative roles, promoting intestinal epithelial proliferation via JAK-STAT3 in injury models, with deficiency worsening mucosal damage.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_4uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup> Overall, balanced cytokine signalingâ€”shifting from pro- (e.g., TNF-Î±, IL-6) to anti-inflammatory (e.g., IL-10, TGF-Î²3)â€”dictates regeneration fidelity, as evidenced by mouse hepatectomy and wound models where dysregulation favors fibrosis over functional tissue restoration.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_8uqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[65]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_auqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[64]</sup></span>
<h2 id="pathological-roles" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Pathological Roles<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="acute-inflammation-and-infections" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Acute Inflammation and Infections<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Acute inflammation represents the body&#x27;s immediate response to infection or tissue injury, orchestrated primarily by pro-inflammatory cytokines such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-Î±), and interleukin-6 (IL-6). These cytokines are rapidly secreted by resident macrophages and other innate immune cells upon detection of pathogen-associated molecular patterns (PAMPs) via pattern recognition receptors like Toll-like receptors (TLRs).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_50qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[69]</sup> IL-1 and TNF-Î± initiate vasodilation, increased vascular permeability, and adhesion molecule expression on endothelial cells, facilitating neutrophil recruitment to the site of infection.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_90qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[70]</sup> IL-6, in turn, stimulates hepatocytes to produce acute-phase proteins such as C-reactive protein (CRP) and serum amyloid A, which enhance opsonization and complement activation to amplify pathogen clearance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d0qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[71]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In bacterial and viral infections, these cytokines drive systemic effects including fever induction through hypothalamic prostaglandin synthesis and anorexia to conserve energy for immune defense. For instance, TNF-Î± and IL-1 elevate leptin levels and suppress appetite during acute infections, contributing to cachexia-like symptoms observed in sepsis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[72]</sup> Empirical studies in mouse models demonstrate that IL-1Î± specifically exacerbates intestinal inflammation in Peyer&#x27;s patches during bacterial challenge, underscoring its role in localized mucosal defense.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[73]</sup> However, balanced cytokine signaling is crucial; anti-inflammatory interleukins like IL-10 counter excessive responses to prevent tissue damage while preserving antimicrobial activity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d1abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[74]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Dysregulated cytokine production can escalate to a cytokine storm, characterized by hypersecretion of pro-inflammatory mediators leading to septic shock and multi-organ failure in severe infections. Infections, particularly respiratory viruses, are the predominant triggers, with elevated TNF-Î±, IL-6, and IL-1Î² correlating with poor outcomes in conditions like COVID-19 and influenza.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_51qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[75]</sup> Laboratory evidence from human cohorts shows leukocytosis, thrombocytopenia, and markedly increased CRP and ferritin levels during such storms, reflecting the pathological amplification of inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_91qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[76]</sup> This phenomenon highlights the dual-edged nature of cytokines: essential for pathogen containment in acute settings but potentially lethal when unchecked.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d1qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[77]</sup></span>
<h3 id="chronic-inflammation-and-autoimmunity" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Chronic Inflammation and Autoimmunity<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic inflammation represents a maladaptive persistence of cytokine-driven immune activation, characterized by continuous low-level production of pro-inflammatory mediators that promote tissue remodeling, fibrosis, and organ dysfunction rather than resolution seen in acute responses. Cytokines such as TNF-Î±, IL-1Î², and IL-6, secreted by macrophages, T cells, and activated fibroblasts, form self-amplifying loops: TNF-Î± induces further IL-6 and IL-1Î² expression via NF-ÎºB signaling, recruiting additional leukocytes and sustaining endothelial activation for prolonged vascular permeability.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_52qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_72qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> In rheumatoid arthritis (RA), synovial fluids exhibit elevated TNF-Î± levels correlating with joint erosion, where it synergizes with IL-17 to upregulate matrix metalloproteinases (MMPs) and RANKL, driving osteoclastogenesis and bone loss.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> This chronicity contrasts with acute inflammation&#x27;s feedback inhibition by anti-inflammatory cytokines like IL-10, which is often insufficient in dysregulated states.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f2qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In autoimmunity, cytokines causally contribute to self-tolerance breakdown by skewing adaptive immunity toward pathogenic effector responses. IL-6, in concert with TGF-Î², induces Th17 cell differentiation through STAT3 and RORÎ³t transcription factors, overriding Treg suppression and promoting IL-17 secretion that amplifies neutrophil recruitment and barrier disruption.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_73abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup> IL-23 stabilizes pathogenic Th17 phenotypes, as evidenced in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis (MS), where IL-23 knockout prevents Th17 expansion and disease onset despite initial priming.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup> In RA, Th17-derived IL-17 enhances TNF-Î± and IL-6 effects on synovial fibroblasts, forming a network that sustains pannus formation and autoantibody production; serum IL-17 levels correlate with RA activity scores like DAS28.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup> Similarly, in psoriasis and inflammatory bowel disease, IL-17 drives epithelial hyperproliferation and chemokine release (e.g., CXCL1), linking cytokine dysregulation to mucosal auto-reactivity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j3abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[80]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Empirical data from human biopsies and rodent models underscore cytokines&#x27; centrality: in RA synovium, TNF-Î± blockade reduces IL-6 and IL-17 within weeks, alleviating inflammation without altering initial triggers, indicating cytokines as proximal effectors of chronicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_53qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup> Type I interferons, persistently elevated in systemic lupus erythematosus (SLE), further perpetuate autoimmunity by promoting plasmacytoid dendritic cell activation and anti-nuclear antibody responses, though their role varies by disease stage.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_93qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[78]</sup> This positions cytokine networks as both initiatorsâ€”via genetic polymorphisms enhancing IL-6 productionâ€”and propagators of autoimmune pathology, where failure to downregulate pro-inflammatory signals post-antigen clearance enables epitope spreading and chronic self-attack.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d3qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[79]</sup></span>
<h3 id="cancer-promotion-and-suppression" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cancer Promotion and Suppression<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">
Cytokines exhibit dual and context-dependent roles in cancer, promoting tumorigenesis through chronic inflammation and immune evasion in some cases, while suppressing it via direct antiproliferative effects or enhancement of antitumor immunity in others. Pro-tumorigenic cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-Î±), drive cancer progression by activating signaling pathways like STAT3 and NF-ÎºB, which foster tumor cell survival, proliferation, epithelial-mesenchymal transition (EMT), angiogenesis, and metastasis while suppressing cytotoxic immune responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_74qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup> <sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_b4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup> For example, elevated IL-6 levels in the tumor microenvironment correlate with poor prognosis in multiple cancers, including colorectal and ovarian, by recruiting immunosuppressive myeloid-derived suppressor cells and promoting vascular endothelial growth factor (VEGF) expression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_f4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Similarly, transforming growth factor-beta (TGF-Î²) supports tumor invasion and immune tolerance, particularly in advanced stages, despite early antiproliferative effects.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_j4qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In opposition, anti-tumor cytokines like interferon-gamma (IFN-Î³) and interleukin-12 (IL-12) inhibit cancer development by inducing apoptosis in tumor cells, upregulating major histocompatibility complex (MHC) class I expression for enhanced T-cell recognition, and activating natural killer (NK) cells and cytotoxic T lymphocytes. IFN-Î³, produced by activated T cells and NK cells, disrupts tumor angiogenesis and promotes immunogenic cell death, with preclinical models showing reduced tumor burden in IFN-Î³-deficient mice compared to wild-type counterparts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup> Clinical evidence supports these effects; high-dose interleukin-2 (IL-2) therapy, approved by the FDA in 1998 for metastatic melanoma and renal cell carcinoma, yields objective response rates of 15-28% in phase III trials, though limited by vascular leak syndrome and short half-life.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_95abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup> Granulocyte-macrophage colony-stimulating factor (GM-CSF) similarly enhances dendritic cell maturation and antigen presentation, contributing to durable responses in vaccine-adjuvanted settings.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d5abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The tumor microenvironment (TME) often shifts cytokine balance toward promotion via feedback loops, such as IL-6-induced STAT3 activation that sustains immunosuppressive networks, underscoring the need for targeted blockade of pro-tumor signals alongside augmentation of anti-tumor ones.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_55qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Paradoxically, some cytokines like IL-10 exhibit dual functions, suppressing inflammation acutely but enabling tumor escape chronically through STAT3-mediated proliferation in certain contexts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_95qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[83]</sup> Ongoing research emphasizes combinatorial approaches, with IL-6 inhibitors showing synergy with checkpoint blockade in preclinical models of resistant tumors.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d5qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[82]</sup></span>



































<div class="border-border-l1 overflow-x-auto rounded-lg border my-6 w-full"><table node="[object Object]" class="w-full border-collapse text-sm"><thead node="[object Object]" class="border-border-l1 border-b bg-surface-l1"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Cytokine</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Primary Role in Cancer</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Key Mechanisms</span></th><th node="[object Object]" class="dark:text-fg-primary bg-gray-100 px-2 py-1 text-left align-top font-bold dark:bg-black"><span class="text-[1em] leading-7">Example Evidence</span></th></tr></thead><tbody node="[object Object]" class="divide-border-l1 divide-y"><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">IL-6</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Promotion</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">STAT3/NF-ÎºB activation, angiogenesis, EMT</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Correlates with poor survival in ovarian cancer cohorts</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18d6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">TNF-Î±</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Promotion</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Inflammation, immune suppression, survival signaling</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Enhances metastasis in inflammatory TME</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18l6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[81]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">IFN-Î³</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Suppression</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Apoptosis induction, MHC upregulation, NK activation</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Increased tumor growth in IFN-Î³ knockout mice</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_18t6abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[84]</sup></td></tr><tr node="[object Object]" class="divide-border-l1 divide-x bg-surface-l1"><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">IL-2</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">Suppression</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">T/NK cell expansion, cytotoxicity</span></td><td node="[object Object]" class="text-fg-primary px-2 py-1 align-top"><span class="text-[1em] leading-7">15-28% response rates in melanoma trials</span><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_1956abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[85]</sup></td></tr></tbody></table></div>
<h3 id="neuroinflammation-and-behavioral-modulation" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Neuroinflammation and Behavioral Modulation<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Pro-inflammatory cytokines such as interleukin-1 beta (IL-1Î²), tumor necrosis factor alpha (TNF-Î±), and interleukin-6 (IL-6) play a central role in neuroinflammation by activating microglia and astrocytes within the central nervous system (CNS), leading to localized immune responses that can alter neuronal excitability and synaptic plasticity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_57abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[86]</sup> These cytokines gain access to the brain via passive diffusion across the blood-brain barrier (BBB) during inflammation-induced permeability or through active transport and peripheral signaling via the vagus nerve, where they bind to receptors on endothelial cells and immune cells, triggering downstream cascades that influence behavior.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[87]</sup> Empirical evidence from rodent models shows that peripheral injection of IL-1Î² induces rapid activation of hypothalamic neurons within minutes, correlating with decreased locomotor activity and food intake, effects blocked by IL-1 receptor antagonists.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d7abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A key behavioral outcome of cytokine-driven neuroinflammation is <strong>sickness behavior</strong>, an evolutionarily conserved response comprising lethargy, anorexia, hyperalgesia, and social withdrawal, which reallocates energy toward pathogen clearance rather than foraging or reproduction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_97qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[89]</sup> In non-human primates and humans, administration of IFN-Î± (which elevates IL-6 and TNF-Î±) during interferon therapy for hepatitis C induces these symptoms in up to 30-50% of patients, with IL-6 levels predicting severity; positron emission tomography (PET) scans reveal concurrent increases in microglial activation in limbic regions like the insula and anterior cingulate cortex.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[88]</sup> Synergistic interactions amplify this: combined low doses of IL-1Î², IL-6, and TNF-Î± in mice produce robust reductions in open-field exploration and sucrose preference, exceeding individual effects, via shared JAK-STAT and NF-ÎºB pathways that suppress dopamine release in the nucleus accumbens.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[90]</sup> This behavior is adaptive in acute infection but maladaptive when prolonged, as evidenced by lipopolysaccharide (LPS)-induced models where cytokine blockade with etanercept (a TNF-Î± inhibitor) restores normal activity levels within hours.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l7qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[91]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Chronic neuroinflammation links cytokines to mood and cognitive modulation, particularly in major depressive disorder (MDD) and anxiety, where meta-analyses of over 80 studies report elevated peripheral IL-6 (standardized mean difference 0.56) and TNF-Î± (0.40) in MDD patients versus controls, independent of medication status.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_58abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup> Mechanistically, these cytokines reduce tryptophan availability by upregulating indoleamine 2,3-dioxygenase (IDO), shunting it toward neurotoxic kynurenine metabolites and depleting serotonin precursors, while also enhancing glutamate excitotoxicity via reduced astrocyte uptake.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[93]</sup> In the hippocampus, IL-1Î² impairs long-term potentiation (LTP) and adult neurogenesis, as shown in IL-1 receptor knockout mice resistant to stress-induced anhedonia; human imaging corroborates this, with higher CSF IL-6 correlating to smaller hippocampal volumes in MDD (r = -0.35, p&lt;0.01).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[94]</sup> For anxiety, TNF-Î± modulates amygdala hyperactivity: chronic infusion in rats increases fear conditioning via p38 MAPK signaling, reversed by anti-TNF antibodies, suggesting causal involvement beyond correlation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_h8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[95]</sup> However, not all inflammation equates to pathology; low-level IL-10 counter-regulation prevents excessive behavioral suppression, highlighting context-dependent effects where acute cytokine surges enhance vigilance without long-term deficits.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_l8abav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[96]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Therapeutic targeting underscores these mechanisms: anti-cytokine biologics like infliximab reduce depressive symptoms in treatment-resistant MDD patients with high baseline CRP (&gt;3 mg/L), with response rates of 60% versus 29% in low-inflammation subgroups, implicating cytokine-driven subsets.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_58qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[92]</sup> Conversely, antidepressants such as SSRIs attenuate microglial cytokine release in vitro, normalizing HPA axis hyperactivity observed in 40-60% of MDD cases with comorbid inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_98qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[97]</sup> These findings, drawn from controlled trials and animal knockouts, affirm cytokines as causal modulators rather than mere biomarkers, though human causality remains inferred from associative and interventional data due to ethical limits on direct CNS manipulation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_d8qbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[98]</sup></span>
<h2 id="dysregulation-and-adverse-effects" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Dysregulation and Adverse Effects<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="cytokine-release-syndromes" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Cytokine Release Syndromes<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7"></span>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokine release syndrome (CRS) is an acute systemic inflammatory response triggered by the excessive and rapid release of pro-inflammatory cytokines, such as interleukin-6 (IL-6), interferon-gamma (IFN-Î³), and tumor necrosis factor-alpha (TNF-Î±), following massive activation of immune effector cells including T cells, macrophages, and natural killer cells.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7aqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup> This condition manifests as fever and potential multi-organ dysfunction due to endothelial activation, vascular leakage, and disseminated intravascular coagulation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_baqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup> CRS most commonly arises in the context of adoptive cellular therapies, particularly chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, where infused CAR-T cells proliferate and target tumor antigens, leading to cytokine storm within days of infusion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_faqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[102]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_haqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[103]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The pathophysiology involves initial antigen recognition by engineered T cells or monoclonal antibodies, prompting cytokine secretion that amplifies immune activation; this recruits and stimulates bystander immune cells, escalating to a feed-forward loop of inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> Risk factors include high disease burden, prior lymphodepletion, and specific therapy types, with incidence rates exceeding 80% in CAR-T recipients, though severe grades (â‰¥3) vary from 10-30% depending on the product and patient population.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9babav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[103]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[104]</sup> Beyond oncology, CRS has been documented in severe infections, such as those mimicking macrophage activation syndrome, and with bispecific T-cell engagers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fbabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[105]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Clinically, CRS presents with high-grade fever (â‰¥38Â°C) as a hallmark, often accompanied by malaise, myalgias, and chills in mild cases, progressing to hypotension, hypoxia, and organ toxicities like hepatic or renal impairment in severe instances.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[101]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7bqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> Diagnosis relies on clinical criteria excluding alternative causes, supported by elevated serum cytokines and biomarkers like C-reactive protein or ferritin.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup> The American Society for Transplantation and Cellular Therapy (ASTCT) consensus grading system standardizes severity assessment: Grade 1 involves fever without hypotension or hypoxia; Grade 2 adds mild hemodynamic or respiratory compromise; Grade 3 requires vasopressor support or high-flow oxygen; and Grade 4 denotes life-threatening symptoms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[106]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hbqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[107]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Management prioritizes early recognition and supportive care, including fluids, vasopressors, and oxygen; pharmacologic interventions feature IL-6 receptor antagonists like tocilizumab for Grades 2-4, with corticosteroids reserved for refractory or concurrent neurotoxicity cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[100]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7cabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> Prophylactic approaches, such as tocilizumab pre-administration in high-risk patients, have shown efficacy in mitigating severe CRS without compromising antitumor responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[102]</sup> Prognosis is generally favorable with prompt intervention, as most episodes resolve within 1-2 weeks, though fatal outcomes occur in &lt;5% of severe cases, underscoring the need for specialized monitoring in certified centers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[99]</sup> Ongoing research focuses on predictive biomarkers and engineered CAR-T designs to decouple efficacy from toxicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_jcabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[108]</sup></span>
<h3 id="inflammaging-and-age-related-decline" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Inflammaging and Age-Related Decline<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Inflammaging denotes the persistent, low-grade systemic inflammation that escalates with advancing age, characterized by elevated circulating levels of pro-inflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-Î±), and interleukin-1 beta (IL-1Î²).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> These cytokines rise progressively from middle age onward, with plasma IL-6 levels documented to increase in cohorts of older adults, correlating with functional decline and mortality.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> Mechanisms driving this elevation encompass cellular senescence, where the senescence-associated secretory phenotype (SASP) perpetuates cytokine release; mitochondrial dysfunction generating reactive oxygen species (ROS) that activate NF-ÎºB signaling; and NLRP3 inflammasome priming, amplifying IL-1Î² and IL-18 production.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fdabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">This cytokine dysregulation fosters age-related tissue dysfunction by impairing homeostasis, promoting catabolism, and exacerbating extracellular matrix remodeling. In musculoskeletal systems, TNF-Î± and IL-6 induce anabolic resistance in skeletal muscle, contributing to sarcopenia, with longitudinal data linking higher IL-6 to accelerated muscle mass loss in women over age 65.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup> Cardiovascular pathology arises as these cytokines drive endothelial dysfunction and plaque instability; for instance, IL-6 polymorphisms associated with elevated levels predict coronary events, while the 2017 CANTOS trial in 10,061 patients showed IL-1Î² blockade with canakinumab reduced major adverse cardiovascular events by 15% independently of lipid lowering.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9dqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup> In the central nervous system, TNF-Î± and IL-1Î² activate microglia, leading to synaptic loss and amyloid aggregation in Alzheimer&#x27;s disease models.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_ddqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fdqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[111]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Anti-inflammatory cytokines exhibit context-dependent shifts, with IL-10 and transforming growth factor-beta (TGF-Î²) often increasing in centenarians, potentially counterbalancing pro-inflammatory dominance to support longevity, as observed in the BELFAST study of extreme agers.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> However, overall imbalance favors pro-inflammatory dominance, linking inflammaging to multimorbidity; meta-analyses confirm IL-6 as a predictor of frailty and all-cause mortality across elderly populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9eabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[109]</sup> Interventions targeting cytokine pathways, such as senolytics reducing SASP in aged mice, underscore causality by attenuating decline without broad immunosuppression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_deabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[110]</sup></span>
<h3 id="fatigue-and-chronic-syndromes-empirical-evidence" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Fatigue and Chronic Syndromes: Empirical Evidence<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Empirical investigations into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have revealed associations between fatigue severity and dysregulated cytokine profiles, particularly elevations in pro-inflammatory mediators. A 2017 study of 191 ME/CFS patients and 392 controls identified a signature of 17 cytokines correlating with disease severity, including 13 pro-inflammatory types such as interleukin-1Î± (IL-1Î±), IL-1Î², IL-6, IL-8, IL-12p70, IL-13, IL-15, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-Î³ (IFN-Î³), inducible protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP-1), eotaxin, and tumor necrosis factor-Î± (TNF-Î±).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup> These elevations were observed both at rest and post-exercise, suggesting a role in post-exertional malaise, a hallmark of ME/CFS fatigue.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[112]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">A 2019 systematic review of 74 studies encompassing over 2,000 ME/CFS patients found inconsistent but notable differences in cytokine levels compared to healthy controls, with significant elevations in transforming growth factor-Î²1 (TGF-Î²1) (standardized mean difference [SMD] 0.31, p=0.03) and trends toward higher IL-1Î², IL-6, and TNF-Î± in subsets of patients.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> The same review highlighted methodological heterogeneity, such as varying diagnostic criteria and small sample sizes, as contributors to variability, yet confirmed pro-inflammatory shifts in approximately 30% of analyzed cytokines.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9fqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup> A concurrent meta-analysis of circulating inflammatory proteins across 28 studies reported pooled elevations in IL-8 (SMD 0.34, p&lt;0.05) and neopterin, alongside reduced IL-1 receptor antagonist (IL-1RA), indicating a net pro-inflammatory state in ME/CFS despite diagnostic instability in some cohorts.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dfqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[114]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In long COVID, characterized by persistent fatigue post-SARS-CoV-2 infection, cytokine dysregulation mirrors ME/CFS patterns, with empirical data linking sustained inflammation to symptom chronicity. A 2024 study of 55 long COVID patients versus controls detected elevated plasma levels of IL-6, TNF-Î±, and IP-10, correlating with fatigue scores on the Chalder Fatigue Scale (r&gt;0.4 for IL-6, p&lt;0.01).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[115]</sup> Another 2024 analysis of 152 long COVID cases showed systemic T-cell dysregulation alongside upregulated cytokine signaling genes, including those for IFN-Î³ and TNF pathways, persisting up to 12 months post-infection and associating with fatigue severity (odds ratio 2.1 for high IFN-Î³ responders).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9gabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[116]</sup> A 2023 review synthesized evidence from longitudinal cohorts, attributing fatigue to chronic low-grade cytokine activation, including IL-6 and IL-1Î², which disrupts hypothalamic-pituitary-adrenal axis function and mitochondrial bioenergetics.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dgabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[117]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Fibromyalgia, another chronic syndrome dominated by fatigue, exhibits similar cytokine alterations, with a 2023 review of immune profiling studies reporting elevated serum IL-6 (mean 2.5-fold increase), IL-8, and TNF-Î± in patients versus controls, correlating with tender point counts and fatigue indices (r=0.45 for IL-6, p&lt;0.001).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[118]</sup> Cross-syndrome meta-analyses underscore shared pro-inflammatory signatures, yet causality remains inferential, as interventional trials blocking cytokines like TNF-Î± have yielded mixed fatigue relief (e.g., 20-30% symptom reduction in small etanercept cohorts, p=0.04).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9gqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[119]</sup> Overall, while empirical data support cytokine involvement in fatigue pathogenesis across these syndromes, inconsistencies across studiesâ€”attributable to heterogeneity in patient selection, assay sensitivity, and confounders like comorbiditiesâ€”preclude definitive mechanistic attribution without further randomized controlled evidence.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[113]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fgqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[114]</sup></span>
<h2 id="therapeutic-applications" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Therapeutic Applications<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="pro-inflammatory-cytokine-therapies" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Pro-Inflammatory Cytokine Therapies<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Pro-inflammatory cytokine therapies harness the immune-stimulating properties of cytokines such as interleukin-2 (IL-2) and interferon-alpha (IFN-Î±) to treat malignancies and chronic viral infections, primarily by enhancing T-cell activation, natural killer cell cytotoxicity, and antiviral responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> These approaches exploit the cytokines&#x27; role in amplifying inflammation to target pathological cells, though systemic administration often induces dose-limiting toxicities mimicking cytokine storms, including hypotension, fever, and organ dysfunction.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[120]</sup> Early approvals, such as high-dose aldesleukin (recombinant IL-2) by the FDA in 1992 for metastatic renal cell carcinoma and 1998 for melanoma, demonstrated objective response rates of 15-28% with 5-10% complete remissions that can persist beyond 10 years in responders, underscoring causal efficacy in select patients despite limited overall survival benefits in broader populations.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_diabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[121]</sup> Similarly, IFN-Î±, approved in the 1980s for hairy cell leukemia and chronic hepatitis C, achieved sustained virologic response rates of up to 50% in interferon-sensitive genotypes when combined with ribavirin, though its use has declined with direct-acting antivirals.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hiabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[122]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">IL-2 therapy exemplifies the paradigm, where intravenous high-dose regimens (600,000-720,000 IU/kg every 8 hours for up to 14 doses) promote CD8+ T-cell expansion and tumor infiltration, yielding durable antitumor effects independent of PD-L1 expression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[12]</sup> However, adverse events affect over 90% of patients, with capillary leak syndrome causing vascular permeability, edema, and renal impairment in 70-80% of cases, necessitating intensive care monitoring and premedication with steroids or antihistamines.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9iqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[120]</sup> Low-dose subcutaneous IL-2 variants, explored in trials for autoimmune modulation at 1-3 million IU daily, show milder flu-like symptoms and injection-site reactions but reduced efficacy for oncology, prompting combinations with checkpoint inhibitors like nivolumab, which in phase III trials doubled progression-free survival to 11 months in melanoma versus IL-2 monotherapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_diqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[123]</sup> IFN-Î±, administered as pegylated forms (e.g., 180 Î¼g weekly for hepatitis B), induces antiviral states via JAK-STAT signaling, reducing HBV DNA in 30-40% of chronic carriers after 48 weeks, though relapse rates exceed 50% post-treatment due to incomplete immune clearance.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hiqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[124]</sup> In oncology, IFN-Î±2b monotherapy for melanoma post-resection extended relapse-free survival by 9 months in high-risk patients per meta-analyses of trials involving over 4,000 participants.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_liqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[125]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Tumor necrosis factor-alpha (TNF-Î±) administration has been trialed less frequently owing to profound toxicity, including hemorrhagic necrosis and septic shock at doses above 100 Î¼g/mÂ², limiting it to isolated perfusion for limb sarcomas or melanomas since the 1990s, where regional delivery achieves 50-80% response rates with tolerable systemic exposure.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[126]</sup> Emerging strategies mitigate off-target effects through protein engineering, such as IL-2 variants with biased high-affinity binding to IL-2RÎ²Î³ complexes on effector T cells (e.g., bempegaldesleukin, advancing in phase III as of 2023), which expand antitumor CD8+ populations 100-fold in preclinical models while sparing regulatory T cells and reducing vascular leak by 50%.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9jabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[127]</sup> Nanoparticle encapsulation or fusion with tumor-targeting antibodies further localizes delivery, as in cytokine-armed T-cell therapies showing 2-3 log-fold potency gains in xenograft studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_djabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[128]</sup> Despite these advances, pro-inflammatory therapies remain niche, with response durability tied to patient-specific factors like tumor mutational burden, and ongoing trials emphasize multimodal integration to balance efficacy against the inherent risk of exacerbating inflammation in non-responders.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hjabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[129]</sup></span>
<h3 id="anti-cytokine-interventions" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Anti-Cytokine Interventions<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Anti-cytokine interventions encompass biologic agents, including monoclonal antibodies (mAbs) that neutralize pro-inflammatory cytokines or block their receptors, as well as small-molecule Janus kinase (JAK) inhibitors that disrupt downstream signaling pathways shared by multiple cytokines. These therapies target excessive cytokine-driven inflammation in autoimmune and autoinflammatory diseases, demonstrating clinical efficacy in reducing disease activity and preventing tissue damage, though they carry risks of immunosuppression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[130]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7kabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[131]</sup> Development of these agents, beginning with TNF inhibitors in the late 1990s, has transformed management of conditions like rheumatoid arthritis (RA) and inflammatory bowel disease, with response rates often exceeding 50-70% in randomized trials for symptom relief and radiographic progression halt.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[132]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dkabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[133]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">TNF-Î± inhibitors, such as infliximab, adalimumab, and etanercept, bind soluble or membrane-bound TNF-Î±, inhibiting its interaction with receptors and thereby suppressing downstream inflammatory cascades. In RA patients, these agents achieve American College of Rheumatology 20% improvement criteria in up to 60-70% of cases when combined with methotrexate, significantly slowing joint erosion as evidenced by modified Sharp scores in long-term studies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[132]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7kqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[134]</sup> Similar benefits extend to psoriatic arthritis and Crohn&#x27;s disease, where infliximab induces remission in 30-50% of moderate-to-severe cases refractory to conventional therapy.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[133]</sup> However, TNF blockade increases susceptibility to serious infections, including tuberculosis reactivation and opportunistic pathogens like Listeria, with incidence rates 1.5-2 times higher than placebo in meta-analyses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_fkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[135]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hkqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[136]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Interleukin-6 (IL-6) pathway inhibitors, exemplified by tocilizumabâ€”a humanized mAb against the IL-6 receptorâ€”prevent IL-6-mediated signaling, which drives acute-phase responses and B-cell activation. Tocilizumab monotherapy yields Disease Activity Score 28 remission in approximately 30% of active RA patients over 24 weeks, with sustained efficacy in systemic juvenile idiopathic arthritis (sJIA) where it resolves fever and rash in over 80% of pediatric cases.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[137]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7labav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[138]</sup> In severe COVID-19 with cytokine release syndrome, early administration (IL-6 levels &lt;100 pg/mL) improved survival odds by modulating hyperinflammation, though benefits diminish in late-stage critical illness.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_blabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[139]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dlabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[140]</sup> Risks include elevated cholesterol, gastrointestinal perforations, and bacterial infections, particularly in the elderly.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hlabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[137]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">IL-1 inhibitors like anakinra, a recombinant IL-1 receptor antagonist, competitively block IL-1Î± and IL-1Î² binding, attenuating innate immune overactivation. In RA, subcutaneous anakinra (100 mg daily) reduces tender joint counts by 20-40% as monotherapy or adjunctively, with comparable efficacy to TNF inhibitors in early disease but higher injection-site reactions.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[141]</sup> Anakinra proves particularly effective in cryopyrin-associated periodic syndromes and recurrent pericarditis, achieving symptom resolution in 70-90% of refractory cases without disease flares upon continuation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9lqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[142]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_blqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[143]</sup> Infection rates rise modestly, akin to other biologics, but long-term use in non-cancer inflammation shows a favorable safety profile barring contraindications like active sepsis.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_flqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[144]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">JAK inhibitors, such as tofacitinib and baricitinib, non-selectively block JAK1/3 or JAK1/2, inhibiting signaling from cytokines like IL-2, IL-6, and interferons via STAT pathway disruption. In RA, tofacitinib achieves low disease activity in 40-60% of patients failing TNF therapy, offering oral convenience over injectables.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[145]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_7mabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[146]</sup> Selectivity varies; JAK3-focused inhibition suffices for alopecia areata reversal in preclinical models, while pan-JAK blockade aids myelofibrosis but heightens herpes zoster risk 2-4 fold due to impaired antiviral responses.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_bmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[147]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[148]</sup> Overall, anticytokine agents necessitate screening for latent infections pre-initiation, with post-marketing surveillance confirming dose-dependent immunosuppression as the primary adverse causal factor.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[149]</sup><sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_jmabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[150]</sup></span>
<h3 id="engineering-and-next-generation-developments" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Engineering and Next-Generation Developments<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Engineered cytokines mitigate inherent limitations of native forms, such as short serum half-life, systemic toxicity, and inadequate tissue specificity, through protein modifications that extend pharmacokinetics and enhance targeting. Strategies include fusion to Fc domains or albumin-binding motifs to increase circulatory persistence, as demonstrated in interleukin-2 (IL-2) variants where half-life extension reduced dosing frequency while preserving bioactivity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[151]</sup> Site-directed mutagenesis further refines receptor affinity; for instance, &quot;supercytokines&quot; like engineered IL-2 muteins exhibit reduced binding to the high-affinity IL-2 receptor alpha chain (CD25), minimizing regulatory T-cell activation and favoring effector T-cell expansion.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9nabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[152]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Immunocytokines, comprising cytokine-antibody fusions, enable tumor-selective delivery by leveraging antibody specificity for antigens like fibroblast activation protein or extracellular matrix components. A 2024 study reported that IL-2 fused to antibodies targeting pro-inflammatory cells improved antitumor efficacy in mouse models by concentrating cytokine activity at tumor sites, reducing off-target inflammation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[153]</sup> Similarly, fusions incorporating IL-12 or IL-15 with PD-L1-targeting moieties have shown promise in solid tumor models, where CAR-T cells serve as vehicles for localized cytokine release, enhancing persistence without broad immunosuppression.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9nqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[154]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Next-generation developments integrate cytokines with synthetic biology tools, including orthogonal receptor systems that decouple engineered ligands from endogenous pathways for conditional activation. In 2025 research, natural cytokine receptors were reprogrammed into synthetic variants responsive only to designer agonists, enabling precise control in cell therapies and avoiding cytokine storms.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[155]</sup> Armored chimeric antigen receptor (CAR) therapies embed cytokine transgenes, such as IL-18-secreting CAR-T cells, which revived exhausted T cells in refractory lymphoma patients, yielding objective responses in phase I trials with manageable toxicity.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9oabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[156]</sup> Nanoparticle encapsulation and bioconjugation further refine delivery, with polymeric carriers protecting labile cytokines like interferon-gamma during transit to hypoxic tumor niches.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_doabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[157]</sup> These approaches collectively elevate the therapeutic index, though challenges persist in scalability and immunogenicity, necessitating ongoing preclinical validation.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hoabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[158]</sup></span>
<h2 id="historical-and-evolutionary-context" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden" node="[object Object]">Historical and Evolutionary Context<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h2>
<h3 id="discovery-timeline" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Discovery Timeline<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">The identification of the first cytokine traces to 1957, when Alick Isaacs and Jean Lindenmann discovered interferon (IFN) as a soluble protein produced by virus-infected cells that induced resistance to viral replication in neighboring cells, marking the initial recognition of cytokine-like signaling in antiviral defense.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[159]</sup> This breakthrough laid the groundwork for understanding intercellular mediators beyond hormones or antibodies.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9pqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[160]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">In the early 1970s, research expanded to lymphocyte-derived factors, with Igal Gery and Byron Waksman describing &quot;lymphocyte activating factor&quot; (LAF) in 1972 as a macrophage-secreted product that stimulated T-cell proliferation, later identified as interleukin-1 (IL-1).<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> By 1974, Stanley Cohen coined the term &quot;cytokine&quot; to encompass these non-immunoglobulin, non-antibody proteins produced by various cells to regulate immune and inflammatory responses, broadening the concept beyond leukocyte-specific origins.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9qabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[21]</sup> Tumor necrosis factor (TNF), initially observed in 1975 for its cytotoxic effects on tumors, was purified and linked to cachexia in the mid-1980s.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_dqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[161]</sup> Interleukin-2 (IL-2), a T-cell growth factor, was isolated in 1976 from activated lymphocyte supernatants, enabling sustained T-cell expansion in vitro.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_hqabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[162]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">The 1980s accelerated molecular characterization through cloning: IFN-Î± and IL-2 cDNAs were sequenced in 1982â€“1983, followed by IL-1 and TNF-Î± in 1984, allowing recombinant production and functional dissection of their pleiotropic roles in immunity and pathology.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[20]</sup> These advances shifted cytokine research from phenomenological assays to genetic and structural analyses, revealing receptor interactions and signaling cascades essential for therapeutic targeting.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_9qqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[163]</sup></span>
<h3 id="evolutionary-origins-and-first-principles-rationale" class="group relative mb-2 mt-7 scroll-mt-24 font-serif text-[1.428571em] font-semibold" node="[object Object]">Evolutionary Origins and First-Principles Rationale<button class="focus-visible:ring-ring gap-x-2 whitespace-nowrap rounded-full font-medium focus-visible:outline-none focus-visible:ring-1 disabled:pointer-events-none disabled:cursor-not-allowed disabled:opacity-50 [&amp;&gt;[data-slot=icon]]:-mx-0.5 [&amp;&gt;[data-slot=icon]]:my-0.5 [&amp;&gt;[data-slot=icon]]:size-5 [&amp;&gt;[data-slot=icon]]:shrink-0 [&amp;&gt;[data-slot=icon]]:text-[--btn-icon] [&amp;&gt;[data-slot=icon]]:sm:my-1 [&amp;&gt;[data-slot=icon]]:sm:size-4 text-primary text-xs ml-2 inline-flex h-6 w-6 items-center justify-center p-0 align-middle opacity-0 transition-opacity hover:bg-gray-100 dark:hover:bg-gray-800" type="button" aria-label="Copy link to heading" data-state="closed"><svg xmlns="http://www.w3.org/2000/svg" width="24" height="24" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round" class="lucide lucide-link h-4 w-4"><path d="M10 13a5 5 0 0 0 7.54.54l3-3a5 5 0 0 0-7.07-7.07l-1.72 1.71"></path><path d="M14 11a5 5 0 0 0-7.54-.54l-3 3a5 5 0 0 0 7.07 7.07l1.71-1.71"></path></svg></button></h3>
<span class="mb-4 block break-words text-[1em] leading-7">Cytokines emerged as signaling molecules in early metazoan evolution to facilitate intercellular communication in response to environmental threats, with the interleukin-1 (IL-1) superfamily representing one of the most ancient lineages. Phylogenetic reconstruction indicates that proto-IL-1 ligands and receptors co-evolved through tandem gene duplications in the bilaterian ancestor, predating the Cambrian explosion around 540 million years ago and functioning primarily in innate immunity by alerting cells to damage-associated or pathogen-derived signals. This foundational circuitry, conserved in invertebrates such as insects and nematodes, underscores cytokines&#x27; role in coordinating basal defensive mechanisms without reliance on specialized adaptive components.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5rqbav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[164]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">Subsequent diversification occurred via whole-genome duplications during vertebrate evolution, approximately 500 million years ago, giving rise to class I helical cytokines like those in the common gamma chain (Î³c) family (e.g., IL-2, IL-4, IL-7, IL-9, IL-15, IL-21). These arose in jawed vertebrates, paralleling the advent of adaptive immunity, through mechanisms including tandem duplications and positive selection at pathogen-interacting sites, enabling finer regulation of lymphocyte proliferation and differentiation. Shared orthologs between teleost fish and mammals confirm their pre-existence before the teleost-specific genome duplication around 350 million years ago, highlighting evolutionary pressures from host-pathogen co-evolution that favored multifunctional signaling networks.<sup class="text-fg-secondary ml-[2px] cursor-pointer text-xs hover:underline" type="button" aria-haspopup="dialog" aria-expanded="false" aria-controls="radix-_R_5sabav9fiumdb_" data-state="closed" tabindex="-1" style="outline:none">[165]</sup></span>
<span class="mb-4 block break-words text-[1em] leading-7">From causal fundamentals, cytokines address the multicellular challenge of scaling localized threat detectionâ€”triggered by pattern recognition receptors binding conserved microbial motifsâ€”into collective action, such as phagocyte recruitment and vascular permeability changes, which probabilistically elevate survival against infection by amplifying effector responses while containing collateral tissue costs. Absent such diffusible mediators, isolated cellular reactions would yield suboptimal clearance, as evidenced by the lethal susceptibility to pathogens in cytokine-deficient models across taxa; their deep conservation reflects selection for systems that balance acute inflammation against chronic self-harm, prioritizing reproductive fitness in pathogen-rich ecologies.00260-X)</span></article><div id="references" class="min-w-0 scroll-mt-8 overflow-hidden"><div class="text-[16px]"><h2 id="references" node="[object Object]" class="mb-2 mt-7 scroll-mt-24 font-serif text-[1.714286em] font-semibold border-border-l1 pb-1 border-b overflow-hidden">References</h2></div><ol class="columns-1 gap-x-12 [counter-reset:item] md:columns-2"><li id="https://www.ncbi.nlm.nih.gov/books/NBK6294/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK6294/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK6294/</a></span></div></li><li id="https://www.nature.com/articles/s41586-023-06816-9" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41586-023-06816-9" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41586-023-06816-9</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2785020/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2785020/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2785020/</a></span></div></li><li id="https://www.nature.com/articles/s41392-024-01934-w" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41392-024-01934-w" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41392-024-01934-w</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK459450/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK459450/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK459450/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/</a></span></div></li><li id="https://www.nature.com/articles/s41392-025-02178-y" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41392-025-02178-y" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41392-025-02178-y</a></span></div></li><li id="https://users.pfw.edu/blumenth/Immunology/Cytokines.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://users.pfw.edu/blumenth/Immunology/Cytokines.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://users.pfw.edu/blumenth/Immunology/Cytokines.htm</a></span></div></li><li id="https://www2.nau.edu/~fpm/immunology/lectures/Chapter012.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www2.nau.edu/~fpm/immunology/lectures/Chapter012.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www2.nau.edu/~fpm/immunology/lectures/Chapter012.pdf</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK230989/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK230989/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK230989/</a></span></div></li><li id="https://www.nature.com/articles/s41416-018-0328-y" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41416-018-0328-y" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41416-018-0328-y</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC11923798/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC11923798/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC11923798/</a></span></div></li><li id="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cytokine" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cytokine" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cytokine</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S107476131930144X" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S107476131930144X" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S107476131930144X</a></span></div></li><li id="https://www.nature.com/articles/s41592-021-01274-5" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41592-021-01274-5" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41592-021-01274-5</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S2352081715000963" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S2352081715000963" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S2352081715000963</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/15063084/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/15063084/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/15063084/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0014299907012186" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0014299907012186" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0014299907012186</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/</a></span></div></li><li id="https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1607-y" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1607-y" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1607-y</a></span></div></li><li id="https://onlinelibrary.wiley.com/doi/10.1002/eji.200737772" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://onlinelibrary.wiley.com/doi/10.1002/eji.200737772" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://onlinelibrary.wiley.com/doi/10.1002/eji.200737772</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1521692625000179" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1521692625000179" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1521692625000179</a></span></div></li><li id="https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/cytokine" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/cytokine" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/cytokine</a></span></div></li><li id="https://www.news-medical.net/health/Cytokine-Nomenclature.aspx" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.news-medical.net/health/Cytokine-Nomenclature.aspx" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.news-medical.net/health/Cytokine-Nomenclature.aspx</a></span></div></li><li id="https://www.mattioli1885journals.com/index.php/MedHistor/article/download/15526/11924/119610" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mattioli1885journals.com/index.php/MedHistor/article/download/15526/11924/119610" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mattioli1885journals.com/index.php/MedHistor/article/download/15526/11924/119610</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7243804/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7243804/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7243804/</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01424/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01424/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01424/full</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01412/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01412/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01412/full</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387</a></span></div></li><li id="https://www.aatbio.com/resources/faq-frequently-asked-questions/what-are-the-differences-between-cytokines-and-hormones" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.aatbio.com/resources/faq-frequently-asked-questions/what-are-the-differences-between-cytokines-and-hormones" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.aatbio.com/resources/faq-frequently-asked-questions/what-are-the-differences-between-cytokines-and-hormones</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK9902/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK9902/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK9902/</a></span></div></li><li id="https://my.clevelandclinic.org/health/body/24585-cytokines" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://my.clevelandclinic.org/health/body/24585-cytokines" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://my.clevelandclinic.org/health/body/24585-cytokines</a></span></div></li><li id="https://joe.bioscientifica.com/view/journals/joe/128/2/joe_128_2_001.pdf" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://joe.bioscientifica.com/view/journals/joe/128/2/joe_128_2_001.pdf" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://joe.bioscientifica.com/view/journals/joe/128/2/joe_128_2_001.pdf</a></span></div></li><li id="https://njms.rutgers.edu/departments/pathology/genpath/lec_1/Comparison_of_H___C/comparison_of_h___c.htm" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://njms.rutgers.edu/departments/pathology/genpath/lec_1/Comparison_of_H___C/comparison_of_h___c.htm" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://njms.rutgers.edu/departments/pathology/genpath/lec_1/Comparison_of_H___C/comparison_of_h___c.htm</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3981547/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3981547/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3981547/</a></span></div></li><li id="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/cytokine-receptor" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/cytokine-receptor" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/cytokine-receptor</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4445396/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4445396/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4445396/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1074761319301451" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1074761319301451" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1074761319301451</a></span></div></li><li id="https://rupress.org/jem/article/217/1/e20191247/132567/Effects-of-interleukin-2-in-immunostimulation-and" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://rupress.org/jem/article/217/1/e20191247/132567/Effects-of-interleukin-2-in-immunostimulation-and" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://rupress.org/jem/article/217/1/e20191247/132567/Effects-of-interleukin-2-in-immunostimulation-and</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/21856167/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/21856167/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/21856167/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6914340/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6914340/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6914340/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/</a></span></div></li><li id="https://www.nature.com/articles/s41392-021-00791-1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41392-021-00791-1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41392-021-00791-1</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3899974/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3899974/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3899974/</a></span></div></li><li id="https://www.nature.com/articles/sigtrans201723" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/sigtrans201723" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/sigtrans201723</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4670773/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4670773/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4670773/</a></span></div></li><li id="https://www.sinobiological.com/resource/cytokines/all-proinflammatory-cytokines" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sinobiological.com/resource/cytokines/all-proinflammatory-cytokines" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sinobiological.com/resource/cytokines/all-proinflammatory-cytokines</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10917571/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10917571/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10917571/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/7946039/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/7946039/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/7946039/</a></span></div></li><li id="https://www.cell.com/cell/fulltext/S0092-8674%2824%2900352-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cell.com/cell/fulltext/S0092-8674%2824%2900352-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cell.com/cell/fulltext/S0092-8674%2824%2900352-0</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7174020/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7174020/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7174020/</a></span></div></li><li id="https://ashpublications.org/blood/article/118/1/9/28431/Cytokine-release-from-innate-immune-cells" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ashpublications.org/blood/article/118/1/9/28431/Cytokine-release-from-innate-immune-cells" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ashpublications.org/blood/article/118/1/9/28431/Cytokine-release-from-innate-immune-cells</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3107839/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3107839/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3107839/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6152841/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6152841/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6152841/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2677548/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2677548/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2677548/</a></span></div></li><li id="https://www.cell.com/stem-cell-reports/fulltext/S2213-6711%2823%2900452-6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cell.com/stem-cell-reports/fulltext/S2213-6711%2823%2900452-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cell.com/stem-cell-reports/fulltext/S2213-6711%2823%2900452-6</a></span></div></li><li id="https://rupress.org/jem/article/218/7/e20201545/212383/Inflammatory-signaling-regulates-hematopoietic" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://rupress.org/jem/article/218/7/e20201545/212383/Inflammatory-signaling-regulates-hematopoietic" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://rupress.org/jem/article/218/7/e20201545/212383/Inflammatory-signaling-regulates-hematopoietic</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2761713/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2761713/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2761713/</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1161067/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1161067/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1161067/full</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.641986/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.641986/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.641986/full</a></span></div></li><li id="https://www.nature.com/articles/s41590-019-0557-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41590-019-0557-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41590-019-0557-0</a></span></div></li><li id="https://www.rndsystems.com/resources/articles/cytokines-wound-healing" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.rndsystems.com/resources/articles/cytokines-wound-healing" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.rndsystems.com/resources/articles/cytokines-wound-healing</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3377328/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3377328/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3377328/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9308828/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9308828/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9308828/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9909416/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9909416/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9909416/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/9159205/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/9159205/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/9159205/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6929211/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6929211/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6929211/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4176007/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4176007/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4176007/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/8996253/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/8996253/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/8996253/</a></span></div></li><li id="https://www.pnas.org/doi/10.1073/pnas.191214498" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.pnas.org/doi/10.1073/pnas.191214498" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.pnas.org/doi/10.1073/pnas.191214498</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10818686/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10818686/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10818686/</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMra2026131" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMra2026131" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMra2026131</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8876409/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8876409/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8876409/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7079934/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7079934/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7079934/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/</a></span></div></li><li id="https://www.mdpi.com/1422-0067/22/20/10922" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.mdpi.com/1422-0067/22/20/10922" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.mdpi.com/1422-0067/22/20/10922</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5337858/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5337858/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5337858/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/</a></span></div></li><li id="https://jitc.bmj.com/content/11/11/e007530" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://jitc.bmj.com/content/11/11/e007530" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://jitc.bmj.com/content/11/11/e007530</a></span></div></li><li id="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692142/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692142/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692142/full</a></span></div></li><li id="https://www.nature.com/articles/s41392-024-01868-3" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41392-024-01868-3" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41392-024-01868-3</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6350412/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6350412/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6350412/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5025335/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5025335/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5025335/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4141874/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4141874/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4141874/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2745948/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2745948/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2745948/</a></span></div></li><li id="https://journals.biologists.com/jeb/article/224/9/jeb225847/260576/Sickness-behaviors-across-vertebrate-taxa" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.biologists.com/jeb/article/224/9/jeb225847/260576/Sickness-behaviors-across-vertebrate-taxa" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.biologists.com/jeb/article/224/9/jeb225847/260576/Sickness-behaviors-across-vertebrate-taxa</a></span></div></li><li id="https://www.nature.com/articles/1395490" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/1395490" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/1395490</a></span></div></li><li id="https://www.pnas.org/doi/10.1073/pnas.1014557107" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.pnas.org/doi/10.1073/pnas.1014557107" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.pnas.org/doi/10.1073/pnas.1014557107</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3741070/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3741070/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3741070/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10213648/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10213648/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10213648/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC4250287/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC4250287/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC4250287/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2666354622001442" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2666354622001442" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2666354622001442</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8878213/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8878213/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8878213/</a></span></div></li><li id="https://www.nature.com/articles/s41398-025-03532-y" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41398-025-03532-y" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41398-025-03532-y</a></span></div></li><li id="https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1538026/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1538026/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1538026/full</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/</a></span></div></li><li id="https://ashpublications.org/blood/article/124/2/188/32896/Current-concepts-in-the-diagnosis-and-management" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ashpublications.org/blood/article/124/2/188/32896/Current-concepts-in-the-diagnosis-and-management" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ashpublications.org/blood/article/124/2/188/32896/Current-concepts-in-the-diagnosis-and-management</a></span></div></li><li id="https://www.uptodate.com/contents/cytokine-release-syndrome-crs" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.uptodate.com/contents/cytokine-release-syndrome-crs" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.uptodate.com/contents/cytokine-release-syndrome-crs</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/30586620/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/30586620/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/30586620/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/29808005/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/29808005/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/29808005/</a></span></div></li><li id="https://ashpublications.org/bloodadvances/article/4/4/676/452527/Comparing-CAR-T-cell-toxicity-grading-systems" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ashpublications.org/bloodadvances/article/4/4/676/452527/Comparing-CAR-T-cell-toxicity-grading-systems" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ashpublications.org/bloodadvances/article/4/4/676/452527/Comparing-CAR-T-cell-toxicity-grading-systems</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6825470/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6825470/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6825470/</a></span></div></li><li id="https://www.astctjournal.org/article/S1083-8791%2818%2931691-4/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.astctjournal.org/article/S1083-8791%2818%2931691-4/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.astctjournal.org/article/S1083-8791%2818%2931691-4/fulltext</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/30592986/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/30592986/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/30592986/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/36590643/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/36590643/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/36590643/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/</a></span></div></li><li id="https://www.nature.com/articles/s41392-023-01502-8" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41392-023-01502-8" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41392-023-01502-8</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6146930/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6146930/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6146930/</a></span></div></li><li id="https://www.pnas.org/doi/10.1073/pnas.1710519114" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.pnas.org/doi/10.1073/pnas.1710519114" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.pnas.org/doi/10.1073/pnas.1710519114</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6708220/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6708220/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6708220/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/31465778/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/31465778/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/31465778/</a></span></div></li><li id="https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05148-0" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05148-0" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05148-0</a></span></div></li><li id="https://www.nature.com/articles/s41590-023-01724-6" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41590-023-01724-6" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41590-023-01724-6</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10103649/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10103649/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10103649/</a></span></div></li><li id="https://www.explorationpub.com/Journals/ei/Article/1003206" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.explorationpub.com/Journals/ei/Article/1003206" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.explorationpub.com/Journals/ei/Article/1003206</a></span></div></li><li id="https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0971-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0971-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0971-z</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC8480956/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8480956/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC8480956/</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1433989/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1433989/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1433989/full</a></span></div></li><li id="https://www.ncbi.nlm.nih.gov/books/NBK547867/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ncbi.nlm.nih.gov/books/NBK547867/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ncbi.nlm.nih.gov/books/NBK547867/</a></span></div></li><li id="https://www.nature.com/articles/s41392-022-00887-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41392-022-00887-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41392-022-00887-2</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.733364/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.733364/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.733364/full</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/38110058/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/38110058/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/38110058/</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.903679/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.903679/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.903679/full</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10330431/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10330431/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10330431/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/37104673/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/37104673/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/37104673/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC10357296/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC10357296/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC10357296/</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/19519438/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/19519438/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/19519438/</a></span></div></li><li id="https://www.nature.com/articles/ni.3612" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/ni.3612" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/ni.3612</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC3956207/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC3956207/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC3956207/</a></span></div></li><li id="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.591365/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.591365/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.591365/full</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC2111629/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC2111629/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC2111629/</a></span></div></li><li id="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2825%2900421-3/fulltext" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2825%2900421-3/fulltext" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2825%2900421-3/fulltext</a></span></div></li><li id="https://www.sciencedirect.com/science/article/abs/pii/S0264410X03001968" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/abs/pii/S0264410X03001968" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/abs/pii/S0264410X03001968</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC5074778/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5074778/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC5074778/</a></span></div></li><li id="https://www.nature.com/articles/s41584-020-0419-z" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41584-020-0419-z" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41584-020-0419-z</a></span></div></li><li id="https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.651662/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.651662/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.651662/full</a></span></div></li><li id="https://www.nejm.org/doi/full/10.1056/NEJMoa2100433" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nejm.org/doi/full/10.1056/NEJMoa2100433" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nejm.org/doi/full/10.1056/NEJMoa2100433</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/15172046/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/15172046/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/15172046/</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/JAHA.121.021685" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/JAHA.121.021685" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/JAHA.121.021685</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7326122/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7326122/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7326122/</a></span></div></li><li id="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.01157/full" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.01157/full" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.01157/full</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC6168198/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC6168198/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC6168198/</a></span></div></li><li id="https://ard.bmj.com/content/83/2/139" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://ard.bmj.com/content/83/2/139" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://ard.bmj.com/content/83/2/139</a></span></div></li><li id="https://insight.jci.org/articles/view/142205" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://insight.jci.org/articles/view/142205" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://insight.jci.org/articles/view/142205</a></span></div></li><li id="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313129" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313129" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313129</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/17917545/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/17917545/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/17917545/</a></span></div></li><li id="https://journals.sagepub.com/doi/10.1177/0885066604267854" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://journals.sagepub.com/doi/10.1177/0885066604267854" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://journals.sagepub.com/doi/10.1177/0885066604267854</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S2590018825000243" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S2590018825000243" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S2590018825000243</a></span></div></li><li id="https://www.nature.com/articles/s41467-019-11782-w" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41467-019-11782-w" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41467-019-11782-w</a></span></div></li><li id="https://insight.jci.org/articles/view/173469" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://insight.jci.org/articles/view/173469" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://insight.jci.org/articles/view/173469</a></span></div></li><li id="https://www.nature.com/articles/s41551-025-01509-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41551-025-01509-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41551-025-01509-2</a></span></div></li><li id="https://www.nature.com/articles/s41589-025-01986-1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41589-025-01986-1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41589-025-01986-1</a></span></div></li><li id="https://www.cell.com/trends/cancer/fulltext/S2405-8033%2825%2900151-7" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.cell.com/trends/cancer/fulltext/S2405-8033%2825%2900151-7" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.cell.com/trends/cancer/fulltext/S2405-8033%2825%2900151-7</a></span></div></li><li id="https://www.tandfonline.com/doi/abs/10.1080/17425247.2023.2208344" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.tandfonline.com/doi/abs/10.1080/17425247.2023.2208344" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.tandfonline.com/doi/abs/10.1080/17425247.2023.2208344</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9933837/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9933837/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9933837/</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC7123835/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC7123835/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC7123835/</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S0021925819779939" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S0021925819779939" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S0021925819779939</a></span></div></li><li id="https://www.sciencedirect.com/science/article/pii/S1359610114000781" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.sciencedirect.com/science/article/pii/S1359610114000781" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.sciencedirect.com/science/article/pii/S1359610114000781</a></span></div></li><li id="https://irp.nih.gov/accomplishments/discovery-of-interleukin-2-il-2" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://irp.nih.gov/accomplishments/discovery-of-interleukin-2-il-2" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://irp.nih.gov/accomplishments/discovery-of-interleukin-2-il-2</a></span></div></li><li id="https://pubmed.ncbi.nlm.nih.gov/11530802/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pubmed.ncbi.nlm.nih.gov/11530802/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pubmed.ncbi.nlm.nih.gov/11530802/</a></span></div></li><li id="https://www.nature.com/articles/s41467-018-03362-1" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://www.nature.com/articles/s41467-018-03362-1" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://www.nature.com/articles/s41467-018-03362-1</a></span></div></li><li id="https://pmc.ncbi.nlm.nih.gov/articles/PMC9465101/" class="mb-2 grid break-inside-avoid grid-cols-[auto_1fr] gap-2 text-sm leading-relaxed [counter-increment:item] before:font-semibold before:content-[counter(item)&#x27;.&#x27;]"><div class="relative -top-[3px] overflow-hidden break-words text-[16px] [&amp;_*]:mb-0"><span class="mb-4 block break-words text-[1em] leading-7"><a href="https://pmc.ncbi.nlm.nih.gov/articles/PMC9465101/" target="_blank" rel="noopener noreferrer" class="break-all text-[1em] text-blue-500 hover:underline dark:text-blue-300">https://pmc.ncbi.nlm.nih.gov/articles/PMC9465101/</a></span></div></li></ol></div></div></div><div class="hidden min-[1400px]:block"></div></div></div><!--$--><!--/$--><div role="region" aria-label="Notifications (F8)" tabindex="-1" style="pointer-events:none"><ol tabindex="-1" class="pointer-events-none fixed top-0 z-[100] flex max-h-screen w-full flex-col-reverse p-4 max-sm:left-0 sm:bottom-0 sm:right-0 sm:top-auto sm:max-w-[420px] sm:flex-col pl-16 pr-2 pt-16 sm:px-4"></ol></div><script type="application/json" id="server-client-data-experimentation">{"status":"uninitialized"}</script><script src="/_next/static/chunks/webpack-e121ed42680f327e.js" nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm" id="_R_" async=""></script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">(self.__next_f=self.__next_f||[]).push([0])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"1:\"$Sreact.fragment\"\n3:I[91363,[],\"\"]\n4:I[23775,[],\"\"]\n5:I[57654,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"PageHeaderProvider\"]\n6:I[17618,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"3699\",\"static/chunks/app/page/%5Bslug%5D/layout-55a344716dd57c44.js\"],\"HeaderContent\"]\n7:I[25529,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"6751\",\"static/chunks/app/page/%5Bslug%5D/not-found-69a3edc7db5749d6.js\"],\"default\"]\n9:I[6666,[],\"OutletBoundary\"]\nb:I[80415,[],\"AsyncMetadataOutlet\"]\nd:I[6666,[],\"ViewportBoundary\"]\nf:I[6666,[],\"MetadataBoundary\"]\n10:\"$Sreact.suspense\"\n12:I[95909,[\"4219\",\"static/chunks/app/global-error-4d07d20223cd4b4c.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"13:I[51498,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"ConstantsProvider\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"14:I[91073,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"15:I[38642,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"16:I[99648,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"17:I[78825,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"18:I[8550,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MixpanelProvider\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"19:I[12290,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"MobileTocProvider\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"1a:I[53947,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"NuqsAdapter\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"1b:I[91873,[\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8039\",\"static/chunks/app/error-4a29e9399afba038.js\"],\"default\"]\n1c:I[5091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"7618\",\"static/chunks/7618-43536a8fb0dd3bfe.js\",\"4345\",\"static/chunks/app/not-found-dd95690acf732f18.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"1d:I[16091,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"927\",\"static/chunks/927-34e2a6da3e15e26b.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"2660\",\"static/chunks/2660-d983a7f287e89f18.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"3655\",\"static/chunks/3655-6717081f7512305a.js\",\"8945\",\"static/chunks/8945-e4e3cf487f5e27c7.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"2225\",\"static/chunks/2225-454cf9f44775e7ce.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"7177\",\"static/chunks/app/layout-226f2bd71acf9f9e.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,":HL[\"/_next/static/media/1f2316909698f815.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/3d4419af2cf8609b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/4dec29efcaeb336c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/74452ea3ef0f9101.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/904ef0a86fe32a00.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/d886a03bcda7ad8f.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/e1447589d6f59c4b.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/media/f5a90156f8995c8c.p.woff2\",\"font\",{\"crossOrigin\":\"\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"type\":\"font/woff2\"}]\n:HL[\"/_next/static/css/62c4caba71dfda84.css\",\"style\",{\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}]\n:HL[\"/_next/static/css/eb3d87f98fe1565f.css\",\"style\",{\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}]\n:HL[\"/_next/static/css/1b5e561215938d4d.css\",\"style\",{\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}]\n:HL[\"/_next/static/css/0227d069a630d414.css\",\"style\",{\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}]\n:HL[\"/_next/static/css/f87fff2ab93d05a7.css\",\"style\",{\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"0:{\"P\":null,\"b\":\"BpM29AX4fmgcUxZ_6t0le\",\"p\":\"\",\"c\":[\"\",\"page\",\"Cytokine\"],\"i\":false,\"f\":[[[\"\",{\"children\":[\"page\",{\"children\":[[\"slug\",\"Cytokine\",\"d\"],{\"children\":[\"__PAGE__\",{}]}]}]},\"$undefined\",\"$undefined\",true],[\"\",[\"$\",\"$1\",\"c\",{\"children\":[[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/62c4caba71dfda84.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}],[\"$\",\"link\",\"1\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/eb3d87f98fe1565f.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}],[\"$\",\"link\",\"2\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/1b5e561215938d4d.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}],[\"$\",\"link\",\"3\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/0227d069a630d414.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}]],\"$L2\"]}],{\"children\":[\"page\",[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":\"$undefined\",\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}],{\"children\":[[\"slug\",\"Cytokine\",\"d\"],[\"$\",\"$1\",\"c\",{\"children\":[null,[\"$\",\"$L5\",null,{\"children\":[[\"$\",\"$L6\",null,{\"maxWidth\":\"full\",\"mobileOptions\":{\"right\":{\"showFixedIssues\":true,\"showThemeSwitcher\":true,\"showSearch\":true,\"showTableOfContents\":true}}}],[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$undefined\",\"errorStyles\":\"$undefined\",\"errorScripts\":\"$undefined\",\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L7\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}]]}]]}],{\"children\":[\"__PAGE__\",[\"$\",\"$1\",\"c\",{\"children\":[\"$L8\",[[\"$\",\"link\",\"0\",{\"rel\":\"stylesheet\",\"href\":\"/_next/static/css/f87fff2ab93d05a7.css\",\"precedence\":\"next\",\"crossOrigin\":\"$undefined\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\"}]],[\"$\",\"$L9\",null,{\"children\":[\"$La\",[\"$\",\"$Lb\",null,{\"promise\":\"$@c\"}]]}]]}],{},null,false]},null,false]},null,false]},null,false],[\"$\",\"$1\",\"h\",{\"children\":[null,[[\"$\",\"$Ld\",null,{\"children\":\"$Le\"}],[\"$\",\"meta\",null,{\"name\":\"next-size-adjust\",\"content\":\"\"}]],[\"$\",\"$Lf\",null,{\"children\":[\"$\",\"div\",null,{\"hidden\":true,\"children\":[\"$\",\"$10\",null,{\"fallback\":null,\"children\":\"$L11\"}]}]}]]}],false]],\"m\":\"$undefined\",\"G\":[\"$12\",[]],\"s\":false,\"S\":false}\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"2:[\"$\",\"html\",null,{\"lang\":\"en\",\"className\":\"bg-surface-base antialiased\",\"suppressHydrationWarning\":true,\"children\":[[\"$\",\"head\",null,{\"children\":[[\"$\",\"title\",null,{\"children\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"type\":\"image/x-icon\",\"href\":\"/favicon.ico\",\"sizes\":\"48x48\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-dark.png\",\"media\":\"(prefers-color-scheme: light)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"icon\",\"href\":\"/images/icon-light.png\",\"media\":\"(prefers-color-scheme: dark)\",\"type\":\"image/png\"}],[\"$\",\"link\",null,{\"rel\":\"apple-touch-icon\",\"href\":\"/icon-192x192.png\"}],[\"$\",\"link\",null,{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\"}],[\"$\",\"meta\",null,{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",null,{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"meta\",null,{\"property\":\"og:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"property\":\"og:url\",\"content\":\"https://grokipedia.com\"}],[\"$\",\"meta\",null,{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"property\":\"og:locale\",\"content\":\"en_US\"}],[\"$\",\"meta\",null,{\"property\":\"og:type\",\"content\":\"website\"}],[\"$\",\"meta\",null,{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",null,{\"property\":\"og:image:alt\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:title\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:description\",\"content\":\"Grokipedia is an open source, comprehensive collection of all knowledge.\"}],[\"$\",\"meta\",null,{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}]]}],[\"$\",\"body\",null,{\"className\":\"flex h-[100svh] w-full flex-col __variable_13c637 __variable_8a0ba0 __variable_779740 __variable_2484fd __variable_525cc3 __variable_13486b\",\"children\":[[\"$\",\"$L13\",null,{\"children\":[\"$\",\"$L14\",null,{\"children\":[\"$\",\"$L15\",null,{\"defaultTheme\":\"dark\",\"nonce\":\"ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm\",\"children\":[\"$\",\"$L16\",null,{\"children\":[\"$\",\"$L17\",null,{\"children\":[\"$\",\"$L18\",null,{\"children\":[\"$\",\"$L19\",null,{\"children\":[\"$\",\"$L1a\",null,{\"children\":[[\"$\",\"$L3\",null,{\"parallelRouterKey\":\"children\",\"error\":\"$1b\",\"errorStyles\":[],\"errorScripts\":[],\"template\":[\"$\",\"$L4\",null,{}],\"templateStyles\":\"$undefined\",\"templateScripts\":\"$undefined\",\"notFound\":[[\"$\",\"$L1c\",null,{}],[]],\"forbidden\":\"$undefined\",\"unauthorized\":\"$undefined\"}],[\"$\",\"$L1d\",null,{}]]}]}]}]}]}]}]}]}],[\"$\",\"script\",null,{\"type\":\"application/json\",\"id\":\"server-client-data-experimentation\",\"children\":\"{\\\"status\\\":\\\"uninitialized\\\"}\"}]]}]]}]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"e:[[\"$\",\"meta\",\"0\",{\"charSet\":\"utf-8\"}],[\"$\",\"meta\",\"1\",{\"name\":\"viewport\",\"content\":\"width=device-width, initial-scale=1, interactive-widget=resizes-content\"}]]\na:null\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"1e:I[42712,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"HydrationBoundary\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"21:I[6367,[],\"IconMark\"]\n1f:T15112,"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"# Cytokine\n\n![Cytokine release from immune cells](./_assets_/Cytokine_release.jpg)\nCytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis.[](https://www.ncbi.nlm.nih.gov/books/NBK6294/)[](https://www.nature.com/articles/s41586-023-06816-9)\nProduced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which trigger intracellular cascades such as the JAK-STAT pathway to modulate gene expression and cellular behaviors like proliferation, differentiation, apoptosis, and migration.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2785020/)[](https://www.nature.com/articles/s41392-024-01934-w)\nMajor cytokine families include interleukins (e.g., IL-1, IL-6), interferons (e.g., IFN-Î±, IFN-Î³), tumor necrosis factors (e.g., TNF-Î±), and chemokines, characterized by pleiotropyâ€”where one cytokine influences multiple cell types and functionsâ€”and redundancy, allowing overlapping biological activities across different molecules.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/)[](https://www.ncbi.nlm.nih.gov/books/NBK459450/)\nEssential for orchestrating innate and adaptive immunity against pathogens, cytokines also contribute to wound healing and developmental processes, yet their dysregulation underlies numerous pathologies, including autoimmune disorders, chronic inflammatory conditions, and life-threatening cytokine storms in severe infections or during cytokine-based immunotherapies.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/)[](https://www.nature.com/articles/s41392-025-02178-y)\n\n## Definition and Characteristics\n\n### Core Definition and Properties\n\nCytokines constitute a diverse group of small secreted proteins produced primarily by immune cells, such as lymphocytes, macrophages, and dendritic cells, that serve as key mediators of intercellular signaling in the regulation of immunity, inflammation, hematopoiesis, and tissue repair.[](https://www.ncbi.nlm.nih.gov/books/NBK459450/) These proteins are synthesized de novo in response to environmental stimuli like pathogens or tissue damage, rather than being pre-stored, enabling precise, transient control over cellular activities.[](https://users.pfw.edu/blumenth/Immunology/Cytokines.htm) The term \"cytokine,\" introduced by Stanley Cohen in 1974, originates from Greek roots denoting \"cell movement,\" underscoring their role in coordinating dynamic cellular interactions within the immune system.[](https://www.ncbi.nlm.nih.gov/books/NBK459450/)[](https://www2.nau.edu/~fpm/immunology/lectures/Chapter012.pdf)\n\nStructurally, cytokines are typically polypeptides or glycoproteins with molecular weights between 8 and 30 kilodaltons, often featuring alpha-helical bundles or four-helix motifs that facilitate receptor binding.[](https://www.ncbi.nlm.nih.gov/books/NBK230989/)[](https://www.nature.com/articles/s41416-018-0328-y) This compact size allows for rapid diffusion and local action, predominantly in paracrine or autocrine fashions, though certain cytokines like interleukins can exhibit endocrine effects at systemic levels under specific conditions.[](https://www.ncbi.nlm.nih.gov/books/NBK6294/) Their production is tightly regulated, with expression levels fluctuating dramaticallyâ€”often increasing by orders of magnitude within hours of stimulationâ€”to amplify or suppress immune responses as needed.[](https://www.ncbi.nlm.nih.gov/books/NBK6294/)\n\nA fundamental property of cytokines is their high specificity for cognate receptors on target cells, which are transmembrane proteins that, upon ligand binding, initiate signal transduction pathways such as JAK-STAT, MAPK, or PI3K-Akt, ultimately altering gene transcription and protein synthesis.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC11923798/) This receptor-mediated mechanism ensures directional signaling, distinguishing cytokines from nonspecific soluble factors, while their short half-livesâ€”typically minutes to hoursâ€”prevent prolonged effects without continuous production.[](https://www.nature.com/articles/s41392-024-01934-w) Cytokines lack intrinsic enzymatic activity, relying entirely on receptor engagement for biological function, which underscores their dependence on cellular context for efficacy.[](https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cytokine)\n\n### Pleiotropy, Redundancy, and Antagonism\n\nCytokines frequently display **pleiotropy**, the capacity of a single cytokine to exert diverse biological effects on multiple cell types or within different physiological contexts, often mediated by widespread receptor expression and variable downstream signaling. For example, interleukin-6 (IL-6) promotes acute-phase responses in hepatocytes, supports B-cell differentiation into plasma cells, and drives T-cell differentiation toward Th17 phenotypes, while also exhibiting context-dependent pro- or anti-inflammatory roles depending on signaling via classic or trans-signaling pathways.75588-9/fulltext)[](https://www.sciencedirect.com/science/article/pii/S107476131930144X) This pleiotropic nature enhances adaptive immune flexibility but poses challenges for selective therapeutic intervention, as inhibiting one function may disrupt others.[](https://www.nature.com/articles/s41592-021-01274-5)\n\n**Redundancy** characterizes the overlap in functions among distinct cytokines, where multiple molecules induce similar cellular responses through shared receptor subunits or convergent signaling cascades, providing evolutionary robustness to immune signaling networks. Type I interferons (e.g., IFN-Î± and IFN-Î²) exemplify this, as over a dozen subtypes bind a common heterodimeric receptor (IFNAR), eliciting comparable antiviral states, natural killer cell activation, and upregulation of MHC class I molecules across target cells. Similarly, within the common Î³-chain receptor family, cytokines like IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21 share signaling components, yielding redundant T-cell proliferation and survival signals. This redundancy buffers against single-cytokine deficiencies but amplifies risks of hyperactivation in pathological states.75588-9/fulltext)[](https://www.nature.com/articles/s41592-021-01274-5)\n\n**Antagonism** describes instances where one cytokine directly inhibits or offsets the effects of another, facilitating balanced regulation of inflammation and immune polarization. Pro-inflammatory cytokines such as IFN-Î³, which enhances macrophage phagocytosis and Th1 responses, are antagonized by IL-4, which promotes Th2 differentiation and suppresses IFN-Î³-driven pathways via STAT6 activation. IL-10 further exemplifies antagonism by binding its receptor on immune cells to transcriptionally repress pro-inflammatory genes, thereby inhibiting TNF-Î± and IL-1 production and mitigating excessive tissue damage during infection or autoimmunity. These interactions, rooted in competitive receptor engagement or opposing transcription factor activation, underscore cytokines' role in dynamic homeostasis, though their disruption contributes to chronic diseases like rheumatoid arthritis.[](https://www.sciencedirect.com/science/article/abs/pii/S2352081715000963)[](https://pubmed.ncbi.nlm.nih.gov/15063084/)[](https://www.sciencedirect.com/science/article/abs/pii/S0014299907012186)\n\n## Nomenclature and Classification\n\n### Terminology Evolution\n\nThe term \"lymphokine\" emerged in the late 1960s to describe soluble proteins secreted by activated lymphocytes that modulated immune responses, distinguishing them from hormones due to their localized paracrine action.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) This nomenclature reflected an early emphasis on cellular origin, as researchers identified factors like migration inhibition factor from lymphocyte supernatants.[](https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1607-y) Similarly, \"monokine\" was coined for analogous mediators from monocytes and macrophages, such as those promoting fever or acute-phase responses, highlighting source-specific classification amid limited understanding of functional overlap.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/)[](https://onlinelibrary.wiley.com/doi/10.1002/eji.200737772)\n\nIn 1974, Stanley Cohen and colleagues proposed the term \"cytokine,\" derived from Greek roots *cyto-* (cell) and *-kine* (movement), to unify these factors under a broader descriptor for any cell-derived, non-immunoglobulin signaling proteins that induce cellular movement or activity.[](https://www.ncbi.nlm.nih.gov/books/NBK6294/)[](https://www.sciencedirect.com/science/article/pii/S1521692625000179) This shift addressed the recognition that non-leukocytic cells, including fibroblasts and endothelial cells, also produced such mediators, rendering cell-type-specific terms like lymphokine and monokine overly restrictive.[](https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1607-y) Cytokines were characterized as low-molecular-weight (typically under 30 kDa) regulatory peptides acting primarily via paracrine or autocrine mechanisms, contrasting with endocrine hormones.[](https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/cytokine)\n\nSubsequent refinements introduced systematic subclassifications. The \"interleukin\" nomenclature began in 1979 with IL-1 (initially termed lymphocyte-activating factor) and IL-2 (T-cell growth factor), assigning sequential numbers to cytokines presumed to act on leukocytes, moving away from activity-based naming (e.g., macrophage migration inhibitory factor) toward a neutral, discovery-order system.[](https://www.news-medical.net/health/Cytokine-Nomenclature.aspx)[](https://www.mattioli1885journals.com/index.php/MedHistor/article/download/15526/11924/119610) This evolved to encompass broader immunomodulatory roles, with interleukins now numbering over 30 distinct members, though the term's leukocyte-centric origin proved imprecise as targets expanded to diverse cell types.[](https://www.news-medical.net/health/Cytokine-Nomenclature.aspx) Parallel terms like \"interferons\" (coined in 1957 for antiviral proteins) and \"chemokines\" (1990s, for chemoattractants) further diversified the lexicon, reflecting functional specialization while retaining \"cytokine\" as the inclusive category for pleiotropic, redundant signaling molecules.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7243804/) By the 1990s, cytokine terminology stabilized around structural families (e.g., four-helix bundles) and functional clusters (pro- vs. anti-inflammatory), informed by cloning and receptor studies that revealed evolutionary conservation from invertebrates.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7243804/)\n\n### Structural Classification\n\nCytokines are classified into structural families primarily based on their tertiary protein structures, which often correlate with shared evolutionary origins and receptor-binding mechanisms. The largest and most prominent family consists of those exhibiting a four Î±-helical bundle motif with an up-up-down-down topological arrangement, encompassing both short-chain and long-chain variants.[](https://www.ncbi.nlm.nih.gov/books/NBK459450/) Short-chain cytokines, such as interleukin-2 (IL-2) and IL-3, feature compact bundles with helices A-B separated by a longer loop, while long-chain members like erythropoietin (EPO) and growth hormone (GH) have extended loops between helices.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01424/full) This family includes class I cytokines (hematopoietins), which bind receptors with cytokine-binding homology domains, and class II cytokines (interferons and IL-10 family), distinguished by a flatter bundle interface and distinct receptor architecture.[](https://www.nature.com/articles/s41392-024-01934-w)\n\nThe interleukin-1 (IL-1) family cytokines, including IL-1Î±, IL-1Î², and IL-18, adopt a unique six-stranded Î²-trefoil fold resembling a beta-barrel, lacking helical elements and instead relying on a globular arrangement of Î²-sheets for stability and receptor engagement.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01412/full) In contrast, the tumor necrosis factor (TNF) superfamily members, such as TNF-Î± and lymphotoxin-Î±, form elongated, trimeric structures with a jelly-roll Î²-sandwich fold per monomer, where each subunit contributes two Î²-sheets stabilized by disulfide bonds, enabling membrane-bound or soluble forms.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/)\n\nChemokines represent a distinct family of small (8-10 kDa), structurally conserved proteins featuring a flexible N-terminal region, a core of three Î²-strands in a Greek key motif, and a C-terminal Î±-helix, with classification into subfamilies (e.g., CXC, CC) dictated by the spacing and pairing of conserved cysteine residues that form disulfide bridges essential for their chemotactic function.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) The IL-17 family cytokines exhibit a conserved cystine-knot-like fold with five Î²-strands and an additional disulfide bond, forming homodimers that diverge from the helical bundles of other families and bind heterodimeric receptors.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01424/full) These structural motifs underpin cytokine-receptor specificity and signaling efficiency, though pleiotropy arises from convergent evolutionary adaptations rather than strict structural determinism.[](https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387)\n\n### Functional Classification\n\nCytokines are functionally classified according to their predominant biological effects, such as promoting inflammation, suppressing immune responses, stimulating hematopoiesis, or driving specific adaptive immunity pathways like Th1, Th2, or Th17 responses.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) This classification reflects their pleiotropic nature, where individual cytokines may exhibit context-dependent activities, but groupings emphasize primary roles in immune regulation, host defense, and tissue homeostasis.[](https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387) Unlike structural or nomenclature-based schemes, functional categorization prioritizes observed outcomes in physiological and pathological contexts, informed by in vitro, animal, and clinical data.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/)\n\n**Pro-inflammatory cytokines** initiate and amplify acute inflammatory responses by activating endothelial cells, recruiting leukocytes, and inducing fever and acute-phase proteins. Key examples include interleukin-1 (IL-1Î± and IL-1Î²), which stimulate prostaglandin synthesis and neutrophil activation; tumor necrosis factor-alpha (TNF-Î±), which promotes vascular permeability and apoptosis; and IL-6, which drives B-cell differentiation and hepatic acute-phase responses.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/) Additional members such as IL-12, IL-18, and interferon-gamma (IFN-Î³) enhance macrophage activation and cytotoxic T-cell function, contributing to antimicrobial defense but also implicated in chronic diseases like rheumatoid arthritis when dysregulated.[](https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387)\n\n**Anti-inflammatory cytokines** counteract excessive inflammation to prevent tissue damage and maintain immune tolerance, often by inhibiting pro-inflammatory signaling or promoting regulatory T-cell activity. Prominent examples are IL-10, which suppresses cytokine production in macrophages and dendritic cells; IL-4 and IL-13, which downregulate Th1 responses and support IgE-mediated immunity; and transforming growth factor-beta (TGF-Î²), which inhibits T-cell proliferation and promotes fibrosis resolution.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/) IL-1 receptor antagonist (IL-1Ra) specifically neutralizes IL-1 activity, as demonstrated in therapeutic applications for conditions like sepsis.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/)\n\n**Type 1 (Th1-associated) cytokines** support cell-mediated immunity against intracellular pathogens, characterized by delayed-type hypersensitivity and IFN-Î³ dominance. This group includes IL-2 for T-cell expansion, IFN-Î³ for antiviral and antitumor effects, and IL-12 for natural killer cell activation, contrasting with humoral responses.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/) Conversely, **Type 2 (Th2-associated) cytokines** favor antibody production and extracellular parasite clearance, encompassing IL-4 for B-cell class switching to IgE, IL-5 for eosinophil recruitment, IL-6 for plasma cell differentiation, IL-10 for suppression, and IL-13 for mucus hypersecretion.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/) [](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/)\n\n**Th17-associated cytokines** drive neutrophil-mediated responses against fungi and bacteria at mucosal sites, featuring IL-17 family members (e.g., IL-17A, IL-17F) that induce antimicrobial peptides and IL-23 for Th17 cell maintenance, with roles in autoimmunity like psoriasis when overactive.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/)\n\n**Hematopoietic growth factors**, a subset functioning as colony-stimulating factors, regulate blood cell production in bone marrow. Examples include granulocyte-macrophage colony-stimulating factor (GM-CSF) for myeloid lineage expansion and macrophage activation, and granulocyte colony-stimulating factor (G-CSF) for neutrophil mobilization, clinically used since the 1990s for chemotherapy-induced neutropenia.[](https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387)\n\n| Functional Category | Key Examples | Primary Effects |\n|---------------------|--------------|-----------------|\n| Pro-inflammatory | IL-1, TNF-Î±, IL-6, IL-12 | Inflammation amplification, leukocyte recruitment[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/) |\n| Anti-inflammatory | IL-10, TGF-Î², IL-4 | Immune suppression, tolerance induction[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) |\n| Th1-associated | IL-2, IFN-Î³ | Cell-mediated immunity[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/) |\n| Th2-associated | IL-4, IL-5, IL-13 | Humoral immunity, allergy[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/) |\n| Hematopoietic | GM-CSF, G-CSF | Blood cell proliferation[](https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387) |\n\nThis classification is not rigid, as cytokines like IL-6 exhibit dual pro- and anti-inflammatory properties depending on signaling pathways (e.g., classical vs. trans-signaling), underscoring the need for context-specific interpretation in research and therapy.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/)\n\n## Distinctions from Other Signaling Molecules\n\n### Comparison to Hormones\n\nCytokines and hormones both function as soluble signaling molecules that bind to cell-surface receptors to initiate intracellular cascades, regulating physiological processes such as growth, differentiation, and response to stimuli.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) Many cytokines, like hormones, are polypeptides or glycoproteins produced in response to environmental cues, though hormones may also include steroids derived from cholesterol.[](https://www.aatbio.com/resources/faq-frequently-asked-questions/what-are-the-differences-between-cytokines-and-hormones) This shared capacity for receptor-mediated signal transduction underscores functional parallels, with cytokines sometimes described as the \"hormones of the immune system\" due to their role in coordinating immune cell activities akin to hormonal orchestration of endocrine targets.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/)\n\nKey distinctions arise in production, range of action, and potency. Hormones are secreted constitutively or in regulated pulses by specialized endocrine glands (e.g., thyroid for thyroxine or pancreas for insulin) and travel via the bloodstream to exert systemic endocrine effects on distant organs, often at low circulating concentrations (picomolar to nanomolar) with longer half-lives enabling sustained influence.[](https://www.ncbi.nlm.nih.gov/books/NBK9902/) Cytokines, by contrast, are produced transiently by diverse cell typesâ€”predominantly leukocytes but also endothelial, epithelial, and fibroblastsâ€”upon activation by pathogens or injury, primarily acting locally through paracrine (on neighboring cells) or autocrine (on the producing cell) mechanisms, with rapid degradation yielding short half-lives (minutes) and high local concentrations but minimal basal systemic levels.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) [](https://my.clevelandclinic.org/health/body/24585-cytokines) While cytokines can disseminate systemically during acute inflammation (e.g., contributing to fever via IL-1 or IL-6), their effects remain more context-dependent and less predictably endocrine than those of hormones.[](https://joe.bioscientifica.com/view/journals/joe/128/2/joe_128_2_001.pdf)\n\nCytokines exhibit greater potency on a molar basis, eliciting responses at lower concentrations; for example, IL-1 induces cyclooxygenase-2 gene expression at approximately 10 pM, surpassing the efficacy thresholds of many hormones.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) Hormones typically target specific tissues with narrower functional repertoires, whereas cytokines display pleiotropy (multiple effects per molecule) and redundancy (overlapping functions among molecules), reflecting their evolutionary adaptation for dynamic immune modulation rather than homeostatic regulation.[](https://njms.rutgers.edu/departments/pathology/genpath/lec_1/Comparison_of_H___C/comparison_of_h___c.htm) These differences, though increasingly blurred by discoveries of cytokine endocrine actions (e.g., IL-6 influencing hypothalamic-pituitary-adrenal axis), maintain cytokines' primary association with localized, inducible responses over the broader, organ-specific signaling of hormones.[](https://joe.bioscientifica.com/view/journals/joe/128/2/joe_128_2_001.pdf)\n\n### Comparison to Chemokines and Growth Factors\n\nChemokines constitute a subclass of cytokines, distinguished primarily by their specialized role in inducing directed cell migration, or chemotaxis, particularly among leukocytes. Structurally, chemokines feature conserved cysteine motifs that form disulfide bonds, enabling classification into subfamilies such as CXC (e.g., CXCL8/IL-8) and CC (e.g., CCL2/MCP-1), which dictate ligand-receptor interactions and functional specificity. In contrast, cytokines broadly encompass pleiotropic mediators of immune regulation, including pro-inflammatory signals like tumor necrosis factor-alpha (TNF-Î±) and anti-inflammatory ones like interleukin-10 (IL-10), without the obligatory chemotactic emphasis. This functional divergence reflects chemokines' adaptation for immune cell trafficking to infection sites, whereas general cytokines orchestrate activation, differentiation, and apoptosis across diverse cellular contexts.[](https://www.ncbi.nlm.nih.gov/books/NBK459450/)\n\nGrowth factors share mechanistic similarities with cytokines, such as autocrine/paracrine signaling via membrane receptors and induction of intracellular cascades like JAK-STAT or MAPK pathways, but are functionally oriented toward promoting cellular proliferation, survival, and tissue morphogenesis. Exemplars include epidermal growth factor (EGF) and fibroblast growth factor (FGF), which primarily drive epithelial and mesenchymal cell expansion in development and repair, often produced by non-immune cells. Certain cytokines, however, blur these lines by exhibiting growth-promoting effects, as seen with IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) in hematopoiesis, leading to conceptual overlap where growth factors can be viewed as a cytokine subset focused on mitogenesis rather than immunomodulation. This terminological distinction persists due to historical and contextual usage, though empirical evidence from receptor binding affinities and downstream effects reveals substantial redundancy.[](https://njms.rutgers.edu/departments/pathology/genpath/lec_1/Comparison_of_H___C/comparison_of_h___c.htm)[](https://www.ncbi.nlm.nih.gov/books/NBK459450/)\n\n## Molecular Mechanisms\n\n### Receptors and Binding Affinity\n\nCytokine receptors comprise a heterogeneous group of transmembrane glycoproteins that selectively bind cytokines to initiate cellular signaling, featuring extracellular ligand-binding domains, a transmembrane helix, and intracellular motifs for signal propagation. These receptors are structurally classified into several superfamilies based on conserved extracellular motifs: the type I cytokine receptor family (hematopoietin receptors, including shared chains like gp130, Î²c, and Î³c), the type II family (interferon and IL-10 receptors), the immunoglobulin-like IL-1 receptor family, the tumor necrosis factor receptor (TNFR) superfamily, G-protein-coupled receptors (primarily for chemokines), and others such as the IL-17 receptor family.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3981547/)[](https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/cytokine-receptor)\n\nBinding typically requires assembly of multi-subunit complexes, where cytokines engage a specific low-affinity chain before recruiting accessory signaling chains to achieve high-affinity interaction and receptor dimerization or oligomerization. In type I receptors, such as those for IL-3, IL-5, and GM-CSF sharing the Î²c chain, or the Î³c family (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21), the cytokine binds first to a cytokine-specific Î±-chain (low affinity, often nM range), inducing recruitment of the shared chain for ternary complex formation. Type II receptors, like IFNAR for type I interferons, involve sequential binding where high-affinity interaction with one chain (e.g., IFNAR2) precedes low-affinity recruitment of the second (IFNAR1). IL-1 family receptors form heterodimers with accessory proteins, while TNFRs often trimerize upon ligand binding.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4445396/)[](https://www.sciencedirect.com/science/article/pii/S1074761319301451)\n\nHigh-affinity binding constants (Kd) generally fall in the picomolar to low nanomolar range, enabling response to trace cytokine levels, though individual chains exhibit lower affinities. For IL-2, the trimeric high-affinity receptor (Î±Î²Î³) has a Kd of ~10 pM, the intermediate Î²Î³ dimer ~1 nM, and the low-affinity Î± chain ~10-100 nM. Type I interferons bind IFNAR2 with Kd values of 0.4-5 nM and IFNAR1 at 0.5-5 Î¼M, with the ternary complex optimizing overall potency through cooperative effects. Variations in affinity influence signaling duration and selectivity, as seen in engineered IL-6 variants where altered gp130 binding (Kd differences) modulates functional outcomes like proliferation versus inflammation.[](https://rupress.org/jem/article/217/1/e20191247/132567/Effects-of-interleukin-2-in-immunostimulation-and)[](https://pubmed.ncbi.nlm.nih.gov/21856167/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6914340/)\n\n### Intracellular Signaling Pathways\n\n![A scalable vector graphic of signal transduction pathways](./_assets_/Signal_transduction_pathways.svg.png)\nCytokines transduce signals primarily through cell surface receptors lacking intrinsic kinase domains, which associate with intracellular Janus kinases (JAKs) upon ligand binding, leading to receptor dimerization or oligomerization and subsequent activation of downstream cascades.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/) This process initiates rapid gene expression changes critical for immune responses, hematopoiesis, and inflammation.[](https://www.nature.com/articles/s41392-021-00791-1)\n\nThe Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway represents the canonical mechanism for many cytokines, including interleukins (e.g., IL-2, IL-4, IL-6), interferons (e.g., IFN-Î±, IFN-Î³), and colony-stimulating factors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/) Ligand-induced receptor clustering activates specific JAK family members (JAK1, JAK2, JAK3, TYK2), which cross-phosphorylate each other and receptor tyrosine residues, recruiting and phosphorylating STAT proteins (STAT1-6).[](https://www.nature.com/articles/s41392-021-00791-1) Phosphorylated STATs dimerize, translocate to the nucleus, and bind gamma-activated sites to drive transcription of target genes involved in proliferation, differentiation, and apoptosis.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/) Over 50 cytokines utilize this pathway, with specificity arising from distinct JAK-STAT combinations; for example, IL-6 signaling predominantly activates STAT3 via JAK1 and JAK2.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01424/full)\n\nBeyond JAK-STAT, cytokine receptors engage mitogen-activated protein kinase (MAPK) pathways, including extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38 MAPK, which modulate cellular responses to stress, growth, and inflammation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3899974/) Receptor tyrosine phosphorylation recruits adapter proteins like Shc or IRS, activating Ras-Raf cascades that culminate in MAPK nuclear translocation and regulation of AP-1 transcription factors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3899974/) Cytokines such as IL-1 and TNF-Î± also activate NF-ÎºB via the canonical pathway involving the IÎºB kinase (IKK) complex, which phosphorylates inhibitory IÎºB proteins for degradation, freeing NF-ÎºB to enter the nucleus and induce proinflammatory gene expression.[](https://www.nature.com/articles/sigtrans201723) The phosphoinositide 3-kinase (PI3K)/Akt pathway, triggered by cytokines like IL-3 and GM-CSF, promotes survival and metabolism through receptor-associated adapters.[](https://www.nature.com/articles/s41392-021-00791-1)\n\nThese pathways exhibit extensive cross-talk; for instance, JAK activation can enhance MAPK or PI3K signaling, integrating inputs for context-dependent outcomes, while negative regulators like suppressors of cytokine signaling (SOCS) proteins provide feedback to prevent excessive activation.[](https://www.nature.com/articles/s41392-021-00791-1) Dysregulation of these cascades underlies pathologies such as chronic inflammation and autoimmunity, highlighting their causal role in cytokine-mediated diseases.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/)\n\n## Physiological Roles\n\n### Immune Regulation and Defense\n\n![](./_assets_/Cytokine_release.jpg)\nCytokines function as critical signaling molecules in immune regulation and defense, coordinating both innate and adaptive responses to pathogens while preventing excessive tissue damage. Produced primarily by immune cells such as macrophages, dendritic cells, and lymphocytes, they mediate paracrine and autocrine signaling to activate effector cells, promote leukocyte recruitment, and modulate inflammation intensity.[](https://www.ncbi.nlm.nih.gov/books/NBK6294/) In innate immunity, cytokines like interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-Î±), and IL-6 trigger acute-phase responses, inducing fever, endothelial activation for leukocyte adhesion, and antimicrobial protein synthesis in the liver.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2785020/) These pro-inflammatory cytokines amplify pathogen clearance by enhancing phagocytosis and natural killer cell cytotoxicity.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4670773/)\n\nAnti-inflammatory cytokines, including IL-10 and transforming growth factor-beta (TGF-Î²), counteract pro-inflammatory signals to resolve inflammation and maintain immune homeostasis, inhibiting excessive cytokine production and promoting regulatory T cell activity.[](https://www.sinobiological.com/resource/cytokines/all-proinflammatory-cytokines) This balance is essential, as dysregulated pro-inflammatory dominance can lead to immunopathology, while insufficient responses impair defense.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10917571/) Type I interferons (IFN-Î± and IFN-Î²), secreted by virus-infected cells, exemplify antiviral defense by inducing an intracellular antiviral state, upregulating MHC class I for enhanced T cell recognition, and activating NK cells for early cytotoxicity.[](https://pubmed.ncbi.nlm.nih.gov/7946039/)\n\nIn bridging innate and adaptive immunity, cytokines from antigen-presenting cells direct T helper cell differentiation: IL-12 promotes Th1 cells for intracellular pathogen control via IFN-Î³ production, while IL-4 drives Th2 responses against helminths through IL-5 and IL-13 for eosinophil and IgE-mediated defense.[](https://www.cell.com/cell/fulltext/S0092-8674%2824%2900352-0) B cell activation and antibody class switching rely on cytokines like IL-4 for IgE and IFN-Î³ for IgG2a, tailoring humoral responses to threat type.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7174020/) Overall, cytokine networks ensure rapid innate containment followed by antigen-specific adaptive amplification, with empirical studies showing their necessity in vaccine efficacy and infection outcomes.[](https://ashpublications.org/blood/article/118/1/9/28431/Cytokine-release-from-innate-immune-cells)\n\n### Developmental and Homeostatic Functions\n\nCytokines play essential roles in embryonic development by regulating cell proliferation, differentiation, and migration during critical phases such as implantation and organogenesis. For instance, growth factors and cytokines like leukemia inhibitory factor (LIF) and interleukin-11 (IL-11) facilitate blastocyst implantation by modulating endometrial receptivity and trophoblast invasion in the uterus.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3107839/) In fetal development, interferons and proinflammatory cytokines such as interferon-gamma (IFN-Î³) influence placental formation and vascular remodeling, ensuring adequate nutrient exchange, though dysregulation can lead to developmental defects.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6152841/)\n\nHematopoiesis, the formation of blood cells, exemplifies cytokine-driven developmental processes from embryonic stages onward. Cytokines including stem cell factor (SCF), FMS-like tyrosine kinase 3 ligand (FLT3L), and interleukin-3 (IL-3) support hematopoietic stem cell (HSC) survival, self-renewal, and lineage commitment toward myeloid or lymphoid progenitors.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2677548/) These signals act via receptor complexes to promote differentiation into mature blood cells, with SCF and FLT3L specifically enhancing Stat5-mediated expression of anti-apoptotic proteins like Mcl1 in lymphoid-primed multipotent progenitors.[](https://www.cell.com/stem-cell-reports/fulltext/S2213-6711%2823%2900452-6) Embryonic hematopoiesis further relies on inflammatory cytokines to establish definitive HSC compartments in the fetal liver and bone marrow.[](https://rupress.org/jem/article/218/7/e20201545/212383/Inflammatory-signaling-regulates-hematopoietic)\n\nIn homeostatic functions, cytokines maintain physiological balance by fine-tuning cell populations and tissue integrity without eliciting overt inflammation. Common gamma-chain (Î³c) cytokines such as IL-7 and IL-15 are pivotal for lymphocyte homeostasis, promoting naive and memory T-cell survival through signaling pathways that prevent apoptosis and support basal proliferation in peripheral lymphoid organs.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2761713/) IL-10, produced by regulatory T cells and other subsets, preserves immune tolerance and mucosal barrier integrity by suppressing excessive effector responses, thereby preventing chronic activation that could disrupt tissue equilibrium.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1161067/full)\n\nThe IL-17 cytokine family contributes to epithelial and barrier tissue homeostasis by coordinating repair and antimicrobial defenses in the skin, gut, and lungs, where IL-17A and IL-17F stimulate keratinocyte proliferation and neutrophil recruitment to sustain microbial control under steady-state conditions.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.641986/full) Overall, these homeostatic roles ensure adaptive responses to minor perturbations, with cytokines integrating signals from multiple cell types to sustain organismal stability, as evidenced by perturbations in cytokine-deficient models leading to lymphopenia or barrier dysfunction.[](https://www.nature.com/articles/s41590-019-0557-0)\n\n### Tissue Repair and Regeneration\n\nCytokines orchestrate the transition from inflammatory to reparative phases in tissue repair, recruiting immune cells, stimulating fibroblast proliferation, and regulating extracellular matrix (ECM) deposition to restore structural integrity. In wound healing, proinflammatory cytokines such as TNF-Î± and IL-1Î² initiate leukocyte infiltration and proteolytic activity during the early inflammatory stage, while IL-6 supports epithelialization and acute-phase responses.[](https://www.rndsystems.com/resources/articles/cytokines-wound-healing)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/) TGF-Î²1 then drives granulation tissue formation by recruiting fibroblasts, inducing collagen synthesis (types I, III, and V), and promoting angiogenesis, though sustained elevation risks excessive ECM accumulation and fibrosis.[](https://www.rndsystems.com/resources/articles/cytokines-wound-healing)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/)\n\nRegenerative outcomes vary by cytokine profile and context; fetal wounds achieve scarless repair through elevated TGF-Î²3 and IL-10, which dampen inflammation, favor type III collagen, and enhance hyaluronan-mediated remodeling, unlike adult wounds where TGF-Î²1/2 dominance yields scarring.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/) Experimental overexpression of IL-10 in adult models reduces scar formation by curbing proinflammatory cascades.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/) In contrast, PDGF, often acting alongside cytokines, amplifies fibroblast mitogenesis and granulation but can exacerbate fibrosis if unbalanced.[](https://www.rndsystems.com/resources/articles/cytokines-wound-healing)\n\nOrgan-specific regeneration highlights cytokine specificity: IL-6 is indispensable for liver repair post-hepatectomy, activating hepatocyte STAT3 to drive DNA synthesis and mass restoration; IL-6 knockout mice exhibit regeneration failure and elevated mortality.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3377328/) TNF-Î± complements this by NF-ÎºB-mediated anti-apoptosis and IL-6 induction, with TNFR1-deficient models showing impaired proliferation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/) In skeletal muscle, muscle-derived IL-6 and TGF-Î² regulate satellite cell activation and myoblast fusion, while TNF-Î± and IL-1Î² from macrophages sustain early inflammation to clear debris, enabling myogenic differentiation; disruptions prolong recovery.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9308828/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9909416/)\n\nIL-22 further exemplifies reparative roles, promoting intestinal epithelial proliferation via JAK-STAT3 in injury models, with deficiency worsening mucosal damage.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/) Overall, balanced cytokine signalingâ€”shifting from pro- (e.g., TNF-Î±, IL-6) to anti-inflammatory (e.g., IL-10, TGF-Î²3)â€”dictates regeneration fidelity, as evidenced by mouse hepatectomy and wound models where dysregulation favors fibrosis over functional tissue restoration.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/)\n\n## Pathological Roles\n\n### Acute Inflammation and Infections\n\n![Cytokine release during acute inflammation](./_assets_/Cytokine_release.jpg)\n\nAcute inflammation represents the body's immediate response to infection or tissue injury, orchestrated primarily by pro-inflammatory cytokines such as interleukin-1 (IL-1), tumor necrosis factor-alpha (TNF-Î±), and interleukin-6 (IL-6). These cytokines are rapidly secreted by resident macrophages and other innate immune cells upon detection of pathogen-associated molecular patterns (PAMPs) via pattern recognition receptors like Toll-like receptors (TLRs).[](https://pubmed.ncbi.nlm.nih.gov/9159205/) IL-1 and TNF-Î± initiate vasodilation, increased vascular permeability, and adhesion molecule expression on endothelial cells, facilitating neutrophil recruitment to the site of infection.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6929211/) IL-6, in turn, stimulates hepatocytes to produce acute-phase proteins such as C-reactive protein (CRP) and serum amyloid A, which enhance opsonization and complement activation to amplify pathogen clearance.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4176007/)\n\nIn bacterial and viral infections, these cytokines drive systemic effects including fever induction through hypothalamic prostaglandin synthesis and anorexia to conserve energy for immune defense. For instance, TNF-Î± and IL-1 elevate leptin levels and suppress appetite during acute infections, contributing to cachexia-like symptoms observed in sepsis.[](https://pubmed.ncbi.nlm.nih.gov/8996253/) Empirical studies in mouse models demonstrate that IL-1Î± specifically exacerbates intestinal inflammation in Peyer's patches during bacterial challenge, underscoring its role in localized mucosal defense.[](https://www.pnas.org/doi/10.1073/pnas.191214498) However, balanced cytokine signaling is crucial; anti-inflammatory interleukins like IL-10 counter excessive responses to prevent tissue damage while preserving antimicrobial activity.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10818686/)\n\nDysregulated cytokine production can escalate to a cytokine storm, characterized by hypersecretion of pro-inflammatory mediators leading to septic shock and multi-organ failure in severe infections. Infections, particularly respiratory viruses, are the predominant triggers, with elevated TNF-Î±, IL-6, and IL-1Î² correlating with poor outcomes in conditions like COVID-19 and influenza.[](https://www.nejm.org/doi/full/10.1056/NEJMra2026131) Laboratory evidence from human cohorts shows leukocytosis, thrombocytopenia, and markedly increased CRP and ferritin levels during such storms, reflecting the pathological amplification of inflammation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8876409/) This phenomenon highlights the dual-edged nature of cytokines: essential for pathogen containment in acute settings but potentially lethal when unchecked.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7079934/)\n\n### Chronic Inflammation and Autoimmunity\n\nChronic inflammation represents a maladaptive persistence of cytokine-driven immune activation, characterized by continuous low-level production of pro-inflammatory mediators that promote tissue remodeling, fibrosis, and organ dysfunction rather than resolution seen in acute responses. Cytokines such as TNF-Î±, IL-1Î², and IL-6, secreted by macrophages, T cells, and activated fibroblasts, form self-amplifying loops: TNF-Î± induces further IL-6 and IL-1Î² expression via NF-ÎºB signaling, recruiting additional leukocytes and sustaining endothelial activation for prolonged vascular permeability.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/)[](https://www.mdpi.com/1422-0067/22/20/10922) In rheumatoid arthritis (RA), synovial fluids exhibit elevated TNF-Î± levels correlating with joint erosion, where it synergizes with IL-17 to upregulate matrix metalloproteinases (MMPs) and RANKL, driving osteoclastogenesis and bone loss.[](https://www.mdpi.com/1422-0067/22/20/10922) This chronicity contrasts with acute inflammation's feedback inhibition by anti-inflammatory cytokines like IL-10, which is often insufficient in dysregulated states.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/)\n\nIn autoimmunity, cytokines causally contribute to self-tolerance breakdown by skewing adaptive immunity toward pathogenic effector responses. IL-6, in concert with TGF-Î², induces Th17 cell differentiation through STAT3 and RORÎ³t transcription factors, overriding Treg suppression and promoting IL-17 secretion that amplifies neutrophil recruitment and barrier disruption.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5337858/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/) IL-23 stabilizes pathogenic Th17 phenotypes, as evidenced in experimental autoimmune encephalomyelitis (EAE) models of multiple sclerosis (MS), where IL-23 knockout prevents Th17 expansion and disease onset despite initial priming.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5337858/) In RA, Th17-derived IL-17 enhances TNF-Î± and IL-6 effects on synovial fibroblasts, forming a network that sustains pannus formation and autoantibody production; serum IL-17 levels correlate with RA activity scores like DAS28.[](https://www.mdpi.com/1422-0067/22/20/10922) Similarly, in psoriasis and inflammatory bowel disease, IL-17 drives epithelial hyperproliferation and chemokine release (e.g., CXCL1), linking cytokine dysregulation to mucosal auto-reactivity.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5337858/)\n\nEmpirical data from human biopsies and rodent models underscore cytokines' centrality: in RA synovium, TNF-Î± blockade reduces IL-6 and IL-17 within weeks, alleviating inflammation without altering initial triggers, indicating cytokines as proximal effectors of chronicity.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/) Type I interferons, persistently elevated in systemic lupus erythematosus (SLE), further perpetuate autoimmunity by promoting plasmacytoid dendritic cell activation and anti-nuclear antibody responses, though their role varies by disease stage.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/) This positions cytokine networks as both initiatorsâ€”via genetic polymorphisms enhancing IL-6 productionâ€”and propagators of autoimmune pathology, where failure to downregulate pro-inflammatory signals post-antigen clearance enables epitope spreading and chronic self-attack.[](https://www.mdpi.com/1422-0067/22/20/10922)\n\n### Cancer Promotion and Suppression\n\n![A scalable vector graphic of signal transduction pathways](./_assets_/Signal_transduction_pathways.svg.png)\nCytokines exhibit dual and context-dependent roles in cancer, promoting tumorigenesis through chronic inflammation and immune evasion in some cases, while suppressing it via direct antiproliferative effects or enhancement of antitumor immunity in others. Pro-tumorigenic cytokines, such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-Î±), drive cancer progression by activating signaling pathways like STAT3 and NF-ÎºB, which foster tumor cell survival, proliferation, epithelial-mesenchymal transition (EMT), angiogenesis, and metastasis while suppressing cytotoxic immune responses.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/) [](https://jitc.bmj.com/content/11/11/e007530) For example, elevated IL-6 levels in the tumor microenvironment correlate with poor prognosis in multiple cancers, including colorectal and ovarian, by recruiting immunosuppressive myeloid-derived suppressor cells and promoting vascular endothelial growth factor (VEGF) expression.[](https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692142/full) Similarly, transforming growth factor-beta (TGF-Î²) supports tumor invasion and immune tolerance, particularly in advanced stages, despite early antiproliferative effects.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/)\n\nIn opposition, anti-tumor cytokines like interferon-gamma (IFN-Î³) and interleukin-12 (IL-12) inhibit cancer development by inducing apoptosis in tumor cells, upregulating major histocompatibility complex (MHC) class I expression for enhanced T-cell recognition, and activating natural killer (NK) cells and cytotoxic T lymphocytes. IFN-Î³, produced by activated T cells and NK cells, disrupts tumor angiogenesis and promotes immunogenic cell death, with preclinical models showing reduced tumor burden in IFN-Î³-deficient mice compared to wild-type counterparts.[](https://www.nature.com/articles/s41392-024-01868-3) Clinical evidence supports these effects; high-dose interleukin-2 (IL-2) therapy, approved by the FDA in 1998 for metastatic melanoma and renal cell carcinoma, yields objective response rates of 15-28% in phase III trials, though limited by vascular leak syndrome and short half-life.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6350412/) Granulocyte-macrophage colony-stimulating factor (GM-CSF) similarly enhances dendritic cell maturation and antigen presentation, contributing to durable responses in vaccine-adjuvanted settings.[](https://www.nature.com/articles/s41392-024-01868-3)\n\nThe tumor microenvironment (TME) often shifts cytokine balance toward promotion via feedback loops, such as IL-6-induced STAT3 activation that sustains immunosuppressive networks, underscoring the need for targeted blockade of pro-tumor signals alongside augmentation of anti-tumor ones.[](https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692142/full) Paradoxically, some cytokines like IL-10 exhibit dual functions, suppressing inflammation acutely but enabling tumor escape chronically through STAT3-mediated proliferation in certain contexts.[](https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692142/full) Ongoing research emphasizes combinatorial approaches, with IL-6 inhibitors showing synergy with checkpoint blockade in preclinical models of resistant tumors.[](https://jitc.bmj.com/content/11/11/e007530)\n\n| Cytokine | Primary Role in Cancer | Key Mechanisms | Example Evidence |\n|----------|------------------------|----------------|------------------|\n| IL-6    | Promotion             | STAT3/NF-ÎºB activation, angiogenesis, EMT | Correlates with poor survival in ovarian cancer cohorts[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/) |\n| TNF-Î±   | Promotion             | Inflammation, immune suppression, survival signaling | Enhances metastasis in inflammatory TME[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/) |\n| IFN-Î³   | Suppression           | Apoptosis induction, MHC upregulation, NK activation | Increased tumor growth in IFN-Î³ knockout mice[](https://www.nature.com/articles/s41392-024-01868-3) |\n| IL-2    | Suppression           | T/NK cell expansion, cytotoxicity | 15-28% response rates in melanoma trials[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6350412/) |\n\n### Neuroinflammation and Behavioral Modulation\n\nPro-inflammatory cytokines such as interleukin-1 beta (IL-1Î²), tumor necrosis factor alpha (TNF-Î±), and interleukin-6 (IL-6) play a central role in neuroinflammation by activating microglia and astrocytes within the central nervous system (CNS), leading to localized immune responses that can alter neuronal excitability and synaptic plasticity.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5025335/) These cytokines gain access to the brain via passive diffusion across the blood-brain barrier (BBB) during inflammation-induced permeability or through active transport and peripheral signaling via the vagus nerve, where they bind to receptors on endothelial cells and immune cells, triggering downstream cascades that influence behavior.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4141874/) Empirical evidence from rodent models shows that peripheral injection of IL-1Î² induces rapid activation of hypothalamic neurons within minutes, correlating with decreased locomotor activity and food intake, effects blocked by IL-1 receptor antagonists.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2745948/)\n\nA key behavioral outcome of cytokine-driven neuroinflammation is **sickness behavior**, an evolutionarily conserved response comprising lethargy, anorexia, hyperalgesia, and social withdrawal, which reallocates energy toward pathogen clearance rather than foraging or reproduction.[](https://journals.biologists.com/jeb/article/224/9/jeb225847/260576/Sickness-behaviors-across-vertebrate-taxa) In non-human primates and humans, administration of IFN-Î± (which elevates IL-6 and TNF-Î±) during interferon therapy for hepatitis C induces these symptoms in up to 30-50% of patients, with IL-6 levels predicting severity; positron emission tomography (PET) scans reveal concurrent increases in microglial activation in limbic regions like the insula and anterior cingulate cortex.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2745948/) Synergistic interactions amplify this: combined low doses of IL-1Î², IL-6, and TNF-Î± in mice produce robust reductions in open-field exploration and sucrose preference, exceeding individual effects, via shared JAK-STAT and NF-ÎºB pathways that suppress dopamine release in the nucleus accumbens.[](https://www.nature.com/articles/1395490) This behavior is adaptive in acute infection but maladaptive when prolonged, as evidenced by lipopolysaccharide (LPS)-induced models where cytokine blockade with etanercept (a TNF-Î± inhibitor) restores normal activity levels within hours.[](https://www.pnas.org/doi/10.1073/pnas.1014557107)\n\nChronic neuroinflammation links cytokines to mood and cognitive modulation, particularly in major depressive disorder (MDD) and anxiety, where meta-analyses of over 80 studies report elevated peripheral IL-6 (standardized mean difference 0.56) and TNF-Î± (0.40) in MDD patients versus controls, independent of medication status.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3741070/) Mechanistically, these cytokines reduce tryptophan availability by upregulating indoleamine 2,3-dioxygenase (IDO), shunting it toward neurotoxic kynurenine metabolites and depleting serotonin precursors, while also enhancing glutamate excitotoxicity via reduced astrocyte uptake.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10213648/) In the hippocampus, IL-1Î² impairs long-term potentiation (LTP) and adult neurogenesis, as shown in IL-1 receptor knockout mice resistant to stress-induced anhedonia; human imaging corroborates this, with higher CSF IL-6 correlating to smaller hippocampal volumes in MDD (r = -0.35, p\u003c0.01).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC4250287/) For anxiety, TNF-Î± modulates amygdala hyperactivity: chronic infusion in rats increases fear conditioning via p38 MAPK signaling, reversed by anti-TNF antibodies, suggesting causal involvement beyond correlation.[](https://www.sciencedirect.com/science/article/pii/S2666354622001442) However, not all inflammation equates to pathology; low-level IL-10 counter-regulation prevents excessive behavioral suppression, highlighting context-dependent effects where acute cytokine surges enhance vigilance without long-term deficits.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8878213/)\n\nTherapeutic targeting underscores these mechanisms: anti-cytokine biologics like infliximab reduce depressive symptoms in treatment-resistant MDD patients with high baseline CRP (\u003e3 mg/L), with response rates of 60% versus 29% in low-inflammation subgroups, implicating cytokine-driven subsets.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3741070/) Conversely, antidepressants such as SSRIs attenuate microglial cytokine release in vitro, normalizing HPA axis hyperactivity observed in 40-60% of MDD cases with comorbid inflammation.[](https://www.nature.com/articles/s41398-025-03532-y) These findings, drawn from controlled trials and animal knockouts, affirm cytokines as causal modulators rather than mere biomarkers, though human causality remains inferred from associative and interventional data due to ethical limits on direct CNS manipulation.[](https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1538026/full)\n\n## Dysregulation and Adverse Effects\n\n### Cytokine Release Syndromes\n\n![Cytokine release in immune response](./_assets_/Cytokine_release.jpg)\n\nCytokine release syndrome (CRS) is an acute systemic inflammatory response triggered by the excessive and rapid release of pro-inflammatory cytokines, such as interleukin-6 (IL-6), interferon-gamma (IFN-Î³), and tumor necrosis factor-alpha (TNF-Î±), following massive activation of immune effector cells including T cells, macrophages, and natural killer cells.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/)[](https://ashpublications.org/blood/article/124/2/188/32896/Current-concepts-in-the-diagnosis-and-management) This condition manifests as fever and potential multi-organ dysfunction due to endothelial activation, vascular leakage, and disseminated intravascular coagulation.[](https://www.uptodate.com/contents/cytokine-release-syndrome-crs) CRS most commonly arises in the context of adoptive cellular therapies, particularly chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, where infused CAR-T cells proliferate and target tumor antigens, leading to cytokine storm within days of infusion.[](https://pubmed.ncbi.nlm.nih.gov/30586620/)[](https://pubmed.ncbi.nlm.nih.gov/29808005/)\n\nThe pathophysiology involves initial antigen recognition by engineered T cells or monoclonal antibodies, prompting cytokine secretion that amplifies immune activation; this recruits and stimulates bystander immune cells, escalating to a feed-forward loop of inflammation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/) Risk factors include high disease burden, prior lymphodepletion, and specific therapy types, with incidence rates exceeding 80% in CAR-T recipients, though severe grades (â‰¥3) vary from 10-30% depending on the product and patient population.[](https://pubmed.ncbi.nlm.nih.gov/29808005/)[](https://ashpublications.org/bloodadvances/article/4/4/676/452527/Comparing-CAR-T-cell-toxicity-grading-systems) Beyond oncology, CRS has been documented in severe infections, such as those mimicking macrophage activation syndrome, and with bispecific T-cell engagers.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6825470/)\n\nClinically, CRS presents with high-grade fever (â‰¥38Â°C) as a hallmark, often accompanied by malaise, myalgias, and chills in mild cases, progressing to hypotension, hypoxia, and organ toxicities like hepatic or renal impairment in severe instances.[](https://www.uptodate.com/contents/cytokine-release-syndrome-crs)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/) Diagnosis relies on clinical criteria excluding alternative causes, supported by elevated serum cytokines and biomarkers like C-reactive protein or ferritin.[](https://ashpublications.org/blood/article/124/2/188/32896/Current-concepts-in-the-diagnosis-and-management) The American Society for Transplantation and Cellular Therapy (ASTCT) consensus grading system standardizes severity assessment: Grade 1 involves fever without hypotension or hypoxia; Grade 2 adds mild hemodynamic or respiratory compromise; Grade 3 requires vasopressor support or high-flow oxygen; and Grade 4 denotes life-threatening symptoms.[](https://www.astctjournal.org/article/S1083-8791%2818%2931691-4/fulltext)[](https://pubmed.ncbi.nlm.nih.gov/30592986/)\n\nManagement prioritizes early recognition and supportive care, including fluids, vasopressors, and oxygen; pharmacologic interventions feature IL-6 receptor antagonists like tocilizumab for Grades 2-4, with corticosteroids reserved for refractory or concurrent neurotoxicity cases.[](https://ashpublications.org/blood/article/124/2/188/32896/Current-concepts-in-the-diagnosis-and-management)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/) Prophylactic approaches, such as tocilizumab pre-administration in high-risk patients, have shown efficacy in mitigating severe CRS without compromising antitumor responses.[](https://pubmed.ncbi.nlm.nih.gov/30586620/) Prognosis is generally favorable with prompt intervention, as most episodes resolve within 1-2 weeks, though fatal outcomes occur in \u003c5% of severe cases, underscoring the need for specialized monitoring in certified centers.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/) Ongoing research focuses on predictive biomarkers and engineered CAR-T designs to decouple efficacy from toxicity.[](https://pubmed.ncbi.nlm.nih.gov/36590643/)\n\n### Inflammaging and Age-Related Decline\n\nInflammaging denotes the persistent, low-grade systemic inflammation that escalates with advancing age, characterized by elevated circulating levels of pro-inflammatory cytokines including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-Î±), and interleukin-1 beta (IL-1Î²).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/) These cytokines rise progressively from middle age onward, with plasma IL-6 levels documented to increase in cohorts of older adults, correlating with functional decline and mortality.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/) Mechanisms driving this elevation encompass cellular senescence, where the senescence-associated secretory phenotype (SASP) perpetuates cytokine release; mitochondrial dysfunction generating reactive oxygen species (ROS) that activate NF-ÎºB signaling; and NLRP3 inflammasome priming, amplifying IL-1Î² and IL-18 production.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/)[](https://www.nature.com/articles/s41392-023-01502-8)\n\nThis cytokine dysregulation fosters age-related tissue dysfunction by impairing homeostasis, promoting catabolism, and exacerbating extracellular matrix remodeling. In musculoskeletal systems, TNF-Î± and IL-6 induce anabolic resistance in skeletal muscle, contributing to sarcopenia, with longitudinal data linking higher IL-6 to accelerated muscle mass loss in women over age 65.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6146930/) Cardiovascular pathology arises as these cytokines drive endothelial dysfunction and plaque instability; for instance, IL-6 polymorphisms associated with elevated levels predict coronary events, while the 2017 CANTOS trial in 10,061 patients showed IL-1Î² blockade with canakinumab reduced major adverse cardiovascular events by 15% independently of lipid lowering.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6146930/) In the central nervous system, TNF-Î± and IL-1Î² activate microglia, leading to synaptic loss and amyloid aggregation in Alzheimer's disease models.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6146930/)\n\nAnti-inflammatory cytokines exhibit context-dependent shifts, with IL-10 and transforming growth factor-beta (TGF-Î²) often increasing in centenarians, potentially counterbalancing pro-inflammatory dominance to support longevity, as observed in the BELFAST study of extreme agers.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/) However, overall imbalance favors pro-inflammatory dominance, linking inflammaging to multimorbidity; meta-analyses confirm IL-6 as a predictor of frailty and all-cause mortality across elderly populations.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/) Interventions targeting cytokine pathways, such as senolytics reducing SASP in aged mice, underscore causality by attenuating decline without broad immunosuppression.[](https://www.nature.com/articles/s41392-023-01502-8)\n\n### Fatigue and Chronic Syndromes: Empirical Evidence\n\nEmpirical investigations into myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) have revealed associations between fatigue severity and dysregulated cytokine profiles, particularly elevations in pro-inflammatory mediators. A 2017 study of 191 ME/CFS patients and 392 controls identified a signature of 17 cytokines correlating with disease severity, including 13 pro-inflammatory types such as interleukin-1Î± (IL-1Î±), IL-1Î², IL-6, IL-8, IL-12p70, IL-13, IL-15, granulocyte-macrophage colony-stimulating factor (GM-CSF), interferon-Î³ (IFN-Î³), inducible protein 10 (IP-10), monocyte chemoattractant protein 1 (MCP-1), eotaxin, and tumor necrosis factor-Î± (TNF-Î±).[](https://www.pnas.org/doi/10.1073/pnas.1710519114) These elevations were observed both at rest and post-exercise, suggesting a role in post-exertional malaise, a hallmark of ME/CFS fatigue.[](https://www.pnas.org/doi/10.1073/pnas.1710519114)\n\nA 2019 systematic review of 74 studies encompassing over 2,000 ME/CFS patients found inconsistent but notable differences in cytokine levels compared to healthy controls, with significant elevations in transforming growth factor-Î²1 (TGF-Î²1) (standardized mean difference [SMD] 0.31, p=0.03) and trends toward higher IL-1Î², IL-6, and TNF-Î± in subsets of patients.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6708220/) The same review highlighted methodological heterogeneity, such as varying diagnostic criteria and small sample sizes, as contributors to variability, yet confirmed pro-inflammatory shifts in approximately 30% of analyzed cytokines.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6708220/) A concurrent meta-analysis of circulating inflammatory proteins across 28 studies reported pooled elevations in IL-8 (SMD 0.34, p\u003c0.05) and neopterin, alongside reduced IL-1 receptor antagonist (IL-1RA), indicating a net pro-inflammatory state in ME/CFS despite diagnostic instability in some cohorts.[](https://pubmed.ncbi.nlm.nih.gov/31465778/)\n\nIn long COVID, characterized by persistent fatigue post-SARS-CoV-2 infection, cytokine dysregulation mirrors ME/CFS patterns, with empirical data linking sustained inflammation to symptom chronicity. A 2024 study of 55 long COVID patients versus controls detected elevated plasma levels of IL-6, TNF-Î±, and IP-10, correlating with fatigue scores on the Chalder Fatigue Scale (r\u003e0.4 for IL-6, p\u003c0.01).[](https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05148-0) Another 2024 analysis of 152 long COVID cases showed systemic T-cell dysregulation alongside upregulated cytokine signaling genes, including those for IFN-Î³ and TNF pathways, persisting up to 12 months post-infection and associating with fatigue severity (odds ratio 2.1 for high IFN-Î³ responders).[](https://www.nature.com/articles/s41590-023-01724-6) A 2023 review synthesized evidence from longitudinal cohorts, attributing fatigue to chronic low-grade cytokine activation, including IL-6 and IL-1Î², which disrupts hypothalamic-pituitary-adrenal axis function and mitochondrial bioenergetics.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10103649/)\n\nFibromyalgia, another chronic syndrome dominated by fatigue, exhibits similar cytokine alterations, with a 2023 review of immune profiling studies reporting elevated serum IL-6 (mean 2.5-fold increase), IL-8, and TNF-Î± in patients versus controls, correlating with tender point counts and fatigue indices (r=0.45 for IL-6, p\u003c0.001).[](https://www.explorationpub.com/Journals/ei/Article/1003206) Cross-syndrome meta-analyses underscore shared pro-inflammatory signatures, yet causality remains inferential, as interventional trials blocking cytokines like TNF-Î± have yielded mixed fatigue relief (e.g., 20-30% symptom reduction in small etanercept cohorts, p=0.04).[](https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0971-z) Overall, while empirical data support cytokine involvement in fatigue pathogenesis across these syndromes, inconsistencies across studiesâ€”attributable to heterogeneity in patient selection, assay sensitivity, and confounders like comorbiditiesâ€”preclude definitive mechanistic attribution without further randomized controlled evidence.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6708220/)[](https://pubmed.ncbi.nlm.nih.gov/31465778/)\n\n## Therapeutic Applications\n\n### Pro-Inflammatory Cytokine Therapies\n\nPro-inflammatory cytokine therapies harness the immune-stimulating properties of cytokines such as interleukin-2 (IL-2) and interferon-alpha (IFN-Î±) to treat malignancies and chronic viral infections, primarily by enhancing T-cell activation, natural killer cell cytotoxicity, and antiviral responses.[](https://www.nature.com/articles/s41416-018-0328-y) These approaches exploit the cytokines' role in amplifying inflammation to target pathological cells, though systemic administration often induces dose-limiting toxicities mimicking cytokine storms, including hypotension, fever, and organ dysfunction.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8480956/) Early approvals, such as high-dose aldesleukin (recombinant IL-2) by the FDA in 1992 for metastatic renal cell carcinoma and 1998 for melanoma, demonstrated objective response rates of 15-28% with 5-10% complete remissions that can persist beyond 10 years in responders, underscoring causal efficacy in select patients despite limited overall survival benefits in broader populations.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1433989/full) Similarly, IFN-Î±, approved in the 1980s for hairy cell leukemia and chronic hepatitis C, achieved sustained virologic response rates of up to 50% in interferon-sensitive genotypes when combined with ribavirin, though its use has declined with direct-acting antivirals.[](https://www.ncbi.nlm.nih.gov/books/NBK547867/)\n\nIL-2 therapy exemplifies the paradigm, where intravenous high-dose regimens (600,000-720,000 IU/kg every 8 hours for up to 14 doses) promote CD8+ T-cell expansion and tumor infiltration, yielding durable antitumor effects independent of PD-L1 expression.[](https://www.nature.com/articles/s41416-018-0328-y) However, adverse events affect over 90% of patients, with capillary leak syndrome causing vascular permeability, edema, and renal impairment in 70-80% of cases, necessitating intensive care monitoring and premedication with steroids or antihistamines.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC8480956/) Low-dose subcutaneous IL-2 variants, explored in trials for autoimmune modulation at 1-3 million IU daily, show milder flu-like symptoms and injection-site reactions but reduced efficacy for oncology, prompting combinations with checkpoint inhibitors like nivolumab, which in phase III trials doubled progression-free survival to 11 months in melanoma versus IL-2 monotherapy.[](https://www.nature.com/articles/s41392-022-00887-2) IFN-Î±, administered as pegylated forms (e.g., 180 Î¼g weekly for hepatitis B), induces antiviral states via JAK-STAT signaling, reducing HBV DNA in 30-40% of chronic carriers after 48 weeks, though relapse rates exceed 50% post-treatment due to incomplete immune clearance.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.733364/full) In oncology, IFN-Î±2b monotherapy for melanoma post-resection extended relapse-free survival by 9 months in high-risk patients per meta-analyses of trials involving over 4,000 participants.[](https://pubmed.ncbi.nlm.nih.gov/38110058/)\n\nTumor necrosis factor-alpha (TNF-Î±) administration has been trialed less frequently owing to profound toxicity, including hemorrhagic necrosis and septic shock at doses above 100 Î¼g/mÂ², limiting it to isolated perfusion for limb sarcomas or melanomas since the 1990s, where regional delivery achieves 50-80% response rates with tolerable systemic exposure.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.903679/full) Emerging strategies mitigate off-target effects through protein engineering, such as IL-2 variants with biased high-affinity binding to IL-2RÎ²Î³ complexes on effector T cells (e.g., bempegaldesleukin, advancing in phase III as of 2023), which expand antitumor CD8+ populations 100-fold in preclinical models while sparing regulatory T cells and reducing vascular leak by 50%.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10330431/) Nanoparticle encapsulation or fusion with tumor-targeting antibodies further localizes delivery, as in cytokine-armed T-cell therapies showing 2-3 log-fold potency gains in xenograft studies.[](https://pubmed.ncbi.nlm.nih.gov/37104673/) Despite these advances, pro-inflammatory therapies remain niche, with response durability tied to patient-specific factors like tumor mutational burden, and ongoing trials emphasize multimodal integration to balance efficacy against the inherent risk of exacerbating inflammation in non-responders.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC10357296/)\n\n### Anti-Cytokine Interventions\n\nAnti-cytokine interventions encompass biologic agents, including monoclonal antibodies (mAbs) that neutralize pro-inflammatory cytokines or block their receptors, as well as small-molecule Janus kinase (JAK) inhibitors that disrupt downstream signaling pathways shared by multiple cytokines. These therapies target excessive cytokine-driven inflammation in autoimmune and autoinflammatory diseases, demonstrating clinical efficacy in reducing disease activity and preventing tissue damage, though they carry risks of immunosuppression.[](https://pubmed.ncbi.nlm.nih.gov/19519438/)[](https://www.nature.com/articles/ni.3612) Development of these agents, beginning with TNF inhibitors in the late 1990s, has transformed management of conditions like rheumatoid arthritis (RA) and inflammatory bowel disease, with response rates often exceeding 50-70% in randomized trials for symptom relief and radiographic progression halt.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3956207/)[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.591365/full)\n\nTNF-Î± inhibitors, such as infliximab, adalimumab, and etanercept, bind soluble or membrane-bound TNF-Î±, inhibiting its interaction with receptors and thereby suppressing downstream inflammatory cascades. In RA patients, these agents achieve American College of Rheumatology 20% improvement criteria in up to 60-70% of cases when combined with methotrexate, significantly slowing joint erosion as evidenced by modified Sharp scores in long-term studies.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3956207/)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC2111629/) Similar benefits extend to psoriatic arthritis and Crohn's disease, where infliximab induces remission in 30-50% of moderate-to-severe cases refractory to conventional therapy.[](https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.591365/full) However, TNF blockade increases susceptibility to serious infections, including tuberculosis reactivation and opportunistic pathogens like Listeria, with incidence rates 1.5-2 times higher than placebo in meta-analyses.[](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2825%2900421-3/fulltext)[](https://www.sciencedirect.com/science/article/abs/pii/S0264410X03001968)\n\nInterleukin-6 (IL-6) pathway inhibitors, exemplified by tocilizumabâ€”a humanized mAb against the IL-6 receptorâ€”prevent IL-6-mediated signaling, which drives acute-phase responses and B-cell activation. Tocilizumab monotherapy yields Disease Activity Score 28 remission in approximately 30% of active RA patients over 24 weeks, with sustained efficacy in systemic juvenile idiopathic arthritis (sJIA) where it resolves fever and rash in over 80% of pediatric cases.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5074778/)[](https://www.nature.com/articles/s41584-020-0419-z) In severe COVID-19 with cytokine release syndrome, early administration (IL-6 levels \u003c100 pg/mL) improved survival odds by modulating hyperinflammation, though benefits diminish in late-stage critical illness.[](https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.651662/full)[](https://www.nejm.org/doi/full/10.1056/NEJMoa2100433) Risks include elevated cholesterol, gastrointestinal perforations, and bacterial infections, particularly in the elderly.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC5074778/)\n\nIL-1 inhibitors like anakinra, a recombinant IL-1 receptor antagonist, competitively block IL-1Î± and IL-1Î² binding, attenuating innate immune overactivation. In RA, subcutaneous anakinra (100 mg daily) reduces tender joint counts by 20-40% as monotherapy or adjunctively, with comparable efficacy to TNF inhibitors in early disease but higher injection-site reactions.[](https://pubmed.ncbi.nlm.nih.gov/15172046/) Anakinra proves particularly effective in cryopyrin-associated periodic syndromes and recurrent pericarditis, achieving symptom resolution in 70-90% of refractory cases without disease flares upon continuation.[](https://www.ahajournals.org/doi/10.1161/JAHA.121.021685)[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7326122/) Infection rates rise modestly, akin to other biologics, but long-term use in non-cancer inflammation shows a favorable safety profile barring contraindications like active sepsis.[](https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.01157/full)\n\nJAK inhibitors, such as tofacitinib and baricitinib, non-selectively block JAK1/3 or JAK1/2, inhibiting signaling from cytokines like IL-2, IL-6, and interferons via STAT pathway disruption. In RA, tofacitinib achieves low disease activity in 40-60% of patients failing TNF therapy, offering oral convenience over injectables.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC6168198/)[](https://ard.bmj.com/content/83/2/139) Selectivity varies; JAK3-focused inhibition suffices for alopecia areata reversal in preclinical models, while pan-JAK blockade aids myelofibrosis but heightens herpes zoster risk 2-4 fold due to impaired antiviral responses.[](https://insight.jci.org/articles/view/142205)[](https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313129) Overall, anticytokine agents necessitate screening for latent infections pre-initiation, with post-marketing surveillance confirming dose-dependent immunosuppression as the primary adverse causal factor.[](https://pubmed.ncbi.nlm.nih.gov/17917545/)[](https://journals.sagepub.com/doi/10.1177/0885066604267854)\n\n### Engineering and Next-Generation Developments\n\nEngineered cytokines mitigate inherent limitations of native forms, such as short serum half-life, systemic toxicity, and inadequate tissue specificity, through protein modifications that extend pharmacokinetics and enhance targeting. Strategies include fusion to Fc domains or albumin-binding motifs to increase circulatory persistence, as demonstrated in interleukin-2 (IL-2) variants where half-life extension reduced dosing frequency while preserving bioactivity.[](https://www.sciencedirect.com/science/article/pii/S2590018825000243) Site-directed mutagenesis further refines receptor affinity; for instance, \"supercytokines\" like engineered IL-2 muteins exhibit reduced binding to the high-affinity IL-2 receptor alpha chain (CD25), minimizing regulatory T-cell activation and favoring effector T-cell expansion.[](https://www.nature.com/articles/s41467-019-11782-w)\n\nImmunocytokines, comprising cytokine-antibody fusions, enable tumor-selective delivery by leveraging antibody specificity for antigens like fibroblast activation protein or extracellular matrix components. A 2024 study reported that IL-2 fused to antibodies targeting pro-inflammatory cells improved antitumor efficacy in mouse models by concentrating cytokine activity at tumor sites, reducing off-target inflammation.[](https://insight.jci.org/articles/view/173469) Similarly, fusions incorporating IL-12 or IL-15 with PD-L1-targeting moieties have shown promise in solid tumor models, where CAR-T cells serve as vehicles for localized cytokine release, enhancing persistence without broad immunosuppression.[](https://www.nature.com/articles/s41551-025-01509-2)\n\nNext-generation developments integrate cytokines with synthetic biology tools, including orthogonal receptor systems that decouple engineered ligands from endogenous pathways for conditional activation. In 2025 research, natural cytokine receptors were reprogrammed into synthetic variants responsive only to designer agonists, enabling precise control in cell therapies and avoiding cytokine storms.[](https://www.nature.com/articles/s41589-025-01986-1) Armored chimeric antigen receptor (CAR) therapies embed cytokine transgenes, such as IL-18-secreting CAR-T cells, which revived exhausted T cells in refractory lymphoma patients, yielding objective responses in phase I trials with manageable toxicity.[](https://www.cell.com/trends/cancer/fulltext/S2405-8033%2825%2900151-7) Nanoparticle encapsulation and bioconjugation further refine delivery, with polymeric carriers protecting labile cytokines like interferon-gamma during transit to hypoxic tumor niches.[](https://www.tandfonline.com/doi/abs/10.1080/17425247.2023.2208344) These approaches collectively elevate the therapeutic index, though challenges persist in scalability and immunogenicity, necessitating ongoing preclinical validation.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9933837/)\n\n## Historical and Evolutionary Context\n\n### Discovery Timeline\n\nThe identification of the first cytokine traces to 1957, when Alick Isaacs and Jean Lindenmann discovered interferon (IFN) as a soluble protein produced by virus-infected cells that induced resistance to viral replication in neighboring cells, marking the initial recognition of cytokine-like signaling in antiviral defense.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC7123835/) This breakthrough laid the groundwork for understanding intercellular mediators beyond hormones or antibodies.[](https://www.sciencedirect.com/science/article/pii/S0021925819779939)\n\nIn the early 1970s, research expanded to lymphocyte-derived factors, with Igal Gery and Byron Waksman describing \"lymphocyte activating factor\" (LAF) in 1972 as a macrophage-secreted product that stimulated T-cell proliferation, later identified as interleukin-1 (IL-1).[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) By 1974, Stanley Cohen coined the term \"cytokine\" to encompass these non-immunoglobulin, non-antibody proteins produced by various cells to regulate immune and inflammatory responses, broadening the concept beyond leukocyte-specific origins.[](https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1607-y) Tumor necrosis factor (TNF), initially observed in 1975 for its cytotoxic effects on tumors, was purified and linked to cachexia in the mid-1980s.[](https://www.sciencedirect.com/science/article/pii/S1359610114000781) Interleukin-2 (IL-2), a T-cell growth factor, was isolated in 1976 from activated lymphocyte supernatants, enabling sustained T-cell expansion in vitro.[](https://irp.nih.gov/accomplishments/discovery-of-interleukin-2-il-2)\n\nThe 1980s accelerated molecular characterization through cloning: IFN-Î± and IL-2 cDNAs were sequenced in 1982â€“1983, followed by IL-1 and TNF-Î± in 1984, allowing recombinant production and functional dissection of their pleiotropic roles in immunity and pathology.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/) These advances shifted cytokine research from phenomenological assays to genetic and structural analyses, revealing receptor interactions and signaling cascades essential for therapeutic targeting.[](https://pubmed.ncbi.nlm.nih.gov/11530802/)\n\n### Evolutionary Origins and First-Principles Rationale\n\nCytokines emerged as signaling molecules in early metazoan evolution to facilitate intercellular communication in response to environmental threats, with the interleukin-1 (IL-1) superfamily representing one of the most ancient lineages. Phylogenetic reconstruction indicates that proto-IL-1 ligands and receptors co-evolved through tandem gene duplications in the bilaterian ancestor, predating the Cambrian explosion around 540 million years ago and functioning primarily in innate immunity by alerting cells to damage-associated or pathogen-derived signals. This foundational circuitry, conserved in invertebrates such as insects and nematodes, underscores cytokines' role in coordinating basal defensive mechanisms without reliance on specialized adaptive components.[](https://www.nature.com/articles/s41467-018-03362-1)\n\nSubsequent diversification occurred via whole-genome duplications during vertebrate evolution, approximately 500 million years ago, giving rise to class I helical cytokines like those in the common gamma chain (Î³c) family (e.g., IL-2, IL-4, IL-7, IL-9, IL-15, IL-21). These arose in jawed vertebrates, paralleling the advent of adaptive immunity, through mechanisms including tandem duplications and positive selection at pathogen-interacting sites, enabling finer regulation of lymphocyte proliferation and differentiation. Shared orthologs between teleost fish and mammals confirm their pre-existence before the teleost-specific genome duplication around 350 million years ago, highlighting evolutionary pressures from host-pathogen co-evolution that favored multifunctional signaling networks.[](https://pmc.ncbi.nlm.nih.gov/articles/PMC9465101/)\n\nFrom causal fundamentals, cytokines address the multicellular challenge of scaling localized threat detectionâ€”triggered by pattern recognition receptors binding conserved microbial motifsâ€”into collective action, such as phagocyte recruitment and vascular permeability changes, which probabilistically elevate survival against infection by amplifying effector responses while containing collateral tissue costs. Absent such diffusible mediators, isolated cellular reactions would yield suboptimal clearance, as evidenced by the lethal susceptibility to pathogens in cytokine-deficient models across taxa; their deep conservation reflects selection for systems that balance acute inflammation against chronic self-harm, prioritizing reproductive fitness in pathogen-rich ecologies.00260-X)"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"8:[\"$\",\"$L1e\",null,{\"state\":{\"mutations\":[],\"queries\":[{\"dehydratedAt\":1761886747345,\"state\":{\"data\":{\"page\":{\"citations\":[{\"id\":\"1\",\"title\":\"Cytokines, Chemokines and Their Receptors - NCBI - NIH\",\"description\":\"The cytokine superfamily of proteins is an integral part of the signaling network between cells and is essential in generating and regulating the immune system.Introduction Â· Cytokines, their Receptors and... Â· Chemokines, their Receptors...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK6294/\",\"favicon\":\"\"},{\"id\":\"2\",\"title\":\"Dictionary of immune responses to cytokines at single-cell resolution\",\"description\":\"Dec 6, 2023 Â· Cytokines are a broad class of small, secreted proteins that act locally or systemically by binding to cognate receptors on target cells, whichÂ ...\",\"url\":\"https://www.nature.com/articles/s41586-023-06816-9\",\"favicon\":\"\"},{\"id\":\"3\",\"title\":\"Cytokines, Inflammation and Pain - PMC - PubMed Central - NIH\",\"description\":\"Cytokines are small secreted proteins released by cells have a specific effect on the interactions and communications between cells. Cytokine is a generalÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2785020/\",\"favicon\":\"\"},{\"id\":\"4\",\"title\":\"The JAK-STAT pathway: from structural biology to cytokine ... - Nature\",\"description\":\"Aug 21, 2024 Â· Many cytokines function by modulating the immune system to eliminate aberrant cells, thereby preventing the occurrence of cancer. OneÂ ...\",\"url\":\"https://www.nature.com/articles/s41392-024-01934-w\",\"favicon\":\"\"},{\"id\":\"5\",\"title\":\"The functions of cytokines and their uses in toxicology - PMC\",\"description\":\"Cytokines are critical controllers of cell, and hence tissue, growth, migration, development and differentiation. The family includes the inflammatoryÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2517710/\",\"favicon\":\"\"},{\"id\":\"6\",\"title\":\"Cytokines, chemokines and growth factors - Autoimmunity - NCBI - NIH\",\"description\":\"Cytokines are important molecules for cell communication. The term cytokine (Greek â€“cyto, cell, and â€“kinos, movement) was proposed by Stanley Cohen in 1974.\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK459450/\",\"favicon\":\"\"},{\"id\":\"7\",\"title\":\"Cytokines: From Clinical Significance to Quantification - PMC\",\"description\":\"Cytokines are critical mediators that oversee and regulate immune and inflammatory responses via complex networks and serve as biomarkers for many diseases.Missing:  definition | Show results with:definition\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8336501/\",\"favicon\":\"\"},{\"id\":\"8\",\"title\":\"Deep insight into cytokine storm: from pathogenesis to treatment\",\"description\":\"Apr 16, 2025 Â· Cytokines can suppress bone marrow function, leading to decreased production of key blood cells such as erythrocytes, leukocytes, and platelets.\",\"url\":\"https://www.nature.com/articles/s41392-025-02178-y\",\"favicon\":\"\"},{\"id\":\"9\",\"title\":\"Cytokines\",\"description\":\"Cytokines are small secreted proteins which mediate and regulate immunity, inflammation, and hematopoiesis. They must be produced de novo in response to anÂ ...\",\"url\":\"https://users.pfw.edu/blumenth/Immunology/Cytokines.htm\",\"favicon\":\"\"},{\"id\":\"10\",\"title\":\"[PDF] Chapter 13: Cytokines\",\"description\":\"Chapter 13: Cytokines. Definition: secreted, low-molecular-weight proteins that regulate the nature, intensity and duration of the immune response byÂ ...\",\"url\":\"https://www2.nau.edu/~fpm/immunology/lectures/Chapter012.pdf\",\"favicon\":\"\"},{\"id\":\"11\",\"title\":\"Cytokines and Nutritional Status: Possible Correlations ... - NCBI - NIH\",\"description\":\"What Are the Cytokines? The cytokines are a relatively diverse group of low molecular weight (8,000â€“30,000 daltons) proteins that act to transmit informationÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK230989/\",\"favicon\":\"\"},{\"id\":\"12\",\"title\":\"Cytokines in clinical cancer immunotherapy | British Journal of Cancer\",\"description\":\"Nov 9, 2018 Â· Cytokines are polypeptides or glycoproteins with a molecular weight usually below 30 kDa that provide growth, differentiation andÂ ...Missing:  range | Show results with:range\",\"url\":\"https://www.nature.com/articles/s41416-018-0328-y\",\"favicon\":\"\"},{\"id\":\"13\",\"title\":\"Unveiling Cytokine Charge Disparity as a Potential Mechanism for ...\",\"description\":\"Cytokines are small signaling proteins that regulate the immune responses to infection and tissue damage. Surface charges of cytokines determine their inÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC11923798/\",\"favicon\":\"\"},{\"id\":\"14\",\"title\":\"Cytokine - an overview | ScienceDirect Topics\",\"description\":\"Cytokines are regulatory peptides, with molecular weights typically less than 30 kDa, that act as extracellular signals between cells in immunologicalÂ ...\",\"url\":\"https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cytokine\",\"favicon\":\"\"},{\"id\":\"15\",\"title\":\"Pleiotropy and Specificity: Insights from the Interleukin 6 Family of ...\",\"description\":\"Apr 16, 2019 Â· Research has clarified the role of IL-6 family cytokines in autoimmune diseases and has led to effective therapies that target them.\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S107476131930144X\",\"favicon\":\"\"},{\"id\":\"16\",\"title\":\"Systematic investigation of cytokine signaling activity at the tissue ...\",\"description\":\"Sep 30, 2021 Â· Cytokines are a broad category of intercellular signaling proteins that act in almost every aspect of human immunology, from anti-pathogenÂ ...\",\"url\":\"https://www.nature.com/articles/s41592-021-01274-5\",\"favicon\":\"\"},{\"id\":\"17\",\"title\":\"Cytokines evolution: Role in various diseases - ScienceDirect.com\",\"description\":\"Redundancy â€“ multiple cytokines can mediate similar functions. c. Synergism ... Antagonism â€“ one cytokine inhibiting the effect of another cytokine.\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S2352081715000963\",\"favicon\":\"\"},{\"id\":\"18\",\"title\":\"Historical review: Cytokines as therapeutics and targets of ... - PubMed\",\"description\":\"Prime examples of cytokine antagonists that have profoundly altered the treatment of some inflammatory disorders are agents that inhibit the effects of tumorÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/15063084/\",\"favicon\":\"\"},{\"id\":\"19\",\"title\":\"Review Cytokines and anti-cytokines as therapeutics â€” An update\",\"description\":\"1. Pleiotropy, i.e. a single cytokine can act on many different types of cells rather than a single cell type. Â· 2. Redundancy, i.e. similar function can beÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0014299907012186\",\"favicon\":\"\"},{\"id\":\"20\",\"title\":\"Historical Review of Cytokines - PMC - NIH\",\"description\":\"Cytokine as hormones of the immune system. For sure, the definition of a cytokine as a soluble factor produced by one cell and acting on another cell, in orderÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3140102/\",\"favicon\":\"\"},{\"id\":\"21\",\"title\":\"From supernatants to cytokines: a personal view on the early history ...\",\"description\":\"May 30, 2018 Â· In 1974, Stanley Cohen introduced the term â€œcytokineâ€ as a non-leukocyte also producing cytokines and pointed out that such molecules could beÂ ...\u003c|separator|\u003e\",\"url\":\"https://arthritis-research.biomedcentral.com/articles/10.1186/s13075-018-1607-y\",\"favicon\":\"\"},{\"id\":\"22\",\"title\":\"Historical insights into cytokines - Dinarello - Wiley Online Library\",\"description\":\"Oct 31, 2007 Â· Initially, cytokines were called â€œlymphokinesâ€ to distinguish them from â€œmonokinesâ€ in an attempt to classify these soluble factors by theirÂ ...\",\"url\":\"https://onlinelibrary.wiley.com/doi/10.1002/eji.200737772\",\"favicon\":\"\"},{\"id\":\"23\",\"title\":\"The history of cytokines and growth factors development\",\"description\":\"Mar 4, 2025 Â· Stanley Cohen's proposal of the term \\\"cytokine\\\" (from Greek cyto-, cell, and -kinos, movement) in 1974 encompassed these soluble mediatorÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1521692625000179\",\"favicon\":\"\"},{\"id\":\"24\",\"title\":\"Cytokine - an overview | ScienceDirect Topics\",\"description\":\"DEFINITIONS. The term â€œcytokineâ€ was first coined by Cohen et al. (1974). Cytokines are regulatory peptides, with molecular weights typically less than 30 kDa,Â ...\",\"url\":\"https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/cytokine\",\"favicon\":\"\"},{\"id\":\"25\",\"title\":\"Cytokine Nomenclature - News-Medical\",\"description\":\"Interleukin was originally the term used to describe cytokines that were assumed by researchers to primarily be targeting leukocytes. However, it emerged thatÂ ...\",\"url\":\"https://www.news-medical.net/health/Cytokine-Nomenclature.aspx\",\"favicon\":\"\"},{\"id\":\"26\",\"title\":\"[PDF] The history of discovery of Interleukin-1: A fundamental cytokine of ...\",\"description\":\"Until that point, cytokines were named based solely on their biological activity in a specific assay, rather than their definitive biochemical and biologicalÂ ...\",\"url\":\"https://www.mattioli1885journals.com/index.php/MedHistor/article/download/15526/11924/119610\",\"favicon\":\"\"},{\"id\":\"27\",\"title\":\"Perspective: Insights on the Nomenclature of Cytokines and ... - NIH\",\"description\":\"The history of the cytokines starts in the second half of the 1970's when ... AZ conceived and wrote this opinion on cytokine and chemokine nomenclature based onÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7243804/\",\"favicon\":\"\"},{\"id\":\"28\",\"title\":\"Structural Understanding of Interleukin 6 Family Cytokine Signaling ...\",\"description\":\"The Structure of Cytokines and Their Receptors. The four-Î± helical bundle cytokine family is the largest cytokine family. Both class I cytokines (e.g., GH, IL-6Â ...Introduction Â· The IL-6 Family of Cytokines Â· Therapeutic Targeting of IL-6...\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.01424/full\",\"favicon\":\"\"},{\"id\":\"29\",\"title\":\"Structural Basis of IL-1 Family Cytokine Signaling - Frontiers\",\"description\":\"The primary and secondary structures are both composed of three Ig-like domains. The binding of the cytokine to the primary receptor creates a composite surfaceÂ ...\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2019.01412/full\",\"favicon\":\"\"},{\"id\":\"30\",\"title\":\"A primer on cytokines - ScienceDirect.com\",\"description\":\"Cytokine classification predominantly relies on [1] the target receptor(s), [2] the primary structural features of the extracellular domains of their receptorsÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S1043466621000387\",\"favicon\":\"\"},{\"id\":\"31\",\"title\":\"What are the differences between cytokines and hormones?\",\"description\":\"Nov 16, 2023 Â· Cytokines are small proteins from immune/non-immune cells with rapid response, while hormones are from endocrine glands, act on distant cells,Â ...\",\"url\":\"https://www.aatbio.com/resources/faq-frequently-asked-questions/what-are-the-differences-between-cytokines-and-hormones\",\"favicon\":\"\"},{\"id\":\"32\",\"title\":\"Summary - The Cell - NCBI Bookshelf - NIH\",\"description\":\"Cell-cell signaling is divided into three general categories (endocrine, paracrine, and autocrine signaling) based on the distance over which signals areÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK9902/\",\"favicon\":\"\"},{\"id\":\"33\",\"title\":\"What are Cytokines? Types \u0026 Function - Cleveland Clinic\",\"description\":\"Cytokines are signaling proteins that help control inflammation in your body. They allow your immune system to mount a defense if germs or other substancesÂ ...\",\"url\":\"https://my.clevelandclinic.org/health/body/24585-cytokines\",\"favicon\":\"\"},{\"id\":\"34\",\"title\":\"The endocrine significance of cytokines - Journal of Endocrinology\",\"description\":\"reported. Distant actions of cytokines. Cytokines are certainly able to act locally, as paracrine or autocrine factors.\",\"url\":\"https://joe.bioscientifica.com/view/journals/joe/128/2/joe_128_2_001.pdf\",\"favicon\":\"\"},{\"id\":\"35\",\"title\":\"Comparison of Hormones \u0026 Cytokines\",\"description\":\"Cytokines share properties with hormones and growth factors, and the distinction between them is becoming blurred. Cytokines are classified by properties andÂ ...\",\"url\":\"https://njms.rutgers.edu/departments/pathology/genpath/lec_1/Comparison_of_H___C/comparison_of_h___c.htm\",\"favicon\":\"\"},{\"id\":\"36\",\"title\":\"Structural Biology of Shared Cytokine Receptors - PMC\",\"description\":\"On the basis of common structural features, the cytokine receptors are grouped into six major families: class I cytokine receptors, class II cytokine receptorsÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3981547/\",\"favicon\":\"\"},{\"id\":\"37\",\"title\":\"Cytokine Receptor - an overview | ScienceDirect Topics\",\"description\":\"Classification of cytokine receptors is based on structural homologies in the cytokine-binding regions. There are five families of cytokine receptors: type IÂ ...\",\"url\":\"https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/cytokine-receptor\",\"favicon\":\"\"},{\"id\":\"38\",\"title\":\"Insights into Cytokineâ€“Receptor Interactions from ... - PubMed Central\",\"description\":\"The receptor classes are subdivided broadly based on the hematopoietic (type I) and interferon (IFN) (type II) cytokine receptors. Type I cytokines are furtherÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4445396/\",\"favicon\":\"\"},{\"id\":\"39\",\"title\":\"The Î³c Family of Cytokines: Basic Biology to Therapeutic Ramifications\",\"description\":\"Apr 16, 2019 Â· There are multiple families of cytokines, but in this review, we will focus on one family of type I four Î±-helical bundle cytokines known asÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1074761319301451\",\"favicon\":\"\"},{\"id\":\"40\",\"title\":\"Effects of interleukin-2 in immunostimulation and immunosuppression\",\"description\":\"Although each receptor subunit may independently bind IL-2 with a weak affinity (Kd: âˆ¼10âˆ’8â€“10âˆ’7 M), only the intermediate-affinity Î²Î³ dimeric (Kd: âˆ¼10âˆ’9 M) andÂ ...\u003c|separator|\u003e\",\"url\":\"https://rupress.org/jem/article/217/1/e20191247/132567/Effects-of-interleukin-2-in-immunostimulation-and\",\"favicon\":\"\"},{\"id\":\"41\",\"title\":\"Binding and activity of all human alpha interferon subtypes - PubMed\",\"description\":\"Alpha-IFNs bind IFNAR1 and IFNAR2 at affinities of 0.5-5 Î¼M and 0.4-5 nM respectively (except for IFN-alpha1 - 220 nM).\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/21856167/\",\"favicon\":\"\"},{\"id\":\"42\",\"title\":\"Kinetics of cytokine receptor trafficking determine signaling and ...\",\"description\":\"We have engineered IL-6 variants with different affinities to gp130 to investigate how cytokine receptor binding dwell-times influence functional selectivity.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6914340/\",\"favicon\":\"\"},{\"id\":\"43\",\"title\":\"The molecular details of cytokine signaling via the JAK/STAT pathway\",\"description\":\"More than 50 cytokines signal via the JAK/STAT pathway to orchestrate hematopoiesis, induce inflammation and control the immune response.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6237706/\",\"favicon\":\"\"},{\"id\":\"44\",\"title\":\"The JAK/STAT signaling pathway: from bench to clinic - Nature\",\"description\":\"Nov 26, 2021 Â· The cytokines that activate STAT5 mainly include IL-3, prolactin, and the IL-2 cytokine family (including IL-2, IL-4, IL-7, IL-9, and IL-15). InÂ ...\",\"url\":\"https://www.nature.com/articles/s41392-021-00791-1\",\"favicon\":\"\"},{\"id\":\"45\",\"title\":\"The Role of Mitogen-Activated Protein Kinase ... - PubMed Central\",\"description\":\"MAPK pathways transmit and convert a plethora of extracellular signals by three consecutive phosphorylation events involving a MAPK kinase kinase, a MAPK kinaseÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3899974/\",\"favicon\":\"\"},{\"id\":\"46\",\"title\":\"NF-ÎºB signaling in inflammation - Nature\",\"description\":\"Jul 14, 2017 Â· The activation of NF-ÎºB involves two major signaling pathways, the canonical and noncanonical (or alternative) pathways, both being importantÂ ...\",\"url\":\"https://www.nature.com/articles/sigtrans201723\",\"favicon\":\"\"},{\"id\":\"47\",\"title\":\"Cytokines: Names and Numbers You Should Care About - PMC\",\"description\":\"May 4, 2015 Â· Cytokines play an important role in host defense against microorganisms. They orchestrate innate immunity by inducing protective local inflammation.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4670773/\",\"favicon\":\"\"},{\"id\":\"48\",\"title\":\"Inflammatory Cytokines | Sino Biological\",\"description\":\"Anti-inflammatory cytokines like IL-4, IL-10, and TGF-Î² inhibit the action and production of pro-inflammatory cytokines, altering the function of monocytes andÂ ...\",\"url\":\"https://www.sinobiological.com/resource/cytokines/all-proinflammatory-cytokines\",\"favicon\":\"\"},{\"id\":\"49\",\"title\":\"Illuminating Cytokines as Hubs Within the Immune Network - NIH\",\"description\":\"Feb 26, 2024 Â· The article delves into the dual roles of these cytokines in pathogen defense and in fueling chronic inflammation and autoimmune diseasesÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10917571/\",\"favicon\":\"\"},{\"id\":\"50\",\"title\":\"Cytokines in the generation of immune responses to, and ... - PubMed\",\"description\":\"The major anti-viral players comprise a unique subset. In particular, natural killer cells and CD8+ cytotoxic T cells are prominent in defense against viruses.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/7946039/\",\"favicon\":\"\"},{\"id\":\"51\",\"title\":\"50 years of advancements in innate immunity - Cell Press\",\"description\":\"Importantly, cytokines were found to be a key link from innate immune cells such as macrophages and dendritic cells to adaptive cells, with the messages fromÂ ...\",\"url\":\"https://www.cell.com/cell/fulltext/S0092-8674%2824%2900352-0\",\"favicon\":\"\"},{\"id\":\"52\",\"title\":\"IL-1 and related cytokines in innate and adaptive immunity in health ...\",\"description\":\"5. Type 2 immunity (ILC2, Th2) IL-33 is a central cytokine involved in type 2 innate and adaptive immunity and inflammation, modulating ILC2, Th2 and M2Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7174020/\",\"favicon\":\"\"},{\"id\":\"53\",\"title\":\"Cytokine release from innate immune cells: association with diverse ...\",\"description\":\"Cytokines released from innate immune cells play key roles in the regulation of the immune response. These intercellular messengers are the source ofÂ ...Abstract Â· Introduction Â· Regulated and constitutive... Â· Constitutive exocytosis of...\",\"url\":\"https://ashpublications.org/blood/article/118/1/9/28431/Cytokine-release-from-innate-immune-cells\",\"favicon\":\"\"},{\"id\":\"54\",\"title\":\"The Role of Growth Factors and Cytokines during Implantation - NIH\",\"description\":\"Many crucial growth factors and cytokines affect blastocyst implantation and/or endometrial receptivity; however, the molecular mechanisms regulating thisÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3107839/\",\"favicon\":\"\"},{\"id\":\"55\",\"title\":\"Role of Interferons and Cytokines in Pregnancy and Fetal ...\",\"description\":\"Cytokines and IFNs are critical for healthy pregnancy, but when dysregulated, they can disrupt fetal development and cause birth defects.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6152841/\",\"favicon\":\"\"},{\"id\":\"56\",\"title\":\"Cytokines regulating hematopoietic stem cell function - PMC - NIH\",\"description\":\"Cytokines are secreted proteins that regulate many aspects of hematopoiesis â€“ immune responses and inflammation in particular. Many hematopoietic cytokines wereÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2677548/\",\"favicon\":\"\"},{\"id\":\"57\",\"title\":\"Distinct roles of hematopoietic cytokines in the regulation of ...\",\"description\":\"Dec 14, 2023 Â· We found that SCF or FLT3L promotes the survival of LMPP-like LSCs by stimulating Stat5-mediated Mcl1 expression, whereas interleukin-3 (IL-3)Â ...\",\"url\":\"https://www.cell.com/stem-cell-reports/fulltext/S2213-6711%2823%2900452-6\",\"favicon\":\"\"},{\"id\":\"58\",\"title\":\"Inflammatory signaling regulates hematopoietic stem and progenitor ...\",\"description\":\"Jun 15, 2021 Â· This review focuses on inflammatory signaling in the emergence of the definitive hematopoietic compartment during embryonic life.\",\"url\":\"https://rupress.org/jem/article/218/7/e20201545/212383/Inflammatory-signaling-regulates-hematopoietic\",\"favicon\":\"\"},{\"id\":\"59\",\"title\":\"Functions of Î³C cytokines in immune homeostasis - PubMed Central\",\"description\":\"Cytokines that signal through receptor complexes containing the common Î³ (Î³C) chain receptor subunit are central regulators of lymphocyte homeostasis.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2761713/\",\"favicon\":\"\"},{\"id\":\"60\",\"title\":\"The multifaceted nature of IL-10: regulation, role in immunological ...\",\"description\":\"Interleukin-10 (IL-10) is a pleiotropic cytokine that has a fundamental role in modulating inflammation and in maintaining cell homeostasis.\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1161067/full\",\"favicon\":\"\"},{\"id\":\"61\",\"title\":\"Editorial: The IL-17 Cytokine Family in Tissue Homeostasis and ...\",\"description\":\"Feb 23, 2021 Â· Overall, this special topic highlights recent advances for a better understanding of IL-17 cytokine family in tissue homeostasis and disease.\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.641986/full\",\"favicon\":\"\"},{\"id\":\"62\",\"title\":\"Cytokines in the balance | Nature Immunology\",\"description\":\"Nov 19, 2019 Â· Cytokines are the chemical mediators that regulate immune cell homeostasis and coordinate signal-dependent immune responses.\",\"url\":\"https://www.nature.com/articles/s41590-019-0557-0\",\"favicon\":\"\"},{\"id\":\"63\",\"title\":\"Cytokines in Wound Healing - R\u0026D Systems\",\"description\":\"Cytokines play an important role in the evolution of granulation tissue through recruitment of inflammatory leukocytes and stimulation of fibroblasts andÂ ...Inflammation Â· Granulation Tissue and... Â· Matrix Production and Scar...\",\"url\":\"https://www.rndsystems.com/resources/articles/cytokines-wound-healing\",\"favicon\":\"\"},{\"id\":\"64\",\"title\":\"Reparative inflammation takes charge of tissue regeneration - PMC\",\"description\":\"Jan 21, 2016 Â· One of the first cytokines implicated in tissue repair was IL-6, which promotes liver regeneration after partial hepatectomy or CCl4-inducedÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5228603/\",\"favicon\":\"\"},{\"id\":\"65\",\"title\":\"Targeting Inflammatory Cytokines and Extracellular Matrix ...\",\"description\":\"ILs are mediators of the crosstalk and activation of various inflammatory cells. They play a role in both fetal and adult wound-healing process but theirÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3985537/\",\"favicon\":\"\"},{\"id\":\"66\",\"title\":\"Regulation of liver regeneration by growth factors and cytokines - PMC\",\"description\":\"Interleukin-6 (IL-6). Interleukin-6 is also strongly upregulated after PH and elevated serum levels are found early after surgery (Fausto et al, 2006). SimilarÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3377328/\",\"favicon\":\"\"},{\"id\":\"67\",\"title\":\"Muscle cell-derived cytokines in skeletal muscle regeneration - PMC\",\"description\":\"Released by infiltrating immune cells at skeletal muscle injury sites, cytokines play critical roles in facilitating muscle repair and regeneration.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9308828/\",\"favicon\":\"\"},{\"id\":\"68\",\"title\":\"Inflammation balance in skeletal muscle damage and repair - PMC\",\"description\":\"3.2. Inflammation-related cytokines promote muscle regeneration. Immune cells release a large number of cytokines, such as TNF-Î±, IL-1Î², IL-6 and TGFÎ², andÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9909416/\",\"favicon\":\"\"},{\"id\":\"69\",\"title\":\"Cytokines in acute and chronic inflammation - PubMed\",\"description\":\"Jan 1, 1997 Â· This review describes the role played in acute inflammation by IL-1, TNF-alpha, IL-6, IL-11, IL-8 and other chemokines, G-CSF, and GM-CSF.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/9159205/\",\"favicon\":\"\"},{\"id\":\"70\",\"title\":\"Cytokines in Inflammatory Disease - PMC - PubMed Central\",\"description\":\"In this review, we focus on the existing literature dealing with the biology of cytokines interleukin (IL)-6, IL-1, IL-33, tumor necrosis factor-alpha (TNF-Î±),Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6929211/\",\"favicon\":\"\"},{\"id\":\"71\",\"title\":\"IL-6 in Inflammation, Immunity, and Disease - PMC - PubMed Central\",\"description\":\"TNF-Î± and IL-1Î² also activate transcription factors to produce IL-6. IL-6 also issues a warning signal in the event of tissue damage.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4176007/\",\"favicon\":\"\"},{\"id\":\"72\",\"title\":\"Multiple cytokines and acute inflammation raise mouse leptin levels\",\"description\":\"Several inflammatory cytokines, most notably tumor necrosis factor (TNF) and IL-1, induce anorexia and loss of lean body mass, common manifestations of acuteÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/8996253/\",\"favicon\":\"\"},{\"id\":\"73\",\"title\":\"A role for IL-1Î± in inducing pathologic inflammation during bacterial ...\",\"description\":\"However, in this report we present evidence that IL-1Î± plays a distinct role in the induction of intestinal inflammation in the PPs in response to infectionÂ ...\",\"url\":\"https://www.pnas.org/doi/10.1073/pnas.191214498\",\"favicon\":\"\"},{\"id\":\"74\",\"title\":\"Pro-Inflammatory and Anti-Inflammatory Interleukins in Infectious ...\",\"description\":\"The IL-1 family of cytokines plays an important role in the activities of the innate immune system, which is the first line of defense against pathogenicÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10818686/\",\"favicon\":\"\"},{\"id\":\"75\",\"title\":\"Cytokine Storm | New England Journal of Medicine\",\"description\":\"Dec 2, 2020 Â· Cytokines play a key role in coordinating antimicrobial effector cells and providing regulatory signals that direct, amplify, and resolve theÂ ...\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMra2026131\",\"favicon\":\"\"},{\"id\":\"76\",\"title\":\"Cytokine Storm in COVID-19: Immunopathogenesis and Therapy - NIH\",\"description\":\"Laboratory findings in cytokine storm include leukocytosis, leucopenia, anemia, thrombocytopenia, and elevated levels of C-reactive protein (CRP), ferritin,Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8876409/\",\"favicon\":\"\"},{\"id\":\"77\",\"title\":\"Cytokine storms in infectious diseases - PMC - PubMed Central\",\"description\":\"Jul 3, 2017 Â· Elevated cytokine and chemokine production has been continuously associated with poor clinical outcome and pathogenesis during respiratory viralÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7079934/\",\"favicon\":\"\"},{\"id\":\"78\",\"title\":\"Cytokines in Autoimmunity: Role in Induction, Regulation, and ...\",\"description\":\"Cytokines play a pivotal role in the pathogenesis of autoimmune diseases. The precise triggers for the breakdown of self-tolerance and the subsequent eventsÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3189547/\",\"favicon\":\"\"},{\"id\":\"79\",\"title\":\"Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis - MDPI\",\"description\":\"Proinflammatory cytokines such as TNF, IL-6, and IL-17 activate synovial fibroblasts, which secrete various pathogenic molecules including IL-6, granulocyteÂ ...\",\"url\":\"https://www.mdpi.com/1422-0067/22/20/10922\",\"favicon\":\"\"},{\"id\":\"80\",\"title\":\"The Role of IL-17 and Related Cytokines in Inflammatory ...\",\"description\":\"In this review, we highlight the roles of cytokines that promote the development and maintenance of pathogenic Th17 cells in autoimmune diseases.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5337858/\",\"favicon\":\"\"},{\"id\":\"81\",\"title\":\"Inflammatory Cytokines in Cancer: Comprehensive Understanding ...\",\"description\":\"Jan 8, 2021 Â· Similar to IL-6 and TNF-Î±, TGF-Î² is associated with a wide range of tumor-inductive or cancer-supportive mechanisms, such as EMT, immune escape,Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7827947/\",\"favicon\":\"\"},{\"id\":\"82\",\"title\":\"New perspectives in cancer immunotherapy: targeting IL-6 cytokine ...\",\"description\":\"Nov 9, 2023 Â· Interleukin (IL)-6 represents a keystone cytokine in the link between inflammation and cancer. Many cytokines from the IL-6 family, whichÂ ...\",\"url\":\"https://jitc.bmj.com/content/11/11/e007530\",\"favicon\":\"\"},{\"id\":\"83\",\"title\":\"Tumor-Induced Inflammatory Cytokines and the Emerging ... - Frontiers\",\"description\":\"Here we review cytokines induced by the tumor microenvironment, their roles in various stages of cancer development, and their potential use in diagnostics andÂ ...\",\"url\":\"https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.692142/full\",\"favicon\":\"\"},{\"id\":\"84\",\"title\":\"Targeting cytokine and chemokine signaling pathways for cancer ...\",\"description\":\"Jul 22, 2024 Â· In this review, we summarized the current understanding and therapeutic implications of targeting cytokine and chemokine signaling pathways in cancer.\",\"url\":\"https://www.nature.com/articles/s41392-024-01868-3\",\"favicon\":\"\"},{\"id\":\"85\",\"title\":\"Cytokines in the Treatment of Cancer - PMC - PubMed Central - NIH\",\"description\":\"The goal of this article is to review the nature of cytokines involved in cancer immunotherapy, and to discuss their clinical applications with an overviewÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6350412/\",\"favicon\":\"\"},{\"id\":\"86\",\"title\":\"Neuroinflammation: The Devil is in the Details - PMC\",\"description\":\"The purpose of this review is to distinguish different variations of neuroinflammation in a context-specific manner and detail both positive and negativeÂ ...Microglia: Central Players... Â· Cytokine-Mediated Sickness... Â· Chronic Microglial...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5025335/\",\"favicon\":\"\"},{\"id\":\"87\",\"title\":\"Cytokine Targets in the Brain: Impact on Neurotransmitters and ...\",\"description\":\"Findings from neuroimaging studies in humans indicate that inflammatory cytokines can alter the function of key subcortical and cortical circuits that lead toÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4141874/\",\"favicon\":\"\"},{\"id\":\"88\",\"title\":\"Mechanisms of Cytokine-Induced Behavioral Changes\",\"description\":\"Work in our laboratory has focused on the mechanisms by which cytokines can influence the brain and behavior in humans and non-human primates.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2745948/\",\"favicon\":\"\"},{\"id\":\"89\",\"title\":\"Sickness behaviors across vertebrate taxa: proximate and ultimate ...\",\"description\":\"May 4, 2021 Â· These cytokines [of which the best studied in the context of sickness behaviors are interleukin (IL)-1 beta (IL-1Î²), IL-6 and tumor necrosisÂ ...\",\"url\":\"https://journals.biologists.com/jeb/article/224/9/jeb225847/260576/Sickness-behaviors-across-vertebrate-taxa\",\"favicon\":\"\"},{\"id\":\"90\",\"title\":\"Synergistic Effects of Interleukin-1Î², Interleukin-6, and Tumor ...\",\"description\":\"Jun 1, 2000 Â· The present investigation evaluated the individual and synergistic effects of IL-1Î², IL-6, and TNF-Î± on an index of illness behavior (Â ...\u003c|separator|\u003e\",\"url\":\"https://www.nature.com/articles/1395490\",\"favicon\":\"\"},{\"id\":\"91\",\"title\":\"Tumor necrosis factor-Î± triggers a cytokine cascade yielding ... - PNAS\",\"description\":\"TNF-Î± blockade successfully reduces further elaboration of IL-1, which has been extensively reported to modulate symptoms of â€œsickness behavior,â€ includingÂ ...\",\"url\":\"https://www.pnas.org/doi/10.1073/pnas.1014557107\",\"favicon\":\"\"},{\"id\":\"92\",\"title\":\"Inflammatory Cytokines in Depression: Neurobiological Mechanisms ...\",\"description\":\"Mounting evidence indicates that inflammatory cytokines contribute to the development of depression in both medically ill and medically healthy individuals.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3741070/\",\"favicon\":\"\"},{\"id\":\"93\",\"title\":\"Chronic stress, neuroinflammation, and depression: an overview of ...\",\"description\":\"May 11, 2023 Â· Accumulating evidence implicates cytokines in the pathogenesis of depression particularly in patients with chronic systemic conditions.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10213648/\",\"favicon\":\"\"},{\"id\":\"94\",\"title\":\"Modulation of learning and memory by cytokines - PubMed Central\",\"description\":\"This review describes the role of cytokines and their downstream signaling cascades on the modulation of learning and memory. Immune proteins are requiredÂ ...2.1 Interleukin 1Î² Â· 2.2 Tumor Necrosis Factor Î± Â· 3. Kinase Signaling And...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC4250287/\",\"favicon\":\"\"},{\"id\":\"95\",\"title\":\"Neuroinflammation and neuroprogression in depression: Effects of ...\",\"description\":\"Pro-inflammatory cytokines can reduce the availability of monoamines by increasing the expression and function of presynaptic reuptake pumps leading toÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2666354622001442\",\"favicon\":\"\"},{\"id\":\"96\",\"title\":\"Cytokines in the Brain and Neuroinflammation: We Didn't Starve the ...\",\"description\":\"Jan 25, 2022 Â· Some forms of injury to or infection of the CNS can give rise to cerebral cytokine production and action and result in drastic changes in brain function andÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8878213/\",\"favicon\":\"\"},{\"id\":\"97\",\"title\":\"Modulation of neuroimmune cytokine networks by antidepressants\",\"description\":\"Aug 23, 2025 Â· Additionally, cytokines can modulate brain function through peripheral immune signaling pathways, such as afferent vagus nerve activation, whichÂ ...\",\"url\":\"https://www.nature.com/articles/s41398-025-03532-y\",\"favicon\":\"\"},{\"id\":\"98\",\"title\":\"Neuroinflammation and stress-induced pathophysiology in major ...\",\"description\":\"Apr 22, 2025 Â· This review summarizes the mechanisms through which neuroinflammation induces or promotes the development of depression.\",\"url\":\"https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2025.1538026/full\",\"favicon\":\"\"},{\"id\":\"99\",\"title\":\"Cytokine release syndrome - PMC - PubMed Central\",\"description\":\"Jun 15, 2018 Â· This review provides a comprehensive overview of the mechanisms underlying CRS pathophysiology, risk factors, clinical presentation, differential diagnoses,Â ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6003181/\",\"favicon\":\"\"},{\"id\":\"100\",\"title\":\"Current concepts in the diagnosis and management of cytokine ...\",\"description\":\"Cytokine release syndrome (CRS) is a potentially life-threatening toxicity that has been observed following administration of natural and bispecific antibodiesÂ ...Abstract Â· Introduction Â· Pathophysiology Â· Biomarkers\",\"url\":\"https://ashpublications.org/blood/article/124/2/188/32896/Current-concepts-in-the-diagnosis-and-management\",\"favicon\":\"\"},{\"id\":\"101\",\"title\":\"Cytokine release syndrome (CRS) - UpToDate\",\"description\":\"Apr 2, 2024 Â· Cytokine release syndrome (CRS) is an acute systemic inflammatory syndrome characterized by fever and multiple organ dysfunction.\u003c|separator|\u003e\",\"url\":\"https://www.uptodate.com/contents/cytokine-release-syndrome-crs\",\"favicon\":\"\"},{\"id\":\"102\",\"title\":\"Cytokine Release Syndrome with Chimeric Antigen Receptor T Cell ...\",\"description\":\"Cytokine release syndrome (CRS), resulting from rapid immune activation induced by CAR-Ts, is the most significant treatment-related toxicity.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/30586620/\",\"favicon\":\"\"},{\"id\":\"103\",\"title\":\"CAR T cell-induced cytokine release syndrome is ... - PubMed - NIH\",\"description\":\"CRS usually occurs within days of T cell infusion at the peak of CAR T cell expansion. In ALL, it is most frequent and more severe in patients with high tumorÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/29808005/\",\"favicon\":\"\"},{\"id\":\"104\",\"title\":\"Comparing CAR T-cell toxicity grading systems: application of the ...\",\"description\":\"Feb 21, 2020 Â· CRS defining criteria: ASTCT requires fever â‰¥38Â°C as a defining CRS symptom. The global incidence of CRS across all grading systems was 83%Â ...\",\"url\":\"https://ashpublications.org/bloodadvances/article/4/4/676/452527/Comparing-CAR-T-cell-toxicity-grading-systems\",\"favicon\":\"\"},{\"id\":\"105\",\"title\":\"Cytokine Release Syndrome: Current Perspectives - PMC\",\"description\":\"Oct 29, 2019 Â· Cytokines Profile Of CRSâ€‹â€‹ IFN-Î³ can cause flu-like symptoms and can also trigger macrophage activation, leading to secretion of host cytokinesÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6825470/\",\"favicon\":\"\"},{\"id\":\"106\",\"title\":\"ASTCT Consensus Grading for Cytokine Release Syndrome and ...\",\"description\":\"CRS grade is determined by the more severe event: hypotension or hypoxia not attributable to any other cause. For example, a patient with temperature of 39.5Â°C,Â ...\",\"url\":\"https://www.astctjournal.org/article/S1083-8791%2818%2931691-4/fulltext\",\"favicon\":\"\"},{\"id\":\"107\",\"title\":\"ASTCT Consensus Grading for Cytokine Release Syndrome and ...\",\"description\":\"Dec 25, 2018 Â· The goal is to provide a uniform consensus grading system for CRS and neurotoxicity associated with immune effector cell therapies.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/30592986/\",\"favicon\":\"\"},{\"id\":\"108\",\"title\":\"A Computational Model of Cytokine Release Syndrome during CAR ...\",\"description\":\"Cytokine release syndrome (CRS) is a lethal adverse event in chimeric antigen receptor (CAR) T-cell therapy, hindering this promising therapy for cancers,Â ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/36590643/\",\"favicon\":\"\"},{\"id\":\"109\",\"title\":\"Age and Age-Related Diseases: Role of Inflammation Triggers and ...\",\"description\":\"The major pro-inflammatory cytokines, such as IL-6, TNF-Î±, and IL-1Î± contribute significantly to the phenomenon of inflamm-aging in healthy elderly individualsÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5900450/\",\"favicon\":\"\"},{\"id\":\"110\",\"title\":\"Inflammation and aging: signaling pathways and intervention ...\",\"description\":\"Jun 8, 2023 Â· ... cytokines, such as IL-1 and TNF-Î±, which ... Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?\",\"url\":\"https://www.nature.com/articles/s41392-023-01502-8\",\"favicon\":\"\"},{\"id\":\"111\",\"title\":\"Inflammageing: chronic inflammation in ageing, cardiovascular ...\",\"description\":\"Inflammation has a central role in age-related neuro-degeneration and in neurodegenerative diseases, such as Alzheimer disease. These studies support theÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6146930/\",\"favicon\":\"\"},{\"id\":\"112\",\"title\":\"Cytokine signature associated with disease severity in chronic ...\",\"description\":\"Jul 31, 2017 Â· 17 cytokines correlated with ME/CFS severity. Thirteen of these cytokines are proinflammatory and may contribute to many of the symptoms these patientsÂ ...\",\"url\":\"https://www.pnas.org/doi/10.1073/pnas.1710519114\",\"favicon\":\"\"},{\"id\":\"113\",\"title\":\"A systematic review of cytokines in chronic fatigue syndrome ...\",\"description\":\"Aug 24, 2019 Â· The aim of this study was to conduct a systematic review of the literature regarding cytokines in CFS/ME/SEID and whether there is a significant difference inÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6708220/\",\"favicon\":\"\"},{\"id\":\"114\",\"title\":\"Inflammatory proteins are altered in chronic fatigue syndrome-A ...\",\"description\":\"We undertook a systematic review and meta-analysis to quantify available data on circulating inflammatory proteins, examining studies recruiting patients with aÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/31465778/\",\"favicon\":\"\"},{\"id\":\"115\",\"title\":\"Association of circulating biomarkers with illness severity measures ...\",\"description\":\"Apr 10, 2024 Â· With specific regard to the ME/CFS cohort, our results revealed higher levels of both pro-inflammatory (IL1-Î², IL-6, TNF-Î±, and IP-10) and anti-Â ...\",\"url\":\"https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05148-0\",\"favicon\":\"\"},{\"id\":\"116\",\"title\":\"Long COVID manifests with T cell dysregulation, inflammation and ...\",\"description\":\"Jan 11, 2024 Â· We found that LC individuals exhibited systemic inflammation and immune dysregulation. This was evidenced by global differences in T cell subset distribution.\",\"url\":\"https://www.nature.com/articles/s41590-023-01724-6\",\"favicon\":\"\"},{\"id\":\"117\",\"title\":\"A review of cytokine-based pathophysiology of Long COVID symptoms\",\"description\":\"In Long COVID, dysregulation and chronic activation of cytokine signaling, as discussed later, can cause prolonged CNS effects.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10103649/\",\"favicon\":\"\"},{\"id\":\"118\",\"title\":\"Fibromyalgia syndrome and the immune system: a review with ...\",\"description\":\"In FMS, immune dysregulation is evidenced by elevated levels of pro-inflammatory cytokines (e.g., IL-6, IL-8, TNF-Î±) and decreased anti-inflammatory mediatorsÂ ...Immune Dysregulation In... Â· Cytokine Alterations Â· Comparative Analysis\u003c|separator|\u003e\",\"url\":\"https://www.explorationpub.com/Journals/ei/Article/1003206\",\"favicon\":\"\"},{\"id\":\"119\",\"title\":\"Cytokine inhibition in chronic fatigue syndrome patients - Trials\",\"description\":\"Oct 5, 2015 Â· Dysfunction of the cytokine network has been suspected to play a role in the pathophysiology of CFS. The disturbances of the cytokine networkÂ ...Study Medication... Â· Secondary Outcome Measures Â· Statistical Analysis\",\"url\":\"https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-015-0971-z\",\"favicon\":\"\"},{\"id\":\"120\",\"title\":\"High-dose interleukin-2 therapy related adverse events and ... - NIH\",\"description\":\"HDIL-2 toxicity can manifest in multiple organ systems, most significantly leading to cardiovascular, abdominal, endocrine, and neurological adverse events. TheÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8480956/\",\"favicon\":\"\"},{\"id\":\"121\",\"title\":\"IL-2 based cancer immunotherapies: an evolving paradigm - Frontiers\",\"description\":\"Additionally, major side effects include capillary leak syndrome, hypotension, hypoxia, lymphopenia, thrombocytopenia, and impaired neutrophil chemotaxis. (Â ...Abstract Â· Introduction Â· Limitations of HD IL-2 therapy Â· Novel approaches for IL-2...\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2024.1433989/full\",\"favicon\":\"\"},{\"id\":\"122\",\"title\":\"Alpha Interferon - LiverTox - NCBI Bookshelf - NIH\",\"description\":\"May 4, 2018 Â· Because the major use of peginterferon is for hepatitis C or in patients with cancer on multiple other medications, serum ALT elevations areÂ ...\",\"url\":\"https://www.ncbi.nlm.nih.gov/books/NBK547867/\",\"favicon\":\"\"},{\"id\":\"123\",\"title\":\"Efficacy and safety of low-dose interleukin-2 in combination ... - Nature\",\"description\":\"Mar 7, 2022 Â· The potential adverse effects limit the use of MTX. In this study, gastrointestinal disorders and hepatic enzyme increase were associated withÂ ...\",\"url\":\"https://www.nature.com/articles/s41392-022-00887-2\",\"favicon\":\"\"},{\"id\":\"124\",\"title\":\"Interferon and Hepatitis B: Current and Future Perspectives - Frontiers\",\"description\":\"IFN-Î± and its pegylated form have been used for over thirty years to treat chronic hepatitis B (CHB) with advantages of finite treatment duration and sustainedÂ ...Abstract Â· Introduction Â· Advantages and Mechanisms... Â· Strategies to Improve the...\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2021.733364/full\",\"favicon\":\"\"},{\"id\":\"125\",\"title\":\"Mechanism of interferon alpha therapy for chronic hepatitis B and ...\",\"description\":\"This review article highlights mechanistic insight on IFN control of HBV infection and recent progress in development of novel IFN regimens.Missing:  cancer | Show results with:cancer\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/38110058/\",\"favicon\":\"\"},{\"id\":\"126\",\"title\":\"Tumor Necrosis Factor Î±: Taking a Personalized Road in Cancer ...\",\"description\":\"Moreover, TNFÎ± could improve the efficacy of drugs/chemotherapy in cancer treatment, e.g., by promoting blood vessel permeability (16, 17). In clinical trials (Â ...\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.903679/full\",\"favicon\":\"\"},{\"id\":\"127\",\"title\":\"Advances in engineering and delivery strategies for cytokine ... - NIH\",\"description\":\"Cytokine immunotherapy is a growing field for the treatment of cancer, infectious disease, autoimmunity, and other ailments. Therapeutic cytokines are aÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10330431/\",\"favicon\":\"\"},{\"id\":\"128\",\"title\":\"Advances in engineering and delivery strategies for cytokine ...\",\"description\":\"May 3, 2023 Â· Introduction: Cytokine immunotherapy is a growing field for the treatment of cancer, infectious disease, autoimmunity, and other ailments.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/37104673/\",\"favicon\":\"\"},{\"id\":\"129\",\"title\":\"Engineering cytokines for cancer immunotherapy: a systematic review\",\"description\":\"... cytokine immunotherapy and promoting their clinical translation for the treatment of cancer. IL-2. IL-2, which is typically secreted by activated CD4+ TÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10357296/\",\"favicon\":\"\"},{\"id\":\"130\",\"title\":\"Anti-cytokine therapeutics: history and update - PubMed\",\"description\":\"Anti-cytokine therapy has promoted a revolution in the treatment of several inflammatory disorders during the past 10 years.Missing:  applications | Show results with:applications\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/19519438/\",\"favicon\":\"\"},{\"id\":\"131\",\"title\":\"Targeting cytokines in disease | Nature Immunology\",\"description\":\"Dec 2, 2016 Â· Monoclonal antibodies that specifically block cytokines (soluble mediators of cell communication) have revolutionized the treatment of autoimmune diseases.\",\"url\":\"https://www.nature.com/articles/ni.3612\",\"favicon\":\"\"},{\"id\":\"132\",\"title\":\"TNF inhibitor therapy for rheumatoid arthritis - PMC - PubMed Central\",\"description\":\"Clinical trials have shown that TNF-Î± blocking agents, such as ETN, IFX and ADA, relieve joint inflammations and slow the radiographic progression of jointÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3956207/\",\"favicon\":\"\"},{\"id\":\"133\",\"title\":\"Use of TNF Inhibitors in Rheumatoid Arthritis and Implications for the ...\",\"description\":\"Oct 22, 2020 Â· RA has been treated for two decades with TNF inhibitors which are effective by blocking TNF's destructive action.Abstract Â· Introduction Â· Results Â· Discussion\",\"url\":\"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2020.591365/full\",\"favicon\":\"\"},{\"id\":\"134\",\"title\":\"The efficacy of antiâ€TNF in rheumatoid arthritis, a comparison ...\",\"description\":\"Inhibition of TNF has been shown to reduce disease activity and to delay the process of progressive joint damage.,, Presently, three different antiâ€TNF agentsÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC2111629/\",\"favicon\":\"\"},{\"id\":\"135\",\"title\":\"Safety of TNF-Î± inhibitors therapy in patients with rheumatoid arthritis\",\"description\":\"Sep 10, 2025 Â· TNF-Î± inhibitors are potentially associated with a higher risk of serious infection, while may have beneficial effects on cardiovascular events,Â ...\",\"url\":\"https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370%2825%2900421-3/fulltext\",\"favicon\":\"\"},{\"id\":\"136\",\"title\":\"Anti-cytokine therapeutics and infections - ScienceDirect.com\",\"description\":\"It remains highly doubtful whether any anti-cytokine therapy can completely prevent or eliminate the action of a particular cytokine in host defense mechanisms.Missing:  applications | Show results with:applications\",\"url\":\"https://www.sciencedirect.com/science/article/abs/pii/S0264410X03001968\",\"favicon\":\"\"},{\"id\":\"137\",\"title\":\"Tocilizumab, a humanized anti-interleukin-6 receptor antibody ... - NIH\",\"description\":\"Many patients treated with tocilizumab achieved clinical remission associated with decreased serum IL-6, suggesting that IL-6 enhances autoimmunity. TocilizumabÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC5074778/\",\"favicon\":\"\"},{\"id\":\"138\",\"title\":\"Translating IL-6 biology into effective treatments - Nature\",\"description\":\"Apr 23, 2020 Â· Two subsequent trials of tocilizumab in \u003e150 children with sJIA confirmed extensive improvements in the signs and symptoms of disease followingÂ ...\",\"url\":\"https://www.nature.com/articles/s41584-020-0419-z\",\"favicon\":\"\"},{\"id\":\"139\",\"title\":\"Administration Timing and Efficacy of Tocilizumab in Patients With ...\",\"description\":\"Conclusion: The administration of TCZ in an early stage of cytokine storm (IL-6 level \u003c 100 pg/ml) may effectively improve the clinical prognosis of patientsÂ ...\u003c|separator|\u003e\",\"url\":\"https://www.frontiersin.org/journals/molecular-biosciences/articles/10.3389/fmolb.2021.651662/full\",\"favicon\":\"\"},{\"id\":\"140\",\"title\":\"Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid ...\",\"description\":\"Feb 25, 2021 Â· The efficacy of interleukin-6 receptor antagonists in critically ill patients with coronavirus disease 2019 (Covid-19) is unclear.\",\"url\":\"https://www.nejm.org/doi/full/10.1056/NEJMoa2100433\",\"favicon\":\"\"},{\"id\":\"141\",\"title\":\"The use of anakinra, an interleukin-1 receptor antagonist ... - PubMed\",\"description\":\"Anakinra is safe and effective in the treatment of rheumatoid arthritis, both as monotherapy and in combination with other disease-modifying antirheumatic drugsÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/15172046/\",\"favicon\":\"\"},{\"id\":\"142\",\"title\":\"Emerging Therapies for Recurrent Pericarditis: Interleukinâ€1 inhibitors\",\"description\":\"Sep 25, 2021 Â· Currently, anakinra and rilonacept, have demonstrated beneficial impact in clinical outcomes with a reasonable safety profile in randomizedÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/JAHA.121.021685\",\"favicon\":\"\"},{\"id\":\"143\",\"title\":\"The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever ...\",\"description\":\"Four biologic drugs blocking IL-1 are currently available. Of them, anakinra, and canakinumab have been approved for clinical use in Europe, whereas the solubleÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7326122/\",\"favicon\":\"\"},{\"id\":\"144\",\"title\":\"Anakinra Therapy for Non-cancer Inflammatory Diseases - Frontiers\",\"description\":\"Although anakinra is presently in clinical trials to treat cancer, this review focuses on anakinra treatment of acute as well as chronic inflammatory diseases.\",\"url\":\"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2018.01157/full\",\"favicon\":\"\"},{\"id\":\"145\",\"title\":\"JAK inhibition as a therapeutic strategy for immune and ... - NIH\",\"description\":\"First-generation jakinibs block multiple JAKs and therefore inhibit the actions of a large variety of cytokines and several pan-JAK inhibitors continue to beÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC6168198/\",\"favicon\":\"\"},{\"id\":\"146\",\"title\":\"Selectivity, efficacy and safety of JAKinibs: new evidence for a still ...\",\"description\":\"By inhibiting JAK-STAT signalling pathways common to families of cytokines, JAK-inhibitors (JAKinibs) have created a new paradigm for the treatment ofÂ ...\",\"url\":\"https://ard.bmj.com/content/83/2/139\",\"favicon\":\"\"},{\"id\":\"147\",\"title\":\"Selective inhibition of JAK3 signaling is sufficient to reverse alopecia ...\",\"description\":\"Apr 8, 2021 Â· Our study demonstrates inhibiting JAK3 signaling is sufficient to prevent and reverse disease in the preclinical model of AA.\",\"url\":\"https://insight.jci.org/articles/view/142205\",\"favicon\":\"\"},{\"id\":\"148\",\"title\":\"Anticytokine Agents | Circulation Research\",\"description\":\"Jan 31, 2019 Â· This review provides an overview of cytokines in atherosclerosis, the potential benefits and risks associated with targeted anticytokineÂ ...\",\"url\":\"https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.118.313129\",\"favicon\":\"\"},{\"id\":\"149\",\"title\":\"Targets of anticytokine therapy and the risk of infections in humans ...\",\"description\":\"Recent findings: Interleukin-12p40 and interferon-gamma-blockers may lead to increased incidence of infections with intracellular bacteria, parasites, and fungiÂ ...\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/17917545/\",\"favicon\":\"\"},{\"id\":\"150\",\"title\":\"Serious Infections Associated with Anticytokine Therapies in the ...\",\"description\":\"Anti-cytokine therapeutics and infections. ... Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors.\",\"url\":\"https://journals.sagepub.com/doi/10.1177/0885066604267854\",\"favicon\":\"\"},{\"id\":\"151\",\"title\":\"Protein engineering to overcome limitations of key cytokines in ...\",\"description\":\"We highlight protein engineering strategies that address challenges to increase their therapeutic index, such as poor tolerability, short serum half-life andÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S2590018825000243\",\"favicon\":\"\"},{\"id\":\"152\",\"title\":\"A next-generation tumor-targeting IL-2 preferentially promotes tumor ...\",\"description\":\"Aug 28, 2019 Â· In this study, we construct a recombinant IL-2 immunocytokine comprising a tumor-targeting antibody (Ab) and a super mutant IL-2 (sumIL-2) with decreased CD25Â ...Results Â· High Treg Infiltration Might... Â· Cd8 T Cells But Not Nk Cells...\u003c|separator|\u003e\",\"url\":\"https://www.nature.com/articles/s41467-019-11782-w\",\"favicon\":\"\"},{\"id\":\"153\",\"title\":\"Engineered cytokine/antibody fusion proteins improve IL-2 delivery ...\",\"description\":\"Aug 8, 2024 Â· Engineered cytokine/antibody fusion proteins improve IL-2 delivery to pro-inflammatory cells and promote antitumor activity.\",\"url\":\"https://insight.jci.org/articles/view/173469\",\"favicon\":\"\"},{\"id\":\"154\",\"title\":\"Solid tumour CAR-T cells engineered with fusion proteins targeting ...\",\"description\":\"Oct 1, 2025 Â· Our approach uses a single dose of engineered CAR-T cells as a tumour-guided cellular delivery vehicle for Î±PD-L1â€“IL-12 fusions, enablingÂ ...\",\"url\":\"https://www.nature.com/articles/s41551-025-01509-2\",\"favicon\":\"\"},{\"id\":\"155\",\"title\":\"Conversion of natural cytokine receptors into orthogonal synthetic ...\",\"description\":\"Aug 22, 2025 Â· We generated multiple functional, orthogonal synthetic cytokine receptors, identified design principles and constraints and propose guidance forÂ ...\",\"url\":\"https://www.nature.com/articles/s41589-025-01986-1\",\"favicon\":\"\"},{\"id\":\"156\",\"title\":\"IL-18 revives dysfunctional CAR-T cells: Trends in Cancer - Cell Press\",\"description\":\"Jul 7, 2025 Â· IL-18-armored chimeric antigen receptor (CAR)-engineered T (18.CAR-T) cells have demonstrated enhanced antitumor efficacy in lymphoma patients refractory toÂ ...\",\"url\":\"https://www.cell.com/trends/cancer/fulltext/S2405-8033%2825%2900151-7\",\"favicon\":\"\"},{\"id\":\"157\",\"title\":\"Advances in engineering and delivery strategies for cytokine ...\",\"description\":\"Preclinical and clinical research into bioengineering and delivery strategies for cytokines, consisting of bioconjugation, fusion proteins, nanoparticles, andÂ ...\",\"url\":\"https://www.tandfonline.com/doi/abs/10.1080/17425247.2023.2208344\",\"favicon\":\"\"},{\"id\":\"158\",\"title\":\"Engineering cytokine therapeutics - PMC - PubMed Central - NIH\",\"description\":\"Feb 16, 2023 Â· We show that bioengineers can gain and harness knowledge to develop safe, effective cytokine-based therapies for a variety of immune-mediatedÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9933837/\",\"favicon\":\"\"},{\"id\":\"159\",\"title\":\"Interferons - PMC - NIH\",\"description\":\"Interferon was discovered by Alick Isaacs and Jean Lindenmann in 1957. It was originally thought that interferon could be used as a general anti-viral agentÂ ...\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC7123835/\",\"favicon\":\"\"},{\"id\":\"160\",\"title\":\"The Interferons: 50 Years after Their Discovery, There Is Much More ...\",\"description\":\"The interferons (IFNs) and their receptors are a subset of the class 2 Î±-helical cytokines that have existed in early chordates for about 500 million years (1)Â ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S0021925819779939\",\"favicon\":\"\"},{\"id\":\"161\",\"title\":\"TNF and TNF-receptors: From mediators of cell death and ...\",\"description\":\"This review summarizes the current state of knowledge on TNF/TNFR molecules and discusses the reagents currently being used to block TNF in the treatment ofÂ ...\",\"url\":\"https://www.sciencedirect.com/science/article/pii/S1359610114000781\",\"favicon\":\"\"},{\"id\":\"162\",\"title\":\"Discovery of interleukin-2 (IL-2) | NIH Intramural Research Program\",\"description\":\"Aug 11, 2023 Â· Discovery of interleukin-2 (IL-2). 1976. Challenge. In the 1970s, researchers sought to define whether retroviruses are causative agents ofÂ ...\",\"url\":\"https://irp.nih.gov/accomplishments/discovery-of-interleukin-2-il-2\",\"favicon\":\"\"},{\"id\":\"163\",\"title\":\"Cytokines: past, present, and future - PubMed\",\"description\":\"This review provides an historical account of the discovery and development of cytokines. Cytokines are soluble extracellular proteins or glycoproteins.\",\"url\":\"https://pubmed.ncbi.nlm.nih.gov/11530802/\",\"favicon\":\"\"},{\"id\":\"164\",\"title\":\"Redefining the ancestral origins of the interleukin-1 superfamily\",\"description\":\"Mar 20, 2018 Â· The IL-1 ligands have a different evolutionary history. The first proto-IL-1Î² gene coincided with proto-IL-1R1 and duplication events resultedÂ ...\",\"url\":\"https://www.nature.com/articles/s41467-018-03362-1\",\"favicon\":\"\"},{\"id\":\"165\",\"title\":\"Evolution of Î³ chain cytokines: Mechanisms, methods and applications\",\"description\":\"In this review, we summarise the evolutionary mechanisms that gave rise to the characteristically diverse family of Î³ chain cytokines.\",\"url\":\"https://pmc.ncbi.nlm.nih.gov/articles/PMC9465101/\",\"favicon\":\"\"}],\"images\":[{\"id\":\"73eb0e839104\",\"caption\":\"Cytokine release from immune cells\",\"url\":\"./_assets_/Cytokine_release.jpg\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"f9be2d24f204\",\"caption\":\"A scalable vector graphic of signal transduction pathways\",\"url\":\"./_assets_/Signal_transduction_pathways.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"73eb0e839104\",\"caption\":\"\",\"url\":\"./_assets_/Cytokine_release.jpg\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"73eb0e839104\",\"caption\":\"Cytokine release during acute inflammation\",\"url\":\"./_assets_/Cytokine_release.jpg\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"f9be2d24f204\",\"caption\":\"A scalable vector graphic of signal transduction pathways\",\"url\":\"./_assets_/Signal_transduction_pathways.svg.png\",\"position\":\"CENTER\",\"width\":0,\"height\":0},{\"id\":\"73eb0e839104\",\"caption\":\"Cytokine release in immune response\",\"url\":\"./_assets_/Cytokine_release.jpg\",\"position\":\"CENTER\",\"width\":0,\"height\":0}],\"fixedIssues\":[],\"slug\":\"Cytokine\",\"title\":\"Cytokine\",\"content\":\"$1f\",\"description\":\"Cytokine\\n\\nCytokine release from immune cells\\nCytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling...\",\"metadata\":{\"categories\":[],\"lastModified\":\"1761584844\",\"contentLength\":\"86290\",\"version\":\"1.0\",\"lastEditor\":\"system\",\"language\":\"en\",\"isRedirect\":false,\"redirectTarget\":\"\",\"isWithheld\":false},\"stats\":{\"totalViews\":\"232359\",\"recentViews\":\"232359\",\"dailyAvgViews\":7745.2998046875,\"qualityScore\":1,\"lastViewed\":\"1761886747\"},\"linkedPages\":null},\"found\":true},\"dataUpdateCount\":1,\"dataUpdatedAt\":1761886747340,\"error\":null,\"errorUpdateCount\":0,\"errorUpdatedAt\":0,\"fetchFailureCount\":0,\"fetchFailureReason\":null,\"fetchMeta\":null,\"isInvalidated\":false,\"status\":\"success\",\"fetchStatus\":\"idle\"},\"queryKey\":[\"page\",\"Cytokine\"],\"queryHash\":\"[\\\"page\\\",\\\"Cytokine\\\"]\"}]},\"children\":\"$L20\"}]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"c:{\"metadata\":[[\"$\",\"title\",\"0\",{\"children\":\"Cytokine\"}],[\"$\",\"meta\",\"1\",{\"name\":\"description\",\"content\":\"Cytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis. Produced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which...\"}],[\"$\",\"meta\",\"2\",{\"name\":\"author\",\"content\":\"system\"}],[\"$\",\"link\",\"3\",{\"rel\":\"manifest\",\"href\":\"/manifest.webmanifest\",\"crossOrigin\":\"$undefined\"}],[\"$\",\"meta\",\"4\",{\"name\":\"robots\",\"content\":\"index, follow\"}],[\"$\",\"meta\",\"5\",{\"name\":\"googlebot\",\"content\":\"index, follow, max-snippet:-1\"}],[\"$\",\"link\",\"6\",{\"rel\":\"canonical\",\"href\":\"https://grokipedia.com/page/Cytokine\"}],[\"$\",\"meta\",\"7\",{\"property\":\"og:title\",\"content\":\"Cytokine\"}],[\"$\",\"meta\",\"8\",{\"property\":\"og:description\",\"content\":\"Cytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis. Produced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which...\"}],[\"$\",\"meta\",\"9\",{\"property\":\"og:url\",\"content\":\"https://grokipedia.com/page/Cytokine\"}],[\"$\",\"meta\",\"10\",{\"property\":\"og:site_name\",\"content\":\"Grokipedia\"}],[\"$\",\"meta\",\"11\",{\"property\":\"og:locale\",\"content\":\"en\"}],[\"$\",\"meta\",\"12\",{\"property\":\"og:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"meta\",\"13\",{\"property\":\"og:image:width\",\"content\":\"512\"}],[\"$\",\"meta\",\"14\",{\"property\":\"og:image:height\",\"content\":\"512\"}],[\"$\",\"meta\",\"15\",{\"property\":\"og:image:alt\",\"content\":\"Cytokine\"}],[\"$\",\"meta\",\"16\",{\"property\":\"og:type\",\"content\":\"article\"}],[\"$\",\"meta\",\"17\",{\"property\":\"article:modified_time\",\"content\":\"1970-01-21T09:19:44.844Z\"}],[\"$\",\"meta\",\"18\",{\"name\":\"twitter:card\",\"content\":\"summary\"}],[\"$\",\"meta\",\"19\",{\"name\":\"twitter:creator\",\"content\":\"@Grokipedia\"}],[\"$\",\"meta\",\"20\",{\"name\":\"twitter:title\",\"content\":\"Cytokine\"}],[\"$\",\"meta\",\"21\",{\"name\":\"twitter:description\",\"content\":\"Cytokines are a broad class of small, secreted proteins, generally ranging from 5 to 25 kilodaltons in molecular weight, that function as key signaling molecules in intercellular communication, primarily coordinating immune responses, inflammation, and hematopoiesis. Produced by diverse cell types including immune cells, endothelial cells, and fibroblasts, cytokines exert their effects through paracrine, autocrine, or endocrine mechanisms by binding to specific cell-surface receptors, which...\"}],[\"$\",\"meta\",\"22\",{\"name\":\"twitter:image\",\"content\":\"https://grokipedia.com/icon-512x512.png\"}],[\"$\",\"link\",\"23\",{\"rel\":\"icon\",\"href\":\"/favicon.ico\",\"type\":\"image/x-icon\",\"sizes\":\"16x16\"}],[\"$\",\"$L21\",\"24\",{}]],\"error\":null,\"digest\":\"$undefined\"}\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"11:\"$c:metadata\"\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"22:I[61172,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"PageEditorProvider\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"23:I[63493,[\"8739\",\"static/chunks/63f0ec43-8ee6a76d70472249.js\",\"2254\",\"static/chunks/8208b75a-a48e5a4507a0de91.js\",\"4684\",\"static/chunks/24cf1b50-159cca90b09285e0.js\",\"1829\",\"static/chunks/9ffa21ba-c069766d809bd4c7.js\",\"7670\",\"static/chunks/7670-7326298c9856172b.js\",\"282\",\"static/chunks/282-691fffb366e24ca5.js\",\"7515\",\"static/chunks/7515-336759ef5dad2b52.js\",\"5497\",\"static/chunks/5497-ab85ef3ea59dd353.js\",\"7720\",\"static/chunks/7720-3a1e7e411adba2d3.js\",\"6281\",\"static/chunks/6281-c6e84786dade3614.js\",\"7086\",\"static/chunks/7086-1f1c4891d766e04f.js\",\"600\",\"static/chunks/600-9a9fcafaaa6c1c4c.js\",\"5002\",\"static/chunks/5002-9735c25beda556ba.js\",\"5448\",\"static/chunks/5448-2a3cfd853d899c9a.js\",\"5855\",\"static/chunks/5855-243eeca8f0e4cabd.js\",\"4393\",\"static/chunks/4393-1c8dff25ec904469.js\",\"9214\",\"static/chunks/9214-a10614844a67ba31.js\",\"8\",\"static/chunks/8-8ca70ca619d8e099.js\",\"4789\",\"static/chunks/4789-2080f6497f78b5b6.js\",\"6304\",\"static/chunks/app/page/%5Bslug%5D/page-540a27b6839afde5.js\"],\"default\"]\n"])</script><script nonce="ODE3Yjg0OTgtMzQ5YS00NzU3LTk3NjUtMTg5ZDA3ODg2ODRm">self.__next_f.push([1,"20:[\"$\",\"$L22\",null,{\"children\":[\"$\",\"$L23\",null,{\"slug\":\"Cytokine\"}]}]\n"])</script></body></html>